Skip to main content
PMC home page
Bacteriological Reviews logoLink to Bacteriological Reviews
. 1977 Mar;41(1):217–372. doi: 10.1128/br.41.1.217-372.1977

Mycobacterium.

L Barksdale, K S Kim
PMCID: PMC414000  PMID: 67839

Full text

PDF
217

Images in this article

226Image
on p.226
228Image
on p.228
229Image
on p.229
232Image
on p.232
233Image
on p.233
234Image
on p.234
236Image
on p.236
237Image
on p.237
240Image
on p.240
247Image
on p.247
248Image
on p.248
260Image
on p.260
271Image
on p.271
272Image
on p.272
273Image
on p.273
274Image
on p.274
275Image
on p.275
276Image
on p.276
314Image
on p.314
315Image
on p.315
316Image
on p.316

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AEBI A., ASSELINEAU J., LEDERER E. Sur les lipides de la souche humaine Brevannes. de Mycobacterium tuberculosis. Bull Soc Chim Biol (Paris) 1953;35(7):661–684. [PubMed] [Google Scholar]
  2. AGUILAR P. L., ITURRIBARRIA F. M., MIDDLEBROOK G. Un caso de infeccior humana por Mycobacterium ulcerans en el hemisferio occidental; nota previa. Int J Lepr. 1953 Oct-Dec;21(41):469–476. [PubMed] [Google Scholar]
  3. AKAMATSU Y., NOJIMA S. SEPARATION AND ANALYSES OF THE INDIVIDUAL PHOSPHOLIPIDS OF MYCOBACTERIA. J Biochem. 1965 Mar;57:430–439. doi: 10.1093/oxfordjournals.jbchem.a128097. [DOI] [PubMed] [Google Scholar]
  4. ALLEN S. H., JACOBSON B. E., STJERNHOLM R. BIOCYTIN AS A CONSTITUENT OF METHYLMALONYL-OXALACETIC TRANSCARBOXYLASE AND PROPIONYL COA CARBOXYLASE OF BACTERIAL ORIGIN. Arch Biochem Biophys. 1964 Jun;105:494–500. doi: 10.1016/0003-9861(64)90041-4. [DOI] [PubMed] [Google Scholar]
  5. ANDERSON E. S., FELIX A. The Vi type-determining phages carried by Salmonella typhi. J Gen Microbiol. 1953 Aug;9(1):65–88. doi: 10.1099/00221287-9-1-65. [DOI] [PubMed] [Google Scholar]
  6. ANDERSON J. S., MATSUHASHI M., HASKIN M. A., STROMINGER J. L. LIPID-PHOSPHOACETYLMURAMYL-PENTAPEPTIDE AND LIPID-PHOSPHODISACCHARIDE-PENTAPEPTIDE: PRESUMED MEMBRANE TRANSPORT INTERMEDIATES IN CELL WALL SYNTHESIS. Proc Natl Acad Sci U S A. 1965 Apr;53:881–889. doi: 10.1073/pnas.53.4.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. ANDERSON T. F. The morphology and osmotic properties of bacteriophage systems. Cold Spring Harb Symp Quant Biol. 1953;18:197–203. doi: 10.1101/sqb.1953.018.01.030. [DOI] [PubMed] [Google Scholar]
  8. ASSELINEAU J., BLOCH H., LEDERER E. Synthesis of cord factor-active substances. Biochim Biophys Acta. 1954 Sep;15(1):136–137. doi: 10.1016/0006-3002(54)90103-1. [DOI] [PubMed] [Google Scholar]
  9. ASSELINEAU J., LEDERER E. Sur la constitution chimique des acides mycoliques de deux souches humaines virulentes de Mycobacterium tuberculosis. Biochim Biophys Acta. 1951 May;7(1):126–145. doi: 10.1016/0006-3002(51)90011-x. [DOI] [PubMed] [Google Scholar]
  10. ASSELINEAU J. [On the composition of the lipids of Corynebacterium diphtheriae]. Biochim Biophys Acta. 1961 Dec 9;54:359–360. doi: 10.1016/0006-3002(61)90379-1. [DOI] [PubMed] [Google Scholar]
  11. AZUMA I., YAMAMURA Y. Studies on the firmly bound lipids of human tubercle bacillus. I. Isolation of arabinose mycolate. J Biochem. 1962 Sep;52:200–206. doi: 10.1093/oxfordjournals.jbchem.a127597. [DOI] [PubMed] [Google Scholar]
  12. AZUMA I., YAMAMURA Y. Studies on the firmly bound lipids of human tubercle bacillus. J Biochem. 1963 Apr;53:275–281. [PubMed] [Google Scholar]
  13. Aaronson C. M., Park C. H. Sporotrichoid infection due to Mycobacterium marinum: lesion exacerbated by corticosteroid infiltration. South Med J. 1974 Jan;67(1):117–118. doi: 10.1097/00007611-197401000-00029. [DOI] [PubMed] [Google Scholar]
  14. Abrahams E. W. 'Original mycobacterial sin'. Tubercle. 1970 Sep;51(3):316–321. doi: 10.1016/0041-3879(70)90026-7. [DOI] [PubMed] [Google Scholar]
  15. Acharya P. V., Goldman D. S. Chemical composition of the cell wall of the H37Ra strain of Mycobacterium tuberculosis. J Bacteriol. 1970 Jun;102(3):733–739. doi: 10.1128/jb.102.3.733-739.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Adam A., Ciorbaru R., Ellouz F., Petit J. F., Lederer E. Adjuvant activity of monomeric bacterial cell wall peptidoglycans. Biochem Biophys Res Commun. 1974 Feb 4;56(3):561–567. doi: 10.1016/0006-291x(74)90640-8. [DOI] [PubMed] [Google Scholar]
  17. Adam A., Ciorbaru R., Petit J. F., Lederer E., Chedid L., Lamensans A., Parant F., Parant M., Rosselet J. P., Berger F. M. Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca. Infect Immun. 1973 Jun;7(6):855–861. doi: 10.1128/iai.7.6.855-861.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Adam A., Ciorbaru R., Petit J. F., Lederer E. Isolation and properties of a macromolecular, water-soluble, immuno-adjuvant fraction from the cell wall of Mycobacterium smegmatis. Proc Natl Acad Sci U S A. 1972 Apr;69(4):851–854. doi: 10.1073/pnas.69.4.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Adam A., Petit J. F., Wietzerbin-Falszpan J., Sinay P., Thomas D. W., Lederer E. L'acide N-glycolyl-muramique, constituant des parois de Mycobacterium smegmatis: Identification par spectrometrie de masse. FEBS Lett. 1969 Jul;4(2):87–92. doi: 10.1016/0014-5793(69)80203-6. [DOI] [PubMed] [Google Scholar]
  20. Adams R. M., Remington J. S., Steinberg J., Seibert J. S. Tropical fish aquariums. A source of Mycobacterium marinum infections resembling sporotrichosis. JAMA. 1970 Jan 19;211(3):457–461. doi: 10.1001/jama.211.3.457. [DOI] [PubMed] [Google Scholar]
  21. Adámek L., Trnka L., Mion P., Gutová M. Hemmstoffe vom Bakteriocin-Typus bei schnell wachsenden saphrophytischen Stämmen der Mycobakterien. Beitr Klin Erforsch Tuberk Lungenkr. 1968;138(1):51–55. [PubMed] [Google Scholar]
  22. Affronti L. F., Fife E. H., Grow L. Serodiagnostic test for tuberculosis. Am Rev Respir Dis. 1973 May;107(5):822–825. doi: 10.1164/arrd.1973.107.5.822. [DOI] [PubMed] [Google Scholar]
  23. Affronti L. F., Seibert F. B. Some early investigations of Mycobacterium tuberculosis. Am Rev Respir Dis. 1965 Dec;92(6):1–8. doi: 10.1164/arrd.1965.92.6P2.1. [DOI] [PubMed] [Google Scholar]
  24. Affronti L. F., Wright G. L., Jr, Reich M. Characterization and comparison of mycobacterial antigens by discontinuous pore gradient gel electrophoresis. Infect Immun. 1972 Apr;5(4):474–481. doi: 10.1128/iai.5.4.474-481.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Aho K., Brander E., Estola T. Agglutinins against group 3 atypical mycobacteria. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Oct;81(5):589–592. doi: 10.1111/j.1699-0463.1973.tb02248.x. [DOI] [PubMed] [Google Scholar]
  26. Akamatsu Y., Law J. H. Enzymatic alkylenation of phospholipid fatty acid chains by extracts of Mycobacterium phlei. J Biol Chem. 1970 Feb 25;245(4):701–708. [PubMed] [Google Scholar]
  27. Akamatsu Y., Law J. H. Enzymatic synthesis of 10-methylene stearic acid and tuberculostearic acid. Biochem Biophys Res Commun. 1968 Oct 10;33(1):172–176. doi: 10.1016/0006-291x(68)90274-x. [DOI] [PubMed] [Google Scholar]
  28. Akamatsu Y., Law J. H. The enzymatic synthesis of fatty acid methyl esters by carboxyl group alkylation. J Biol Chem. 1970 Feb 25;245(4):709–713. [PubMed] [Google Scholar]
  29. Akamatsu Y., Ono Y., Nojima S. Phospholipid patterns in subcellular fractions of Mycobacterium phlei. J Biochem. 1966 Feb;59(2):176–182. doi: 10.1093/oxfordjournals.jbchem.a128279. [DOI] [PubMed] [Google Scholar]
  30. Akamatsu Y., Ono Y., Nojima S. Studies on the metabolism of phospholipids in Mycobacterium phlei. I. Difference in turnover rates of individual phospholipids. J Biochem. 1967 Jan;61(1):96–102. doi: 10.1093/oxfordjournals.jbchem.a128525. [DOI] [PubMed] [Google Scholar]
  31. Ali A. J., Oakley C. L. Auto-antibodies in experimental chronic infective disease. J Pathol Bacteriol. 1967 Apr;93(2):413–433. doi: 10.1002/path.1700930203. [DOI] [PubMed] [Google Scholar]
  32. Allison A. C., Davies A. J. Requirement of thymus-dependent lymphocytes for potentiation by adjuvants of antibody formation. Nature. 1971 Oct 1;233(5318):330–332. doi: 10.1038/233330a0. [DOI] [PubMed] [Google Scholar]
  33. Allwood G. G., Asherson G. L. Depression of delayed hypersensitivity by pretreatment with Freund-type adjuvants. II. Mechanism of the phenomenon. Clin Exp Immunol. 1971 Aug;9(2):259–266. [PMC free article] [PubMed] [Google Scholar]
  34. Alsaadi A. I., Smith D. W. The fate of virulent and attenuated Mycobacteria in guinea pigs infected by the respiratory route. Am Rev Respir Dis. 1973 Jun;107(6):1041–1046. doi: 10.1164/arrd.1973.107.6.1041. [DOI] [PubMed] [Google Scholar]
  35. Alsop D. G. The bairnsdale ulcer. Aust N Z J Surg. 1972 May;41(4):317–319. [PubMed] [Google Scholar]
  36. Altman L. J., Ash L., Kowerski R. C., Epstein W. W., Larsen B. R., Rilling H. C., Muscio F., Gregonis D. E. Prephytoene pyrophosphate. A new intermediate in the biosynthesis of carotenoids. J Am Chem Soc. 1972 May 3;94(9):3257–3259. doi: 10.1021/ja00764a073. [DOI] [PubMed] [Google Scholar]
  37. Amar-Nacasch C., Vilkas E. Des parois de Mycobacterium tuberculosis. II. Mise en évidence d'un mycolate d'arabinobiose et d'un glucane dans les parois de M. tuberculosis H37 Ra. Bull Soc Chim Biol (Paris) 1970 Mar 31;52(2):145–151. [PubMed] [Google Scholar]
  38. Amar-Nacasch C., Vilkas E. Etude des parois d'une souche humaine virulente de Mycobacterium tuberculosis. 1. Préparation et analyse chimique. Bull Soc Chim Biol (Paris) 1969 Jul 25;51(3):613–620. [PubMed] [Google Scholar]
  39. Amar C., Vilkas E. Isolement d'un phosphate d'arabinose à partir des parois de Mycobacterium tuberculosis, H 37 Ra. C R Acad Sci Hebd Seances Acad Sci D. 1973 Nov 5;277(18):1949–1951. [PubMed] [Google Scholar]
  40. Amos H. E., Gurner B. W., Olds R. J., Coombs R. R. Passive sensitization of tissue cells. II. Ability of cytophilic antibody to render the migration of guinea pig peritoneal exudate cells inhibitable by antigen. Int Arch Allergy Appl Immunol. 1967;32(5):496–505. [PubMed] [Google Scholar]
  41. Anderson L. C., Binz H., Wigzell H. Specific unresponsiveness to transplantation antigens induced by auto-immunisation with syngeneic, antigen-specific T lymphoblasts. Nature. 1976 Dec 23;264(5588):778–780. doi: 10.1038/264778a0. [DOI] [PubMed] [Google Scholar]
  42. Anderson R. G., Hussey H., Baddiley J. The mechanism of wall synthesis in bacteria. The organization of enzymes and isoprenoid phosphates in the membrane. Biochem J. 1972 Mar;127(1):11–25. doi: 10.1042/bj1270011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ando M., Dannenberg A. M., Jr, Shima K. Macrophage accumulation, division, maturation and digestive and microbicidal capacities in tuberculous lesions. II. Rate at which mononuclear cells enter and divide in primary BCG lesions and those of reinfection. J Immunol. 1972 Jul;109(1):8–19. [PubMed] [Google Scholar]
  44. Ando M. Macrophage activation in tuberculin reactions of rabbits with primary BCG infection and reinfection. J Reticuloendothel Soc. 1973 Aug;14(2):132–145. [PubMed] [Google Scholar]
  45. Andrejew A., Renard A. Essai de séparation des activités catalasique et peroxydasique chez les Mycobactéries. Ann Inst Pasteur (Paris) 1968 Jul;115(1):3–10. [PubMed] [Google Scholar]
  46. Antoine A. D., Tepper B. S. Environmental control of glycogen and lipid content of Mycobacterium phlei. J Gen Microbiol. 1969 Feb;55(2):217–226. doi: 10.1099/00221287-55-2-217. [DOI] [PubMed] [Google Scholar]
  47. Antoine A. D., Tepper B. S. Environmental control of glycogen and lipid content of Mycobacterium tuberculosis. J Bacteriol. 1969 Oct;100(1):538–539. doi: 10.1128/jb.100.1.538-539.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Anz W., Meissner G., Röder U. Serologische Untersuchungen an atypischen Mycobakterien mittels der Agglutinationsmethode. Zentralbl Bakteriol Orig. 1969;211(4):530–550. [PubMed] [Google Scholar]
  49. Anz W., Meissner G. Vergleichende Virulenzprüfungen am Huhn von transparenten und opaken Kolonien aus Stämmen der aviaären Mykobakteriengruppe verschiedener Serotypen. Zentralbl Bakteriol Orig A. 1972 Aug;221(3):334–342. [PubMed] [Google Scholar]
  50. Arber W., Linn S. DNA modification and restriction. Annu Rev Biochem. 1969;38:467–500. doi: 10.1146/annurev.bi.38.070169.002343. [DOI] [PubMed] [Google Scholar]
  51. Armstrong J. A., Hart P. D. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival. J Exp Med. 1975 Jul 1;142(1):1–16. doi: 10.1084/jem.142.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Asano A., Cohen N. S., Baker R. F., Brodie A. F. Orientation of the cell membrane in ghosts and electron transport particles of Mycobacterium phlei. J Biol Chem. 1973 May 25;248(10):3386–3397. [PubMed] [Google Scholar]
  53. Asherson G. L., Allwood G. G. Depression of delayed hypersensitivity by pretreatment with Freund-type adjuvants. I. Description of the phenomenon. Clin Exp Immunol. 1971 Aug;9(2):249–258. [PMC free article] [PubMed] [Google Scholar]
  54. Asselineau C. P., Lacave C. S., Montrozier H. L., Promé J. C. Relations structurales entre les acides mycoliques insaturés et les acides inférieurs insaturés synthétisés par Mycobacterium phlei. Implications métaboliques. Eur J Biochem. 1970 Jul;14(3):406–410. doi: 10.1111/j.1432-1033.1970.tb00304.x. [DOI] [PubMed] [Google Scholar]
  55. Asselineau J., Kato M. Chemical structure and biochemical activity of cord factor analogs. 2. Relationships between activity and stereochemistry of the sugar moiety. Biochimie. 1973 May;55(5):559–568. doi: 10.1016/s0300-9084(73)80416-x. [DOI] [PubMed] [Google Scholar]
  56. Audibert F., Chédid L., Lefrancier P., Choay J. Distinctive adjuvanticity of synthetic analogs of mycobacterial water-soluble components. Cell Immunol. 1976 Feb;21(2):243–249. doi: 10.1016/0008-8749(76)90053-8. [DOI] [PubMed] [Google Scholar]
  57. Ayling J., Pirson R., Lynen F. Participation of covalently linked fatty acyl coenzyme A products in the action of yeast fatty acid synthetase. Biochemistry. 1972 Feb 15;11(4):526–533. doi: 10.1021/bi00754a007. [DOI] [PubMed] [Google Scholar]
  58. Azuma I., Ajisaka M., Yamamura Y. Polysaccharides of Mycobacterium bovis Ushi 10, Mycobacterium smegmatis, Mycobacterium phlei, and Atypical Mycobacterium P1. Infect Immun. 1970 Sep;2(3):347–349. doi: 10.1128/iai.2.3.347-349.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Azuma I., Kanetsuna F., Tanaka Y., Mera M., Yanagihara Y. Partial chemical characterization of the cell wall of Nocardia asteroides strain 131. Jpn J Microbiol. 1973 Mar;17(2):154–159. doi: 10.1111/j.1348-0421.1973.tb00720.x. [DOI] [PubMed] [Google Scholar]
  60. Azuma I., Kanetsuna F., Taniyama T., Yamamura Y., Hori M. Adjuvant activity of mycobacterial fractions. I. Purification and in vivo adjuvant activity of cell wall skeletons of Mycobacterium bovis BCG, Nocardia asteroides 131 and Corynebacterium diphtheriae PW8. Biken J. 1975 Mar;18(1):1–13. [PubMed] [Google Scholar]
  61. Azuma I., Kishimoto S., Yamamura Y., Petit J. F. Adjuvanticity of mycobacterial cell walls. Jpn J Microbiol. 1971 Mar;15(2):193–197. doi: 10.1111/j.1348-0421.1971.tb00569.x. [DOI] [PubMed] [Google Scholar]
  62. Azuma I., Ouchida A., Taniyama T., Yamamura Y., Shoji K. The mycolic acids of Mycobacterium rhodochrous and Nocardia corallina. Biken J. 1974 Mar;17(1):1–9. [PubMed] [Google Scholar]
  63. Azuma I., Ribi E. E., Meyer T. J., Zbar B. Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3. J Natl Cancer Inst. 1974 Jan;52(1):95–101. doi: 10.1093/jnci/52.1.95. [DOI] [PubMed] [Google Scholar]
  64. Azuma I., Thomas D. W., Adam A., Ghuysen J. M., Bonaly R., Petit J. F., Lederer E. Occurrence of N-glycolylmuramic acid in bacterial cell walls. A preliminary survey. Biochim Biophys Acta. 1970 Jun;208(3):444–451. doi: 10.1016/0304-4165(70)90217-5. [DOI] [PubMed] [Google Scholar]
  65. Azuma I., Yamamura Y., Fukushi K. Fractionation of mycobacterial cell wall. Isolation of arabinose mycolate and arabinogalactan from cell wall fraction of Mycobacterium tuberculosis strain Aoyama B. J Bacteriol. 1968 Nov;96(5):1885–1887. doi: 10.1128/jb.96.5.1885-1887.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Azuma I., Yamamura Y., Misaki A. Isolation and characterization of arabinose mycolate from firmly bound lipids of mycobacteria. J Bacteriol. 1969 Apr;98(1):331–333. doi: 10.1128/jb.98.1.331-333.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. BAER H., CHAPARAS S. D. The immunology and chemistry of tuberculin. I. The isolation of dialyzable and nondialyzable tuberculin-active components from unheated BCG culture filtrates. Am Rev Respir Dis. 1963 Jul;88:28–32. doi: 10.1164/arrd.1963.88.1.28. [DOI] [PubMed] [Google Scholar]
  68. BAIN B., VAS M. R., LOWENSTEIN L. THE DEVELOPMENT OF LARGE IMMATURE MONONUCLEAR CELLS IN MIXED LEUKOCYTE CULTURES. Blood. 1964 Jan;23:108–116. [PubMed] [Google Scholar]
  69. BALLOU C. E., LEE Y. C. THE STRUCTURE OF A MYOINOSITOL MANNOSIDE FROM MYCOBACTERIUM TUBERCULOSIS GLYCOLIPID. Biochemistry. 1964 May;3:682–685. doi: 10.1021/bi00893a014. [DOI] [PubMed] [Google Scholar]
  70. BALLOU C. E., VILKAS E., LEDERER E. Structural studies on the myo-inositol phospholipids of Mycobacterium tuberculosis (var. bovis, strain BCG). J Biol Chem. 1963 Jan;238:69–76. [PubMed] [Google Scholar]
  71. BATRA P. P., RILLING H. C. ON THE MECHANISM OF PHOTOINDUCED CAROTENOID SYNTHESIS: ASPECTS OF THE PHOTOINDUCTIVE REACTION. Arch Biochem Biophys. 1964 Sep;107:485–492. doi: 10.1016/0003-9861(64)90305-4. [DOI] [PubMed] [Google Scholar]
  72. BECK A. MYCOBACTERIUM FORTUITUM IN ABSCESSES OF MAN. J Clin Pathol. 1965 May;18:307–313. doi: 10.1136/jcp.18.3.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. BENACERRAF B., OVARY Z., BLOCH K. J., FRANKLIN E. C. Properties of guinea pig 7S antibodies. I. Electrophoretic separation of two types of guinea pig 7S antibodies. J Exp Med. 1963 Jun 1;117:937–949. doi: 10.1084/jem.117.6.937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. BERG J. W. Acid-fastness as a histochemical test. J Histochem Cytochem. 1953 Nov;1(6):436–441. doi: 10.1177/1.6.436. [DOI] [PubMed] [Google Scholar]
  75. BERG J. W. An acid-fast lipid from spermatozoa. AMA Arch Pathol. 1954 Feb;57(2):115–120. [PubMed] [Google Scholar]
  76. BERG J. W. Chemistry of acid-fastness. Proc Soc Exp Biol Med. 1953 Oct;84(1):196–198. doi: 10.3181/00379727-84-20588. [DOI] [PubMed] [Google Scholar]
  77. BERG J. W. The dual nature of acid-fastness. Yale J Biol Med. 1953 Dec;26(3):215–223. [PMC free article] [PubMed] [Google Scholar]
  78. BLOCH H., DEFAYE J., LEDERER E., NOLL H. Constituents of a toxic-lipid obtained from Mycobacterium tuberculosis. Biochim Biophys Acta. 1957 Feb;23(2):312–321. doi: 10.1016/0006-3002(57)90333-5. [DOI] [PubMed] [Google Scholar]
  79. BLOCH H., SEGAL W. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro. J Bacteriol. 1956 Aug;72(2):132–141. doi: 10.1128/jb.72.2.132-141.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. BLOCH K. J., KOURILSKY F. M., OVARY Z., BENACERRAF B. Properties of guinea pig 7S antibodies. III. Identification of antibodies involved in complement fixation and hemolysis. J Exp Med. 1963 Jun 1;117:965–981. doi: 10.1084/jem.117.6.965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. BOENICKSE R., JUHASZ E. BESCHREIBUNG DER NEUEN SPECIES MYCOBACTERIUM VACCAE N. SP. Zentralbl Bakteriol Orig. 1964 Feb;192:133–135. [PubMed] [Google Scholar]
  82. BOJALIL L. F., CERBON J., TRUJILLO A. Adansonian classification of mycobacteria. J Gen Microbiol. 1962 Jun;28:333–346. doi: 10.1099/00221287-28-2-333. [DOI] [PubMed] [Google Scholar]
  83. BOWMAN B. U., Jr, REDMOND W. B. A temperate bacteriophage from Mycobacterium butyricum. Am Rev Respir Dis. 1959 Aug;80:232–239. doi: 10.1164/arrd.1959.80.2.232. [DOI] [PubMed] [Google Scholar]
  84. BOWMAN B., Jr Quantitative studies on some mycobacterial phage-host systems. J Bacteriol. 1958 Jul;76(1):52–62. doi: 10.1128/jb.76.1.52-62.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. BOYDEN S. V. CYTOPHILIC ANTIBODY IN GUINEA-PIGS WITH DELAYED-TYPE HYPERSENSITIVITY. Immunology. 1964 Jul;7:474–483. [PMC free article] [PubMed] [Google Scholar]
  86. BOYDEN S. V., SORKIN E. The adsorption of antigen by spleen cells previously treated with antiserum in vitro. Immunology. 1960 Jul;3:272–283. [PMC free article] [PubMed] [Google Scholar]
  87. BRODY J. A., OVERFIELD T., HAMMES L. M. DEPRESSION OF THE TUBERCULIN REACTION BY VIRAL VACCINES. N Engl J Med. 1964 Dec 17;271:1294–1296. doi: 10.1056/NEJM196412172712505. [DOI] [PubMed] [Google Scholar]
  88. BUHLER V. B., POLLAK A. Human infection with atypical acid-fast organisms; report of two cases with pathologic findings. Am J Clin Pathol. 1953 Apr;23(4):363–374. doi: 10.1093/ajcp/23.4.363. [DOI] [PubMed] [Google Scholar]
  89. Bach F. H., Rood J. J. The major histocompatibility complex--genetics and biology (second of three parts). N Engl J Med. 1976 Oct 14;295(16):872–878. doi: 10.1056/NEJM197610142951606. [DOI] [PubMed] [Google Scholar]
  90. Baess I., Bentzon M. W. Rapidly-growing mycobacteria. Susceptibility to bacteriophages, reactions in the amidase test, production of acid from carbohydrates, and growth at various temperatures. Acta Pathol Microbiol Scand. 1969;75(2):331–347. [PubMed] [Google Scholar]
  91. Baess I. Report on a pseudolysogenic mycobacterium and a review of the literature concerning pseudolysogeny. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;79(3):428–434. doi: 10.1111/j.1699-0463.1971.tb00084.x. [DOI] [PubMed] [Google Scholar]
  92. Baess I. Subdivision of M. tuberculosis by means of bacteriophages. With special reference to epidemiological studies. Acta Pathol Microbiol Scand. 1969;76(3):464–474. [PubMed] [Google Scholar]
  93. Bailey R. K., Wyles S., Dingley M., Hesse F., Kent G. W. The isolation of high catalase Mycobacterium kansasii from tap water. Am Rev Respir Dis. 1970 Mar;101(3):430–431. doi: 10.1164/arrd.1970.101.3.430. [DOI] [PubMed] [Google Scholar]
  94. Baker J. A. LIGHT AS A FACTOR IN THE PRODUCTION OF PIGMENT BY CERTAIN BACTERIA. J Bacteriol. 1938 Jun;35(6):625–631. doi: 10.1128/jb.35.6.625-631.1938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Baker P. J., Reed N. D., Stashak P. W., Amsbaugh D. F., Prescott B. Regulation of the antibody response to type 3 pneumococcal polysaccharide. I. Nature of regulatory cells. J Exp Med. 1973 Jun 1;137(6):1431–1441. doi: 10.1084/jem.137.6.1431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Baker R. E., Hill W. E., Larson C. L. Ribosomes of acid-fast bacilli: immunogenicity, serology, and in vitro correlates of delayed hypersensitivity. Infect Immun. 1973 Aug;8(2):236–244. doi: 10.1128/iai.8.2.236-244.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Baldwin J. H. Pulmonary bovine tuberculosis in an owner and in his dairy herd. Cornell Vet. 1968 Jan;58(1):81–87. [PubMed] [Google Scholar]
  98. Baldwin R. W., Pimm M. V. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas. Rev Eur Etud Clin Biol. 1971 Nov;16(9):875–881. [PubMed] [Google Scholar]
  99. Banerjee R., Hall R., Hughes G. R. Pulmonary Mycobacterium fortuitum infection in association with achalasia of the oesophagus. Case report and review of the literature. Br J Dis Chest. 1970 Apr;64(2):112–118. doi: 10.1016/s0007-0971(70)80038-9. [DOI] [PubMed] [Google Scholar]
  100. Baram P., Soltysik L., Condoulis W. The in vitro assay of tuberculin hypersensitivity in Macaca mulatta sensitized with bacille Calmette Guerin cell wall vaccine and-or infected with virulent Mycobacterium tuberculosis. Lab Anim Sci. 1971 Oct;21(5):727–733. [PubMed] [Google Scholar]
  101. Bardana E. J., Jr, McClatchy J. K., Farr R. S., Minden P. Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals. Clin Exp Immunol. 1973 Jan;13(1):65–77. [PMC free article] [PubMed] [Google Scholar]
  102. Barker D. J. Buruli disease in a district of Uganda. J Trop Med Hyg. 1971 Dec;74(12):260–264. [PubMed] [Google Scholar]
  103. Barksdale L., Arden S. B. Persisting bacteriophage infections, lysogeny, and phage conversions. Annu Rev Microbiol. 1974;28(0):265–299. doi: 10.1146/annurev.mi.28.100174.001405. [DOI] [PubMed] [Google Scholar]
  104. Barksdale L. Corynebacterium diphtheriae and its relatives. Bacteriol Rev. 1970 Dec;34(4):378–422. doi: 10.1128/br.34.4.378-422.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Barrow G. I., Hewitt M. Skin infection with Mycobacterium marinum from a tropical fish tank. Br Med J. 1971 May 29;2(5760):505–506. doi: 10.1136/bmj.2.5760.505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Bartholomew W. R. Multiple catalase enzymes in two species of mycobacteria. Am Rev Respir Dis. 1968 Apr;97(4):710–712. doi: 10.1164/arrd.1968.97.4.710. [DOI] [PubMed] [Google Scholar]
  107. Bartlett G. L., Zbar B. Adjuvants for a tumor-specific vaccine: Bordetella pertussis or mycobacterial cell walls attached to oil droplets. J Natl Cancer Inst. 1973 May;50(5):1385–1390. doi: 10.1093/jnci/50.5.1385. [DOI] [PubMed] [Google Scholar]
  108. Bast R. C., Jr, Zbar B., Borsos T., Rapp H. J. BCG and cancer (first of two parts). N Engl J Med. 1974 Jun 20;290(25):1413–1420. doi: 10.1056/NEJM197406202902506. [DOI] [PubMed] [Google Scholar]
  109. Bast R. C., Jr, Zbar B., Borsos T., Rapp H. J. BCG and cancer. N Engl J Med. 1974 Jun 27;290(26):1458–1469. doi: 10.1056/NEJM197406272902605. [DOI] [PubMed] [Google Scholar]
  110. Basten A., Miller J. F., Sprent J., Pye J. A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med. 1972 Mar 1;135(3):610–626. doi: 10.1084/jem.135.3.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Basten A., Sprent J., Miller J. F. Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol. 1972 Feb 9;235(58):178–180. doi: 10.1038/newbio235178a0. [DOI] [PubMed] [Google Scholar]
  112. Basten A., Warner N. L., Mandel T. A receptor for antibody on B lymphocytes. II. Immunochemical and electron microscopy characteristics. J Exp Med. 1972 Mar 1;135(3):627–642. doi: 10.1084/jem.135.3.627. [DOI] [PMC free article] [PubMed] [Google Scholar]
  113. Bates J. H., Mitchison D. A. Geographic distribution of bacteriophage types of Mycobacterium tuberculosis. Am Rev Respir Dis. 1969 Aug;100(2):189–193. doi: 10.1164/arrd.1969.100.2.189. [DOI] [PubMed] [Google Scholar]
  114. Batra P. P., Gleason R. M., Jr, Jenkins J. Mechanism of photo-induced and antimycin A-induced carotenoid synthesis in Mycobacterium marinum. Requirements for carotenogen- esis and further evidence for protein synthesis following induction. Biochim Biophys Acta. 1969 Feb 18;177(1):124–135. doi: 10.1016/0304-4165(69)90072-5. [DOI] [PubMed] [Google Scholar]
  115. Batra P. P., Harbin T. L., Howes C. D., Bernstein S. C. A study of the relationship of structure and activity of antimycin A in the induction of carotenoid synthesis in Mycobacterium marinum. J Biol Chem. 1971 Dec 10;246(23):7125–7130. [PubMed] [Google Scholar]
  116. Beaman B. L., Burnside J. Pyridine extraction of nocardial acid fastness. Appl Microbiol. 1973 Sep;26(3):426–428. doi: 10.1128/am.26.3.426-428.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Beaman B. L., Kim K. S., Lanéelle M. A., Barksdale L. Chemical characterization of organisms isolated from leprosy patients. J Bacteriol. 1974 Mar;117(3):1320–1329. doi: 10.1128/jb.117.3.1320-1329.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Beaman B. L., Kim K. S., Salton M. R., Barksdale L. Amino acids of the cell wall of Nocardia rubra. J Bacteriol. 1971 Nov;108(2):941–943. doi: 10.1128/jb.108.2.941-943.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Beaman B. L., Shankel D. M. Ultrastructure of Nocardia cell growth and development on defined and complex agar media. J Bacteriol. 1969 Sep;99(3):876–884. doi: 10.1128/jb.99.3.876-884.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Bekierkunst A., Levij I. S., Yarkoni E. Suppression of urethan-induced lung adenomas in mice treated with trehalose-6,6-dimycolate (cord factor) and living bacillus Calmette Guérin. Science. 1971 Dec 17;174(4015):1240–1242. doi: 10.1126/science.174.4015.1240. [DOI] [PubMed] [Google Scholar]
  121. Bekierkunst A., Levij I. S., Yarkoni E., Vilkas E., Adam A., Lederer E. Granuloma formation induced in mice by chemically defined mycobacterial fractions. J Bacteriol. 1969 Oct;100(1):95–102. doi: 10.1128/jb.100.1.95-102.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. Bekierkunst A., Wang L., Toubiana R., Lederer E. Immunotherapy of Cancer with Nonliving BCG and Fractions Derived from Mycobacteria: Role of Cord Factor (Trehalose-6, 6'-Dimycolate) in Tumor Regression. Infect Immun. 1974 Nov;10(5):1044–1050. doi: 10.1128/iai.10.5.1044-1050.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Bekierkunst A., Yarkoni E. Granulomatous hypersensitivity to trehalose-6,6'-dimycolate (cord factor) in mice infected with BCG. Infect Immun. 1973 Apr;7(4):631–638. doi: 10.1128/iai.7.4.631-638.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  124. Ben-Efraim S., Constantini-Sourojon M., Weiss D. W. Potentiation and modulation of the immune response of guinea pigs to poorly immunogenic protein-hapten conjugates by pretreatment with the MER fraction of attenuated tubercle bacilli. Cell Immunol. 1973 Jun;7(3):370–379. doi: 10.1016/0008-8749(73)90201-3. [DOI] [PubMed] [Google Scholar]
  125. Berken A., Benacerraf B. Properties of antibodies cytophilic for macrophages. J Exp Med. 1966 Jan 1;123(1):119–144. doi: 10.1084/jem.123.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Berset C., Etemadi A. H. Acyl-CoA-ACP-transacylases of Mycobacterium smegmatis. An analytical study. Biochimie. 1973;55(11):1381–1394. doi: 10.1016/s0300-9084(74)80545-6. [DOI] [PubMed] [Google Scholar]
  127. Berset C., Etemadi A. H. Séparation complète des activités palmityl-Co-A-ACP-transacylasique et malonyl-CoA-ACP-transacylasique des homogénats de Mycobacterium smegmatis. C R Acad Sci Hebd Seances Acad Sci D. 1973 Oct 8;277(14):1389–1392. [PubMed] [Google Scholar]
  128. Beytía E. D., Porter J. W. Biochemistry of polyisoprenoid biosynthesis. Annu Rev Biochem. 1976;45:113–142. doi: 10.1146/annurev.bi.45.070176.000553. [DOI] [PubMed] [Google Scholar]
  129. Bianco C., Patrick R., Nussenzweig V. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med. 1970 Oct 1;132(4):702–720. doi: 10.1084/jem.132.4.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  130. Biberfeld P., Biberfeld G., Perlmann P., Holm G. Cytological observations on the cytotoxic interaction between lymphocytes and antibody-coated monolayer cells. Cell Immunol. 1973 Apr;7(1):60–72. doi: 10.1016/0008-8749(73)90182-2. [DOI] [PubMed] [Google Scholar]
  131. Biggs T. H. Cervical lymphadenitis caused by atypical Mycobacterium. J Ky Med Assoc. 1971 Jun;69(6):438–439. [PubMed] [Google Scholar]
  132. Birn K. J., Schaefer W. B., Jenkins P. A., Szulga T., Marks J. Classification of Mycobacterium avium and related opportunist mycobacteria met in England and Wales. J Hyg (Lond) 1967 Dec;65(4):575–589. doi: 10.1017/s0022172400046106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Birnbaum S. E., Affronti L. F. Chemical and serological relationships between the heteropolysaccharides of Mycobacterium tuberculosis and Mycobacterium kansasii. J Bacteriol. 1968 Feb;95(2):559–564. doi: 10.1128/jb.95.2.559-564.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  134. Birnbaum S. E., Affronti L. F. Mycobacterial polysaccharides. II. Comparison of polysaccharides from strains of four species of mycobacteria. J Bacteriol. 1969 Oct;100(1):58–63. doi: 10.1128/jb.100.1.58-63.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Bishop D. G., Work E. An extracellular glycolipid produced by Escherichia coli grown under lysine-limiting conditions. Biochem J. 1965 Aug;96(2):567–576. doi: 10.1042/bj0960567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Black M. M., Epstein W. L. Formation of multinucleate giant cells in organized epitheloid cell granulomas. Am J Pathol. 1974 Feb;74(2):263–274. [PMC free article] [PubMed] [Google Scholar]
  137. Black W. A., Tries H. Severe Mycobacterium kansasii infection of the lung. Can J Public Health. 1972 Nov-Dec;63(6):523–526. [PubMed] [Google Scholar]
  138. Blanden R. V., Lefford M. J., Mackaness G. B. The host response to Calmette-Guérin bacillus infection in mice. J Exp Med. 1969 May 1;129(5):1079–1107. doi: 10.1084/jem.129.5.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  139. Bloch-Shtacher N., Hirschhorn K., Uhr J. W. The response of lymphocytes from non-immunized humans to antigen-antibody complexes. Clin Exp Immunol. 1968 Nov;3(9):889–899. [PMC free article] [PubMed] [Google Scholar]
  140. Bloch K. Fatty acid synthases from Mycobacterium phlei. Methods Enzymol. 1975;35:84–90. doi: 10.1016/0076-6879(75)35141-0. [DOI] [PubMed] [Google Scholar]
  141. Bloom B. R., Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966 Jul 1;153(3731):80–82. doi: 10.1126/science.153.3731.80. [DOI] [PubMed] [Google Scholar]
  142. Bloom B. R. In vitro approaches to the mechanism of cell-mediated immune reactions. Adv Immunol. 1971;13:101–208. doi: 10.1016/s0065-2776(08)60184-4. [DOI] [PubMed] [Google Scholar]
  143. Bluming A. Z., Vogel C. L., Ziegler J. L., Mody N., Kamya G. Immunological effects of BCG in malignant melanoma: two modes of administration compared. Ann Intern Med. 1972 Mar;76(3):405–411. doi: 10.7326/0003-4819-76-3-405. [DOI] [PubMed] [Google Scholar]
  144. Boisvert H. Mycobacterium xenopei (Marks et Schwabacher 1965), mycobactérie scotochromogène, thermophile, dysgonique, éventuellement pathogène pour l'homme. Ann Inst Pasteur (Paris) 1965 Sep;109(3):447–453. [PubMed] [Google Scholar]
  145. Bonventre P. F., Black-Schaffer B. The effect of neutral and acidic polysaccharides on natural resistance of mice to bacterial challenge. J Infect Dis. 1965 Oct;115(4):413–420. doi: 10.1093/infdis/115.4.413. [DOI] [PubMed] [Google Scholar]
  146. Borghans J. G., Stanford J. L. Mycobacterium chelonei in abscesses after injection of diphtheria-pertussis-tetanus-polio vaccine. Am Rev Respir Dis. 1973 Jan;107(1):1–8. doi: 10.1164/arrd.1973.107.1.1. [DOI] [PubMed] [Google Scholar]
  147. Borisova L. N., Ivkina N. S., Gomeniuk L. A., Rapoport I. A. Mutatsii i proiavlenie priznakov u Actinomyces streptomycini Krass. Mikrobiologiia. 1970 Jul-Aug;39(4):675–679. [PubMed] [Google Scholar]
  148. Boros D. L., Warren K. S. The bentonite granuloma. Characterization of a model system for infectious and foreign body granulomatous inflammation using soluble mycobacterial, histoplasma and schistosoma antigens. Immunology. 1973 Mar;24(3):511–529. [PMC free article] [PubMed] [Google Scholar]
  149. Bowles J. A., Segal W. Kinetics of Utilization of Organic Compounds in the Growth of Mycobacterium tuberculosis. J Bacteriol. 1965 Jul;90(1):157–163. doi: 10.1128/jb.90.1.157-163.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  150. Bowman B. U. Antigenicity of mycobacteriophages R1, D29, and Leo in rabbits . Proc Soc Exp Biol Med. 1968 Jun;128(2):441–445. doi: 10.3181/00379727-128-33033. [DOI] [PubMed] [Google Scholar]
  151. Bowman B. U., Newman H. A., Moritz J. M., Koehler R. M. Properties of mycobacteriophage DS6A. II. Lipid composition. Am Rev Respir Dis. 1973 Jan;107(1):42–49. doi: 10.1164/arrd.1973.107.1.42. [DOI] [PubMed] [Google Scholar]
  152. Bowman B. U. Properties of mycobacteriophage DS6A. I. Immunogenicity in rabbits. Proc Soc Exp Biol Med. 1969 May;131(1):196–200. doi: 10.3181/00379727-131-33838. [DOI] [PubMed] [Google Scholar]
  153. Boyer H. W. DNA restriction and modification mechanisms in bacteria. Annu Rev Microbiol. 1971;25:153–176. doi: 10.1146/annurev.mi.25.100171.001101. [DOI] [PubMed] [Google Scholar]
  154. Bradley D. E. Ultrastructure of bacteriophage and bacteriocins. Bacteriol Rev. 1967 Dec;31(4):230–314. doi: 10.1128/br.31.4.230-314.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  155. Bradley S. G., Bond J. S. Taxonomic criteria for Mycobacteria and nocardiae. Adv Appl Microbiol. 1974;18(0):131–190. doi: 10.1016/s0065-2164(08)70571-9. [DOI] [PubMed] [Google Scholar]
  156. Bradley S. G. Reassociation of deoxyribonucleic acid from selected mycobacteria with that from Mycobacterium bovis and Mycobacterium farcinica. Am Rev Respir Dis. 1972 Jul;106(1):122–124. doi: 10.1164/arrd.1972.106.1.122. [DOI] [PubMed] [Google Scholar]
  157. Bradley S. G. Relationships among mycobacteria and nocardiae based upon deoxyribonucleic acid reassociation. J Bacteriol. 1973 Feb;113(2):645–651. doi: 10.1128/jb.113.2.645-651.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  158. Brady R. O. THE ENZYMATIC SYNTHESIS OF FATTY ACIDS BY ALDOL CONDENSATION. Proc Natl Acad Sci U S A. 1958 Oct 15;44(10):993–998. doi: 10.1073/pnas.44.10.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  159. Brennan P. J., Lehane D. P. Acylglucoses in corynebacteria. Biochim Biophys Acta. 1969 Apr 29;176(3):675–677. doi: 10.1016/0005-2760(69)90244-6. [DOI] [PubMed] [Google Scholar]
  160. Brennan P. J., Lehane D. P. The phospholipids of corynebacteria. Lipids. 1971 Jun;6(6):401–409. doi: 10.1007/BF02531377. [DOI] [PubMed] [Google Scholar]
  161. Brennan P. J., Lehane D. P., Thomas D. W. Acylglucoses of the corynebacteria and mycobacteria. Eur J Biochem. 1970 Mar 1;13(1):117–123. doi: 10.1111/j.1432-1033.1970.tb00906.x. [DOI] [PubMed] [Google Scholar]
  162. Brennan P. J., Rooney S. A., Winder F. G. The lipids of Mycobacterium tuberculosis BCG: fractionation, composition, turnover and the effects of isoniazid. Ir J Med Sci. 1970 Aug;3(8):371–390. doi: 10.1007/BF02956904. [DOI] [PubMed] [Google Scholar]
  163. Brennan P., Ballou C. E. Biosynthesis of mannophosphoinositides by Mycobacterium phlei. Enzymatic acylation of the dimannophosphoinositides. J Biol Chem. 1968 Jun 10;243(11):2975–2984. [PubMed] [Google Scholar]
  164. Brennan P., Ballou C. E. Biosynthesis of mannophosphoinositides by Mycobacterium phlei. The family of dimannophosphoinositides. J Biol Chem. 1967 Jul 10;242(13):3046–3056. [PubMed] [Google Scholar]
  165. Brindle T. W., Griffiths M. I., Holme T., Stalker R., Burland W. L., Coates G. A., Muggleton P. W. A trial to compare reactions and responses to BCG vaccine prepared from Copenhagen 1331 and Glaxo 1077 strains. Tubercle. 1972 Jun;53(2):100–105. doi: 10.1016/0041-3879(72)90025-6. [DOI] [PubMed] [Google Scholar]
  166. Brosbe E. A., Fox P. G., Bates J. H. Cytotoxic effect of Mycobacterium tuberculosis on J-111 cells. Tex Rep Biol Med. 1970 Fall;28(3):197–202. [PubMed] [Google Scholar]
  167. Brown C. A., Draper P., Hart P. D. Mycobacteria and lysosomes: a paradox. Nature. 1969 Feb 15;221(5181):658–660. doi: 10.1038/221658a0. [DOI] [PubMed] [Google Scholar]
  168. Brown K. A., Ratledge C. Iron transport in Mycobacterium smegmatis: ferrimycobactin reductase (nad(p)h:ferrimycobactin oxidoreductase), the enzyme releasing iron from its carrier. FEBS Lett. 1975 May 1;53(2):262–266. doi: 10.1016/0014-5793(75)80033-0. [DOI] [PubMed] [Google Scholar]
  169. Brownell G. H., Adams J. N. Linkage and segregation of unselected markers in matings of Nocardia erythropolis with Nocardia canicruria. J Bacteriol. 1967 Sep;94(3):650–659. doi: 10.1128/jb.94.3.650-659.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  170. Brundelet P. J. Acid-fast staining of hooklets of Taenia echinococcus. Lancet. 1973 Mar 24;1(7804):678–678. doi: 10.1016/s0140-6736(73)92257-5. [DOI] [PubMed] [Google Scholar]
  171. Buckle G. Notes on mycobacterium ulcerans. Aust N Z J Surg. 1972 May;41(4):320–323. [PubMed] [Google Scholar]
  172. Bullin C. H., Tanner E. I., Collins C. H. Isolation of Mycobacterium xenopei from water taps. J Hyg (Lond) 1970 Mar;68(1):97–100. doi: 10.1017/s0022172400028540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  173. Buraczewska M., Kwiatkowski B., Manowska W., Rdultowska H. Ultrastructure of some mycobacteriophages. Am Rev Respir Dis. 1972 Jan;105(1):22–29. doi: 10.1164/arrd.1972.105.1.22. [DOI] [PubMed] [Google Scholar]
  174. Buraczewska M., Manowska W., Rdultowska H. Induction of phages from lysogenic mycobacteria by means of ultraveiolet irradiation. Am Rev Respir Dis. 1971 Nov;104(5):760–762. doi: 10.1164/arrd.1971.104.5.760. [DOI] [PubMed] [Google Scholar]
  175. Burchard R. P., Dworkin M. Light-induced lysis and carotenogenesis in Myxococcus xanthus. J Bacteriol. 1966 Feb;91(2):535–545. doi: 10.1128/jb.91.2.535-545.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  176. Burchard R. P., Gordon S. A., Dworkin M. Action spectrum for the photolysis of Myxococcus xanthus. J Bacteriol. 1966 Feb;91(2):896–897. doi: 10.1128/jb.91.2.896-897.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Burchard R. P., Hendricks S. B. Action spectrum for carotenogenesis in Myxococcus xanthus. J Bacteriol. 1969 Mar;97(3):1165–1168. doi: 10.1128/jb.97.3.1165-1168.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Burnet F. M. The concept of immunological surveillance. Prog Exp Tumor Res. 1970;13:1–27. doi: 10.1159/000386035. [DOI] [PubMed] [Google Scholar]
  179. Bönicke R. Beschreibung der neuen Species Mycobacterium borstelense n.sp. Zentralbl Bakteriol Orig. 1965 Jul;196(4):535–538. [PubMed] [Google Scholar]
  180. Bönicke R., Juhasz S. E. Mycobakterium diernhoferi n. sp., eine in der Umgebung des Rindes häufig vorkommende neue Mycobakterium-Species. Zentralbl Bakteriol Orig. 1965 Aug;197(2):292–294. [PubMed] [Google Scholar]
  181. Bönicke R. Lysogeny among mycobacteria. Folia Microbiol (Praha) 1969;14(4):297–304. doi: 10.1007/BF02872695. [DOI] [PubMed] [Google Scholar]
  182. CHAPUT M., MICHEL G., LEDERER E. [Structure of mycoside Cm, peptidoglycolipid of Mycobacterium marianum]. Biochim Biophys Acta. 1962 Sep 24;63:310–326. doi: 10.1016/0006-3002(62)90685-6. [DOI] [PubMed] [Google Scholar]
  183. CHASE H. H., DAVIS J. B., RAYMOND R. L. Mycobacterium paraffinicum n. sp., a bacterium isolated from soil. Appl Microbiol. 1956 Nov;4(6):310–315. doi: 10.1128/am.4.6.310-315.1956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. CHEUNG O. T., KONST H. Pulmonary tuberculosis apparently caused by the avian tubercle bacillus. Can Med Assoc J. 1963 Jul 20;89:116–120. [PMC free article] [PubMed] [Google Scholar]
  185. CLAES H., NAKAYAMA T. O. [The photoxidative fading of chlorophyll in vitro in the presence of carotenes with various chromophoric groups]. Z Naturforsch B. 1959 Nov;14B:746–747. [PubMed] [Google Scholar]
  186. CLANCEY J. K., DODGE O. G., LUNN H. F., ODUORI M. L. Mycobacterial skin ulcers in Uganda. Lancet. 1961 Oct 28;2(7209):951–954. doi: 10.1016/s0140-6736(61)90793-0. [DOI] [PubMed] [Google Scholar]
  187. CLANCEY J. K. MYCOBACTERIAL SKIN ULCERS IN UGANDA: DESCRIPTION OF A NEW MYCOBACTERIUM (MYCOBACTERIUM BURULI). J Pathol Bacteriol. 1964 Jul;88:175–187. doi: 10.1002/path.1700880123. [DOI] [PubMed] [Google Scholar]
  188. CLEVELAND D. E. H. Possible tuberculous skin infection from a swimming pool; report of four cases. Acta Derm Venereol. 1951;31(2):147–152. [PubMed] [Google Scholar]
  189. CORPE R. F. CLINICAL ASPECTS, MEDICAL AND SURGICAL, IN THE MANAGEMENT OF BATTEY-TYPE PULMONARY DISEASE. Dis Chest. 1964 Apr;45:380–382. doi: 10.1378/chest.45.4.380. [DOI] [PubMed] [Google Scholar]
  190. CORPE R. F., SMITH C. E., STERGUS I. Death due to Mycobacterium fortuitum. JAMA. 1961 Jul 29;177:262–263. doi: 10.1001/jama.1961.73040300015012a. [DOI] [PubMed] [Google Scholar]
  191. CROW H. E., KING C. T., SMITH C. E., CORPE R. F., STERGUS I. A limited clinical, pathologic, and epidemiologic study of patients with pulmonary lesions associated with atypical acid-fast bacilli in the sputum. Am Rev Tuberc. 1957 Feb;75(2):199–222. doi: 10.1164/artpd.1957.75.2.199. [DOI] [PubMed] [Google Scholar]
  192. CUMMINS C. S. Chemical composition and antigenic structure of cell walls of Corynebacterium, Mycobacterium, Nocardia, Actinomyces and Arthrobacter. J Gen Microbiol. 1962 Apr;28:35–50. doi: 10.1099/00221287-28-1-35. [DOI] [PubMed] [Google Scholar]
  193. CUMMINS C. S., HARRIS H. Studies on the cell-wall composition and taxonomy of Actinomycetales and related groups. J Gen Microbiol. 1958 Feb;18(1):173–189. doi: 10.1099/00221287-18-1-173. [DOI] [PubMed] [Google Scholar]
  194. CUTTINO J. T., McCABE A. M. Pure granulomatous nocardiosis, a new fungus disease distinguished by intracellular parasitism; a description of a new disease in man due to a hitherto undescribed organism, Nocardia intracellularis, n. sp., including a study of the biologic and pathogenic properties of this species. Am J Pathol. 1949 Jan;25(1):1–47. [PMC free article] [PubMed] [Google Scholar]
  195. Cahall D. L., Youmans G. P. Conditions for production, and some characteristics, of mycobacterial growth inhibitory factor produced by spleen cells from mice immunized with viable cells of the attenuated H37Ra strain of Mycobacterium tuberculosis. Infect Immun. 1975 Oct;12(4):833–840. doi: 10.1128/iai.12.4.833-840.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  196. Cahall D. L., Youmans G. P. Macrophage migration inhibitory activity of mycobacterial growth inhibitory factor and the effect of a number of factors on mycobacterial growth inhibitory factor activity. Infect Immun. 1975 Oct;12(4):851–857. doi: 10.1128/iai.12.4.851-857.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  197. Cahall D. L., Youmans G. P. Molecular weight and other characteristics of mycobacterial growth inhibitory factor produced by spleen cells obtained from mice immunized with viable attenuated mycobacterial cells. Infect Immun. 1975 Oct;12(4):841–850. doi: 10.1128/iai.12.4.841-850.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  198. Canilang B., Armstrong D. Subcutaneous abscesses due to Mycobacterium fortuitum. Report of a case. Am Rev Respir Dis. 1968 Mar;97(3):451–454. doi: 10.1164/arrd.1968.97.3.451. [DOI] [PubMed] [Google Scholar]
  199. Cantoni G. L. Biological methylation: selected aspects. Annu Rev Biochem. 1975;44:435–451. doi: 10.1146/annurev.bi.44.070175.002251. [DOI] [PubMed] [Google Scholar]
  200. Casavant C. H., Youmans G. P. The adjuvant activity of mycobacterial RNA preparations and synthetic polynucleotides for induction of delayed hypersensitivity to purified protein derivative in guinea pigs. J Immunol. 1975 Mar;114(3):1014–1022. [PubMed] [Google Scholar]
  201. Casavant C. H., Youmans G. P. The induction of delayed hypersensitivity in guinea pigs to poly U and poly A:U. J Immunol. 1975 May;114(5):1506–1509. [PubMed] [Google Scholar]
  202. Castelnuovo G., Bellezza G., Borrelli F. Les antigènes d'un mycobacteriophage: phage Phlei. Ann Inst Pasteur (Paris) 1970 Feb;118(2):214–219. [PubMed] [Google Scholar]
  203. Castelnuovo G., Bellezza G., Yamanaka S. Phage inhibiting substances of mycobacteria. I. The nature of phage inhibiting substances of Mycobacterium phlei. Ann Inst Pasteur (Paris) 1970 Sep;119(3):302–311. [PubMed] [Google Scholar]
  204. Castelnuovo G., Giuliani H. I., Luchini de Giuliani E., Arancia G. Protein components of a mycobacteriophage. J Gen Virol. 1969 Mar;4(2):253–257. doi: 10.1099/0022-1317-4-2-253. [DOI] [PubMed] [Google Scholar]
  205. Castelnuovo G., Yamanaka S., Zoppis M., Dotti E. The protein components of Mycobacterium phlei: fractionation procedures. Tubercle. 1969 Jun;50(2):194–202. doi: 10.1016/0041-3879(69)90025-7. [DOI] [PubMed] [Google Scholar]
  206. Castets M., Boisvert H., Grumbach F., Brunel M., Rist N. Les bacilles tuberculeux de type Africain: note préliminaire. Rev Tuberc Pneumol (Paris) 1968 Mar;32(2):179–184. [PubMed] [Google Scholar]
  207. Cerottini J. C., Brunner K. T. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol. 1974;18:67–132. doi: 10.1016/s0065-2776(08)60308-9. [DOI] [PubMed] [Google Scholar]
  208. Chamoiseau G., Asselineau J. Examen des lipides d'une souche de Nocardia farcinica: présence d'acides mycoliques. C R Acad Sci Hebd Seances Acad Sci D. 1970 May 25;270(21):2603–2604. [PubMed] [Google Scholar]
  209. Chamoiseau G. Mycobacterium farcinogenes, agent causal du farcin du boeuf en Afrique. Ann Microbiol (Paris) 1973 Mar;124(2):215–222. [PubMed] [Google Scholar]
  210. Chang Y. T., Andersen R. N. Morphological changes of Mycobacterium lepraemurium grown in cultures of mouse peritoneal macrophages. J Bacteriol. 1969 Sep;99(3):867–875. doi: 10.1128/jb.99.3.867-875.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  211. Chaparas S. D., Hedrick S. R. Comparison of strains of BCG. I. Antigenic analysis and tuberculin reactivity. Infect Immun. 1973 May;7(5):777–780. doi: 10.1128/iai.7.5.777-780.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  212. Chaparas S. D., Thor D. E., Hedrick S. R. Comparison of lymphocyte transformation, inhibition of macrophage migration and skin tests using dialyzable and nondialyzable tuberculin fractions from Mycobacterium bovis (BCG). J Immunol. 1971 Jul;107(1):149–153. [PubMed] [Google Scholar]
  213. Chapman J. S. Atypical mycobacterial infections; pathogenesis, clinical manifestations, and treatment. Med Clin North Am. 1967 Mar;51(2):503–517. doi: 10.1016/s0025-7125(16)33070-x. [DOI] [PubMed] [Google Scholar]
  214. Chapman J. S., Dyerly M., Spohn S. Epidemiological notes on Mycobacterium kansasii disease. Arch Environ Health. 1968 May;16(5):673–678. doi: 10.1080/00039896.1968.10665127. [DOI] [PubMed] [Google Scholar]
  215. Chase M. W., Kawata H. Multiple mycobacterial antigens in diagnostic tuberculins. Dev Biol Stand. 1975;29:308–330. [PubMed] [Google Scholar]
  216. Chaves-Carballo E., Sanchez G. A. Regional lymphadenitis following BCG vaccination (BCGitis). Clinical comments based upon 25 instances among 1295 childhood vaccinees. Clin Pediatr (Phila) 1972 Dec;11(12):693–697. doi: 10.1177/000992287201101211. [DOI] [PubMed] [Google Scholar]
  217. Chavganc J., Hanák R., ten Dam H. G. Epidemiological significance of the local reaction to direct BCG vaccination as assessed from a study in Mongolia. Bull World Health Organ. 1969;41(1):45–62. [PMC free article] [PubMed] [Google Scholar]
  218. Chedid L., Lamensans A., Parant F., Parant M., Adam A., Petit J. F., Lederer E. Protective effects of delipidated mycobacterial cells and purified cell walls against Ehrlich carcinoma and a syngeneic lymphoid leukemia in mice. Cancer Res. 1973 Sep;33(9):2187–2195. [PubMed] [Google Scholar]
  219. Chipman D. M., Sharon N. Mechanism of lysozyme action. Science. 1969 Aug 1;165(3892):454–465. doi: 10.1126/science.165.3892.454. [DOI] [PubMed] [Google Scholar]
  220. Cianciulli F. D. The radish bacillus (Mycobacterium terrae): saphrophyte or pathogen? Am Rev Respir Dis. 1974 Jan;109(1):138–141. doi: 10.1164/arrd.1974.109.1.138. [DOI] [PubMed] [Google Scholar]
  221. Ciorbaru R., Adam A., Petit J. F., Lederer E., Bona C., Chedid L. Isolation of mitogenic and adjuvant active fractions from various species of Nocardiae. Infect Immun. 1975 Feb;11(2):257–264. doi: 10.1128/iai.11.2.257-264.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Clapper W. E., Whitcomb J. Mycobacterium fortuitum abscess at injection site. JAMA. 1967 Nov 6;202(6):550–550. [PubMed] [Google Scholar]
  223. Clasener H. Pathogenicity of the L-phase of bacteria. Annu Rev Microbiol. 1972;26:55–84. doi: 10.1146/annurev.mi.26.100172.000415. [DOI] [PubMed] [Google Scholar]
  224. Collins F. M. Immunogenicity of various mycobacteria and the corresponding levels of cross-protection developed between species. Infect Immun. 1971 Dec;4(6):688–696. doi: 10.1128/iai.4.6.688-696.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  225. Comstock G. W., Edwards L. B., Nabangxang H. Tuberculin sensitivity eight to fifteen years after BCG vaccination. Am Rev Respir Dis. 1971 Apr;103(4):572–575. doi: 10.1164/arrd.1971.103.4.572. [DOI] [PubMed] [Google Scholar]
  226. Cone R. E., Johnson A. G. Regulation of the immune system by synthetic polynucleotides. 3. Action on antigen-reactive cells of thymic origin. J Exp Med. 1971 Mar 1;133(3):665–676. doi: 10.1084/jem.133.3.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  227. Cone R. E., Wilson J. D. Adjuvant action of poly A:U on T and B rosette-forming cells in SRBC-immunized mice. Analysis by two rosette assay methods. Int Arch Allergy Appl Immunol. 1972;43(1):123–130. doi: 10.1159/000230828. [DOI] [PubMed] [Google Scholar]
  228. Connor D. H., Lunn H. F. Mycobacterium ulcerans infection (with comments on pathogenesis). Int J Lepr. 1965 Jul-Sep;33(3 Suppl):698–709. [PubMed] [Google Scholar]
  229. Convit J., Avila J. L., Goihman M., Pinardi M. E. A test for the determination of competency in clearing bacilli in leprosy patients. Bull World Health Organ. 1972;46(6):821–826. [PMC free article] [PubMed] [Google Scholar]
  230. Cooper M. D., Keightley R. G., Webb S. R. T- and B-cell interactions in autoimmune syndromes. Ann N Y Acad Sci. 1975 Jun 13;256:105–116. doi: 10.1111/j.1749-6632.1975.tb36040.x. [DOI] [PubMed] [Google Scholar]
  231. Cortez L. M., Pankey G. A. Mycobacterium marinum infections of the hand. Report of three cases and review of the literature. J Bone Joint Surg Am. 1973 Mar;55(2):363–370. [PubMed] [Google Scholar]
  232. Coutinho A., Möller G. B cell mitogenic properties of thymus-independent antigens. Nat New Biol. 1973 Sep 5;245(140):12–14. doi: 10.1038/newbio245012a0. [DOI] [PubMed] [Google Scholar]
  233. Coutinho A., Möller G. Thymus-independent B-cell induction and paralysis. Adv Immunol. 1975;21:113–236. doi: 10.1016/s0065-2776(08)60220-5. [DOI] [PubMed] [Google Scholar]
  234. Cozine W. S., Jr, Stanfield A. B., Stephens C. A., Jr, Mazur M. T. Adjuvant disease-prevention with complete Freund's adjuvant and with mineral oil alone. Proc Soc Exp Biol Med. 1973 Jun;143(2):528–530. doi: 10.3181/00379727-143-37358. [DOI] [PubMed] [Google Scholar]
  235. Csillag A. A simple method to obtain the mycococcus form of Mycobacterium phlei. J Gen Microbiol. 1970 Aug;62(2):251–259. doi: 10.1099/00221287-62-2-251. [DOI] [PubMed] [Google Scholar]
  236. Cummins C. S. Chemical and antigenic studies on cell walls of mycobacteria, corynebacteria, and nocardias. Am Rev Respir Dis. 1965 Dec;92(6):63–72. doi: 10.1164/arrd.1965.92.6P2.63. [DOI] [PubMed] [Google Scholar]
  237. Cunto G., Kanetsuna F., Imaeda T. Chemical analysis of the mucopeptide of Mycobacterium smegmatis. Biochim Biophys Acta. 1969 Nov 18;192(2):358–360. doi: 10.1016/0304-4165(69)90378-x. [DOI] [PubMed] [Google Scholar]
  238. D'ARCY HART P., POLLOCK T. M., SUTHERLAND I. Assessment of the first results of the Medical Research Council's trial of tuberculosis vaccines in adolescents in Great Britain. Bibl Tuberc. 1957;13(12):171–189. [PubMed] [Google Scholar]
  239. DANIEL T. M. OBSERVATIONS ON THE ANTIBODY RESPONSE OF RABBITS TO MYCOBACTERIAL ANTIGENS. J Immunol. 1965 Jul;95:100–108. [PubMed] [Google Scholar]
  240. DARZINS E., FAHR G. Cord-forming property, lethality and pathogenicity of Mycobacteria. Dis Chest. 1956 Dec;30(6):642–648. doi: 10.1378/chest.30.6.642. [DOI] [PubMed] [Google Scholar]
  241. DAVIS J. C., MUDD S. The cytology of a strain of Corynebacterium diphtheriae. J Bacteriol. 1955 Apr;69(4):372–386. doi: 10.1128/jb.69.4.372-386.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  242. DEWIJS H., JOLLES P. CELL WALLS OF THREE STRAINS OF MYCOBACTERIA (MYCOBACTERIUM PHLEI, MYCOBACTERIUM FORTUITUM AND MYCOBACTERIUM KANSASII). PREPARATION, ANALYSIS AND DIGESTION BY LYSOZYMES OF DIFFERENT ORIGINS. Biochim Biophys Acta. 1964 Nov 1;83:326–332. [PubMed] [Google Scholar]
  243. DODGE O. G. MYCOBACTERIAL SKIN ULCERS IN UGANDA: HISTOPATHOLOGICAL AND EXPERIMENTAL ASPECTS. J Pathol Bacteriol. 1964 Jul;88:169–174. doi: 10.1002/path.1700880122. [DOI] [PubMed] [Google Scholar]
  244. DRESSER D. W. Effectiveness of lipid and lipidophilic substances as adjuvants. Nature. 1961 Sep 16;191:1169–1171. doi: 10.1038/1911169a0. [DOI] [PubMed] [Google Scholar]
  245. DROSS I. C., ABBATIELLO A. A., JENNEY F. S., COHEN A. C. PULMONARY INFECTION DUE TO M. FORTUITUM. Am Rev Respir Dis. 1964 Jun;89:923–925. doi: 10.1164/arrd.1964.89.6.923. [DOI] [PubMed] [Google Scholar]
  246. DWORKIN M. Endogenous photosensitization in a carotenoidless mutant of Rhodopseudomonas speroides. J Gen Physiol. 1958 Jul 20;41(6):1099–1112. doi: 10.1085/jgp.41.6.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  247. Daniel T. M., Wisnieski J. J. The reaction of Concanavalin-A with mycobacterial culture filtrates. Am Rev Respir Dis. 1970 May;101(5):762–764. doi: 10.1164/arrd.1970.101.5.762. [DOI] [PubMed] [Google Scholar]
  248. Daniels T. M., Affronti L. F. Immunoelectrophoretic analysis of antigenic constituents of Seibert fractions of mycobacterial culture filtrates. Identification with the proposed United States-Japan reference nomenclature. Am Rev Respir Dis. 1973 Nov;108(5):1244–1248. doi: 10.1164/arrd.1973.108.5.1244. [DOI] [PubMed] [Google Scholar]
  249. Dannenberg A. M., Jr, Ando M., Shima K. Macrophage accumulation, division, maturation, and digestive and microbicidal capacities in tuberculous lesions. 3. The turnover of macrophages and its relation to their activation and antimicrobial immunity in primary BCG lesions and those of reinfection. J Immunol. 1972 Nov;109(5):1109–1121. [PubMed] [Google Scholar]
  250. Dannenberg A. M., Jr Macrophages in inflammation and infection. N Engl J Med. 1975 Sep 4;293(10):489–493. doi: 10.1056/NEJM197509042931010. [DOI] [PubMed] [Google Scholar]
  251. Davey M. E. Some clinical aspects and treatment of anonymous mycobacterial infections. Med J Aust. 1967 Sep 2;2(10):438–441. doi: 10.5694/j.1326-5377.1967.tb73952.x. [DOI] [PubMed] [Google Scholar]
  252. David H. L. Biogenesis of beta-carotene in Mycobacterium kansasii. J Bacteriol. 1974 Aug;119(2):527–533. doi: 10.1128/jb.119.2.527-533.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  253. David H. L. Carotenoid pigments of Mycobacterium kansasii. Appl Microbiol. 1974 Oct;28(4):696–699. doi: 10.1128/am.28.4.696-699.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  254. David H. L., Goldman D. S., Takayama K. Inhibition of the Synthesis of Wax D Peptidoglycolipid of Mycobacterium tuberculosis by d-Cycloserine. Infect Immun. 1970 Jan;1(1):74–77. doi: 10.1128/iai.1.1.74-77.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  255. David H. L., Jones W. D., Jr Biosynthesis of a lipase by Mycobacterium smegmatis ATCC 607 infected by Mycobacteriophage D29. Am Rev Respir Dis. 1970 Nov;102(5):818–820. doi: 10.1164/arrd.1970.102.5.818. [DOI] [PubMed] [Google Scholar]
  256. David H. L. Response of Mycobacteria to ultraviolet light radiation. Am Rev Respir Dis. 1973 Nov;108(5):1175–1185. doi: 10.1164/arrd.1973.108.5.1175. [DOI] [PubMed] [Google Scholar]
  257. David H. L. Response of Mycobacterium tuberculosis to environmental changes. Survival after transfer from amino-acid-supplemented medium to basal medium. Am Rev Respir Dis. 1972 Jun;105(6):944–953. doi: 10.1164/arrd.1972.105.6.944. [DOI] [PubMed] [Google Scholar]
  258. David J. R. Lymphocyte mediators and cellular hypersensitivity. N Engl J Med. 1973 Jan 18;288(3):143–149. doi: 10.1056/NEJM197301182880311. [DOI] [PubMed] [Google Scholar]
  259. Davies M., Stewart-Tull D. E. The dual affinity of a mycobacterial glycopeptide for sheep erythrocyte membranes and guinea-pig gamma-globulin. Immunology. 1973 Jul;25(1):1–9. [PMC free article] [PubMed] [Google Scholar]
  260. Dennert G., Tucker D. Antitumor polysaccharide lentinan. A T cell adjuvant. J Natl Cancer Inst. 1973 Nov;51(5):1727–1729. doi: 10.1093/jnci/51.5.1727. [DOI] [PubMed] [Google Scholar]
  261. Dickey R. F. Sporotrichoid mycobacteriosis caused by M marinum (balnei). Arch Dermatol. 1968 Oct;98(4):385–391. [PubMed] [Google Scholar]
  262. Dickler H. B., Kunkel H. G. Interaction of aggregated -globulin with B lymphocytes. J Exp Med. 1972 Jul 1;136(1):191–196. doi: 10.1084/jem.136.1.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  263. Diena B. B., Wallace R., Carriere J., Greenberg L. Observations on the antibody response to Mycobacterium tuberculosis in laboratory animals. Am Rev Respir Dis. 1971 Nov;104(5):757–759. doi: 10.1164/arrd.1971.104.5.757. [DOI] [PubMed] [Google Scholar]
  264. Dienes L., Mallory T. B. The Influence of Allergy on the Development of Early Tuberculous Lesions. Am J Pathol. 1937 Nov;13(6):897–910.3. doi: 10.3181/00379727-34-8498p. [DOI] [PMC free article] [PubMed] [Google Scholar]
  265. Dixon J. M., Cuthbert E. H. Isolation of tubercle bacilli from uncentrifuged sputum on pyruvic acid medium. Am Rev Respir Dis. 1967 Jul;96(1):119–122. doi: 10.1164/arrd.1967.96.1.119. [DOI] [PubMed] [Google Scholar]
  266. Donald K. J., Pound A. W. Proliferation and migration of reticuloendothelial cells following injection of a tubercle bacillary lipid. Br J Exp Pathol. 1973 Feb;54(1):79–89. [PMC free article] [PubMed] [Google Scholar]
  267. Doyle W. M., Evander L. C., Gurft H. Pulmonary disease caused by Mycobacterium xenopei. Am Rev Respir Dis. 1968 May;97(5):919–922. doi: 10.1164/arrd.1968.97.5.919. [DOI] [PubMed] [Google Scholar]
  268. Draper P., Rees R. J. Electron-transparent zone of mycobacteria may be a defence mechanism. Nature. 1970 Nov 28;228(5274):860–861. doi: 10.1038/228860a0. [DOI] [PubMed] [Google Scholar]
  269. Draper P., Rees R. J. The nature of the electron-transparent zone that surrounds Mycobacterium lepraemurium inside host cells. J Gen Microbiol. 1973 Jul;77(1):79–87. doi: 10.1099/00221287-77-1-79. [DOI] [PubMed] [Google Scholar]
  270. Draper P. The mycoside capsule of Mycobacterium Avium 357. J Gen Microbiol. 1974 Aug;83(2):431–433. doi: 10.1099/00221287-83-2-431. [DOI] [PubMed] [Google Scholar]
  271. Dresser D. W., Popham A. M. Induction of an IgM anti-(bovine)-IgG response in mice by bacterial lipopolysaccharide. Nature. 1976 Dec 9;264(5586):552–554. doi: 10.1038/264552a0. [DOI] [PubMed] [Google Scholar]
  272. Dresser D. W. The role of T cells and adjuvant in the immune response of mice to foreign erythrocytes. Eur J Immunol. 1972 Feb;2(1):50–57. doi: 10.1002/eji.1830020111. [DOI] [PubMed] [Google Scholar]
  273. Dukor P., Hartmann K. U. Hypothesis. Bound C3 as the second signal for B-cell activation. Cell Immunol. 1973 Jun;7(3):349–356. doi: 10.1016/0008-8749(73)90199-8. [DOI] [PubMed] [Google Scholar]
  274. Dumonde D. C., Wolstencroft R. A., Panayi G. S., Matthew M., Morley J., Howson W. T. "Lymphokines": non-antibody mediators of cellular immunity generated by lymphocyte activation. Nature. 1969 Oct 4;224(5214):38–42. doi: 10.1038/224038a0. [DOI] [PubMed] [Google Scholar]
  275. Dumont A., Sheldon H. Changes in the fine structure of macrophages in experimentally produced tuberculous granulomas in hamsters. Lab Invest. 1965 Nov;14(11):2034–2055. [PubMed] [Google Scholar]
  276. Dunsford H. A., Lucia H. L., Doughty B. L., von Lichtenberg F. Artificial granulomas from bentonite and latex carrier particles. Am J Trop Med Hyg. 1974 Mar;23(2):203–217. doi: 10.4269/ajtmh.1974.23.203. [DOI] [PubMed] [Google Scholar]
  277. Dvorak H. F., Colvin R. B., Churchill W. H. Specificity of basophils and lymphocytes in cutaneous basophil hypersensitivity. J Immunol. 1975 Jan;114(1 Pt 2):507–511. [PubMed] [Google Scholar]
  278. Dvorak H. F., Simpson B. A., Bast R. C., Jr, Leskowitz S. Cutaneous basophil hypersensitivity. 3. Participation of the basophil in hypersensitivity to antigen-antibody complexes, delayed hypersensitivity and contact allergy. Passive transfer. J Immunol. 1971 Jul;107(1):138–148. [PubMed] [Google Scholar]
  279. ELBERG S. S., FONG J., SCHNEIDER P. Studies on tubercle bacillus-monocyte relationship. II. Induction of monocyte degeneration by bacteria and culture filtrate: specificity of serum and monocyte effects on resistance to degeneration. J Exp Med. 1957 Jan 1;105(1):25–37. doi: 10.1084/jem.105.1.25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  280. ELBERG S. S., SCHNEIDER P., FONG J. Cross-immunity between Brucella melitensis and Mycobacterium tuberculosis; intracellular behavior of Brucella melitensis in monocytes from vaccinated animals. J Exp Med. 1957 Oct 1;106(4):545–554. doi: 10.1084/jem.106.4.545. [DOI] [PMC free article] [PubMed] [Google Scholar]
  281. ENGBAEK H. C. LYMPH GLAND PROCESSES CAUSED BY ATYPICAL MYCOBACTERIA AND MYCOBACTERIUM AVIUM. BACTERIOLOGICALLY VERIFIED CASES IN DENMARK FROM 1935 TO 1961. Acta Tuberc Pneumol Scand. 1964;44:108–137. [PubMed] [Google Scholar]
  282. ENGBAEK H. C. THREE CASES IN THE SAME FAMILY OF FATAL INFECTION WITH M. AVIUM. Acta Tuberc Pneumol Scand. 1964;45:105–117. [PubMed] [Google Scholar]
  283. ETEMADI A. H., LEDERER E. BIOSYNTHESE DE L'ACIDE ALPHA-SMEGMA-MYCOLIQUE. Biochim Biophys Acta. 1965 Feb 1;98:159–167. [PubMed] [Google Scholar]
  284. Edmond E., Keay A. J., Wallace A. Avian tuberculosis. Scott Med J. 1968 Nov;13(11):379–381. doi: 10.1177/003693306801301103. [DOI] [PubMed] [Google Scholar]
  285. Edwards L. B., Hopwood L., Palmer C. E. Identification of mycobacterial infections. Bull World Health Organ. 1965;33(3):405–412. [PMC free article] [PubMed] [Google Scholar]
  286. Eisenstein T. K. Evidence for O antigens as the antigenic determinants in "ribosomal" vaccines prepared from Salmonella. Infect Immun. 1975 Aug;12(2):364–377. doi: 10.1128/iai.12.2.364-377.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  287. Eisler D. M., Heckly R. J. Possible mechanisms of action of an anti-Pasteurella pestis factor. J Bacteriol. 1968 Dec;96(6):1977–1981. doi: 10.1128/jb.96.6.1977-1981.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  288. Elek G., Vandra E., Földes I. Production of antibodies against Mycobacterium phlei phage. Acta Microbiol Acad Sci Hung. 1969;16(1):69–75. [PubMed] [Google Scholar]
  289. Elliot B. E., Haskill J. S. Separation of T effector cells in humoral and cellular immunity. Nature. 1974 Dec 13;252(5484):607–608. doi: 10.1038/252607a0. [DOI] [PubMed] [Google Scholar]
  290. Ellouz F., Adam A., Ciorbaru R., Lederer E. Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1974 Aug 19;59(4):1317–1325. doi: 10.1016/0006-291x(74)90458-6. [DOI] [PubMed] [Google Scholar]
  291. Elston H. R., Duffy J. P. Mycobacterium xenopi and mycobacteriosis. A clinical bacteriologic report. Am Rev Respir Dis. 1973 Oct;108(4):944–949. doi: 10.1164/arrd.1973.108.4.944. [DOI] [PubMed] [Google Scholar]
  292. Elting J. J., Southwick W. O. Acute infantile septic arthritis of the hip due to Mycobacterium triviale. A case report. J Bone Joint Surg Am. 1974 Jan;56(1):184–186. [PubMed] [Google Scholar]
  293. Engbaek H. C., Vergmann B., Baess I., Will D. W. M. xenopei: a bacteriological study of M. xenopei including case reports of Danish patients. Acta Pathol Microbiol Scand. 1967;69(4):577–594. [PubMed] [Google Scholar]
  294. Engstrom P. F., Dewey G. C., Barrett O. N., Jr Disseminated Mycobacterium kansasii infection: successful treatment of a patient with pancytopenia. Am J Med. 1972 Apr;52(4):533–537. doi: 10.1016/0002-9343(72)90044-7. [DOI] [PubMed] [Google Scholar]
  295. Epstein W. L. Granulomatous hypersensitivity. Prog Allergy. 1967;11:36–88. [PubMed] [Google Scholar]
  296. Erfle J. D. Acetyl-CoA and propionyl-CoA carboxylation by Mycobacterium phlei. Partial purification and some properties of the enzyme. Biochim Biophys Acta. 1973 Aug 23;316(2):143–155. doi: 10.1016/0005-2760(73)90004-0. [DOI] [PubMed] [Google Scholar]
  297. Espejo R. T., Canelo E. S. Properties of bacteriophage PM2: a lipid-containing bacterial virus. Virology. 1968 Apr;34(4):738–747. doi: 10.1016/0042-6822(68)90094-9. [DOI] [PubMed] [Google Scholar]
  298. Etemadi A. H. Corrélations structurales et biogénétiques des acides mycoliques en rapport avec la phylogenèse de quelques genres d'Actinomycétales. Bull Soc Chim Biol (Paris) 1967;49(6):695–706. [PubMed] [Google Scholar]
  299. Etemadi A. H., Gasche J. Sur l'origine biogénétique du 2-eicosanol et du 2-octadécanol de Mycobacterium avium. Bull Soc Chim Biol (Paris) 1965;47(11):2095–2104. [PubMed] [Google Scholar]
  300. Etémadi A. H. Les acides mycoliques structure, biogenèse et intérêt phylogénétique. Expos Annu Biochim Med. 1967;28:77–109. [PubMed] [Google Scholar]
  301. Evans R., Alexander P. Mechanism of immunologically specific killing of tumour cells by macrophages. Nature. 1972 Mar 24;236(5343):168–170. doi: 10.1038/236168a0. [DOI] [PubMed] [Google Scholar]
  302. Evans R., Alexander P. Rendering macrophages specifically cytotoxic by a factor released from immune lymphoid cells. Transplantation. 1971 Sep;12(3):227–229. doi: 10.1097/00007890-197109000-00015. [DOI] [PubMed] [Google Scholar]
  303. FELDMAN W. H., RITTS R. E. Pathogenecity studies of Group III (Battey) mycobacteria from pulmonary lesions of man. Dis Chest. 1963 Jan;43:26–33. doi: 10.1378/chest.43.1.26. [DOI] [PubMed] [Google Scholar]
  304. FENNER F. The significance of the incubation period in infectious diseases. Med J Aust. 1950 Dec 2;2(23):813–818. doi: 10.5694/j.1326-5377.1950.tb106945.x. [DOI] [PubMed] [Google Scholar]
  305. FISCHEL E. E., KABAT E. A., STOERK H. C., BEZER A. E. The role of tubercle bacilli in adjuvant emulsions on antibody production to egg albumin. J Immunol. 1952 Dec;69(6):611–618. [PubMed] [Google Scholar]
  306. FREEDMAN S. O., TURCOTTE R., FISH A. J., SEHON A. H. The in vitro detection of "cell-fixed" hemagglutinating antibodies to tuberculin purified protein derivative (PPD) in humans. J Immunol. 1963 Jan;90:52–59. [PubMed] [Google Scholar]
  307. FREGNAN G. B., SMITH D. W. Description of various colony forms of mycobacteria. J Bacteriol. 1962 Apr;83:819–827. doi: 10.1128/jb.83.4.819-827.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  308. FREGNAN G. B., SMITH D. W., RANDALL H. M. A mutant of a scotochromogenic Mycobacterium detected by colony morphology and lipid studies. J Bacteriol. 1962 Apr;83:828–836. doi: 10.1128/jb.83.4.828-836.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  309. FREUND J., STONE S. H. The effectiveness of tuberculo-glycolipid as an adjuvant in eliciting allergic encephalomyelitis and aspermatogenesis. J Immunol. 1959 Jun;82(6):560–567. [PubMed] [Google Scholar]
  310. FREUND J. The mode of action of immunologic adjuvants. Bibl Tuberc. 1956;(10):130–148. [PubMed] [Google Scholar]
  311. FRIEDBERG D., SHILO M. INFECTION-PROMOTING ACTIVITY OF HIGH MOLECULAR WEIGHT MICROBIAL POLYSACCHARIDES ON MOUSE PERITONEAL INFECTIONS WITH PASTEURELLA PESTIS. J Infect Dis. 1965 Jun;115:263–270. doi: 10.1093/infdis/115.3.263. [DOI] [PubMed] [Google Scholar]
  312. FROMAN S., LECHTMAN M. D., SCAMMON L., WILL D. W., ECKMANN B. R. Mycobacteriophage lysates as serologic antigens. Am Rev Respir Dis. 1961 Jun;83:901–902. doi: 10.1164/arrd.1961.83.6.901. [DOI] [PubMed] [Google Scholar]
  313. FROMAN S., SCAMMON L. EFFECT OF TEMPERATURE ON THE BACTERIOPHAGE SUSCEPTIBILITY OF STRAINS OF MYCOBACTERIUM AVIUM ISOLATED FROM FOWL. Am Rev Respir Dis. 1964 Feb;89:236–239. doi: 10.1164/arrd.1964.89.2.236. [DOI] [PubMed] [Google Scholar]
  314. FROMAN S., WILL D. W., BOGEN E. Bacteriophage active against virulent Mycobacterium tuberculosis. I. Isolation and activity. Am J Public Health Nations Health. 1954 Oct;44(10):1326–1333. doi: 10.2105/ajph.44.10.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  315. Fagiolo E. Immunochemical study of incomplete platelet autoantibodies by the anti-globulin consumption test (AGCT) with specific anti-immunoglobulin sera. J Immunol Methods. 1976;9(3-4):225–229. doi: 10.1016/0022-1759(76)90197-6. [DOI] [PubMed] [Google Scholar]
  316. Falk G. A., Hadley S. J., Sharkey F. E., Liss M., Muschenheim C. Mycobacterium avium infections in man. Am J Med. 1973 Jun;54(6):801–810. doi: 10.1016/0002-9343(73)90069-7. [DOI] [PubMed] [Google Scholar]
  317. Farber E. R., Tsang A. Mycobacterial ("Buruli") ulcer in a Peace Corps worker. Arch Surg. 1967 Aug;95(2):297–300. doi: 10.1001/archsurg.1967.01330140135030. [DOI] [PubMed] [Google Scholar]
  318. Feinberg K. A., Schneierson S. S. Disseminated infection by Mycobactium fortuitum. J Mt Sinai Hosp N Y. 1969 Sep-Oct;36(5):375–379. [PubMed] [Google Scholar]
  319. Feit C., Tewari R. P. Immunogenicity of Ribosomal Preparations from Yeast Cells of Histoplasma capsulatum. Infect Immun. 1974 Nov;10(5):1091–1097. doi: 10.1128/iai.10.5.1091-1097.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  320. Feldman R. A., Hershfield E. Mycobacterial skin infection by an unidentified species. A report of 29 patients. Ann Intern Med. 1974 Apr;80(4):445–452. doi: 10.7326/0003-4819-80-4-445. [DOI] [PubMed] [Google Scholar]
  321. Feldmann M. Cell interactions in the immune response in vitro. V. Specific collaboration via complexes of antigen and thymus-derived cell immunoglobulin. J Exp Med. 1972 Oct 1;136(4):737–760. doi: 10.1084/jem.136.4.737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  322. Feldmann M., Easten A. The relationship between antigenic structure and the requirement for thymus-derived cells in the immune response. J Exp Med. 1971 Jul 1;134(1):103–119. doi: 10.1084/jem.134.1.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  323. Ferguson J. A., Ballou C. E. Biosynthesis of a mycobacterial lipopolysaccharide. Properties of the polysaccharide methyltransferase. J Biol Chem. 1970 Aug 25;245(16):4213–4223. [PubMed] [Google Scholar]
  324. Fields B. T., Jr, Bishop M. C., Brosbe E. A., Bates J. H. Pulmonary disease caused by Mycobacterium xenopei and Histoplasma capsulatum. A case report. Am Rev Respir Dis. 1969 Apr;99(4):590–594. doi: 10.1164/arrd.1969.99.4P1.590. [DOI] [PubMed] [Google Scholar]
  325. Fife E. H., Jr, Kruse R. H., Toussaint A. J., Staab E. V. Serodiagnosis of simian tuberculosis by soluble antigen fluorescent antibody (SAFA) tests. Lab Anim Care. 1970 Oct;20(5):969–978. [PubMed] [Google Scholar]
  326. Fincher G. B., Sawyer W. H., Stone B. A. Chemical and physical properties of an arabinogalactan-peptide from wheat endosperm. Biochem J. 1974 Jun;139(3):535–545. doi: 10.1042/bj1390535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  327. Fischer D. A., Lester W., Schaefer W. B. Infections with atypical mycobacteria. Five years' experience at the National Jewish Hospital. Am Rev Respir Dis. 1968 Jul;98(1):29–34. doi: 10.1164/arrd.1968.98.1.29. [DOI] [PubMed] [Google Scholar]
  328. Fisher C. A., Barksdale L. Cytochemical reactions of human leprosy bacilli and mycobacteria: ultrastructural implications. J Bacteriol. 1973 Mar;113(3):1389–1399. doi: 10.1128/jb.113.3.1389-1399.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  329. Fisher D. A., Lyss R. S. Letter: Mycobacterium marinum infection. Arch Dermatol. 1974 Apr;109(4):571–571. [PubMed] [Google Scholar]
  330. Fiume L., Wielannd T. Amantis. Chemistry and action. FEBS Lett. 1970 May 11;8(1):1–5. doi: 10.1016/0014-5793(70)80210-1. [DOI] [PubMed] [Google Scholar]
  331. Fleer M. A., Bowman B. U. Partial characterization of mycobacteriophage R1 particles surviving chloroform treatment. Microbios. 1973;7(25):37–44. [PubMed] [Google Scholar]
  332. Flick P. K., Bloch K. Vitro alterations of the product distribution of the fatty synthetase from Mycobacterium phlei. J Biol Chem. 1974 Feb 25;249(4):1031–1036. [PubMed] [Google Scholar]
  333. Flower R. L., Turner K. J., Alpers M. P. Mechanism of an action of an antibacterial murine lymphokine. Nature. 1975 Apr 3;254(5499):459–460. doi: 10.1038/254459a0. [DOI] [PubMed] [Google Scholar]
  334. Flowers D. J. Human infection due to Mycobacterium marinum after a dolphin bite. J Clin Pathol. 1970 Sep;23(6):475–477. doi: 10.1136/jcp.23.6.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  335. Fogan L. Atypical mycobacteria. Their clinical, laboratory, and epidemiologic significance. Medicine (Baltimore) 1970 May;49(3):243–255. [PubMed] [Google Scholar]
  336. Foote C. S. Mechanisms of photosensitized oxidation. There are several different types of photosensitized oxidation which may be important in biological systems. Science. 1968 Nov 29;162(3857):963–970. doi: 10.1126/science.162.3857.963. [DOI] [PubMed] [Google Scholar]
  337. Forney F. W., Markovetz A. J. Oxidative degradation of methyl ketones. II. Chemical pathway for degradation of 2-tridecanone by Pseudomonas multivorans and Pseudomonas aeruginosa. J Bacteriol. 1968 Oct;96(4):1055–1064. doi: 10.1128/jb.96.4.1055-1064.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  338. Forsgren A. Significance of protein a production by staphylococci. Infect Immun. 1970 Nov;2(5):672–673. doi: 10.1128/iai.2.5.672-673.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  339. Forsgren A., Sjöquist J. "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol. 1966 Dec;97(6):822–827. [PubMed] [Google Scholar]
  340. Fox T. G. Non-tuberculous mycobacterial infections. N Z Med J. 1972 Aug;76(483):93–97. [PubMed] [Google Scholar]
  341. Freer J., Kim K. S., Krauss M. R., Beaman L., Barksdale L. Ultrastructural changes in bacteria isolated from cases of leprosy. J Bacteriol. 1969 Nov;100(2):1062–1075. doi: 10.1128/jb.100.2.1062-1075.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  342. Frenkel J. K. Adoptive immunity to intracellular infection. J Immunol. 1967 Jun;98(6):1309–1319. [PubMed] [Google Scholar]
  343. Friedman H. M., Johnson A. G., Pan P. Stimulatory effect of polynucleotides on short term leukocyte cultures. Proc Soc Exp Biol Med. 1969 Dec;132(3):916–918. doi: 10.3181/00379727-132-34336. [DOI] [PubMed] [Google Scholar]
  344. Froman S., Burge R., Gedebou M., Pickett M. J. Serologic testing for tuberculosis. Am Rev Respir Dis. 1968 Feb;97(2):201–205. doi: 10.1164/arrd.1968.97.2.201. [DOI] [PubMed] [Google Scholar]
  345. Fulco A. J. Metabolic alterations of fatty acids. Annu Rev Biochem. 1974;43(0):215–241. doi: 10.1146/annurev.bi.43.070174.001243. [DOI] [PubMed] [Google Scholar]
  346. Furuchi A., Tokunaga T. Nature of the receptor substance of Mycobacterium smegmatis for D4 bacteriophage adsorption. J Bacteriol. 1972 Aug;111(2):404–411. doi: 10.1128/jb.111.2.404-411.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  347. Földes I., Somogyi P. Basenanalyse der Nukleinsäuren von Mykobakterien. Z Tuberk Erkr Thoraxorg. 1968;128(1):151–155. [PubMed] [Google Scholar]
  348. GAISFORD W. The protection of infants against tuberculosis. Br Med J. 1955 Nov 12;2(4949):1164–1171. doi: 10.1136/bmj.2.4949.1164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  349. GASTAMBIDE-ODIER M., LEDERER E. Biosynthesis of corynomycolic acid from two molecules of palmitic acid. Nature. 1959 Nov 14;184(Suppl 20):1563–1564. doi: 10.1038/1841563b0. [DOI] [PubMed] [Google Scholar]
  350. GEORGE M., VAUGHAN J. H. In vitro cell migration as a model for delayed hypersensitivity. Proc Soc Exp Biol Med. 1962 Nov;111:514–521. doi: 10.3181/00379727-111-27841. [DOI] [PubMed] [Google Scholar]
  351. GORDON R. E., MIHM J. M. A comparison of four species of mycobacteria. J Gen Microbiol. 1959 Dec;21:736–748. doi: 10.1099/00221287-21-3-736. [DOI] [PubMed] [Google Scholar]
  352. GORDON R. E., SMITH M. M. Rapidly growing, acid fast bacteria. I. Species' descriptions of Mycobacterium phlei Lehmann and Neumann and Mycobacterium smegmatis (Trevisan) Lehmann and Neumann. J Bacteriol. 1953 Jul;66(1):41–48. doi: 10.1128/jb.66.1.41-48.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  353. GORDON R. E., SMITH M. M. Rapidly growing, acid fast bacteria. II. Species' description of Mycobacterium fortuitum Cruz. J Bacteriol. 1955 May;69(5):502–507. doi: 10.1128/jb.69.5.502-507.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  354. GRAY D. F. Detection of small numbers of mycobacteria in sections by fluorescence microscopy. Am Rev Tuberc. 1953 Jul;68(1):82–95. doi: 10.1164/art.1953.68.1.82. [DOI] [PubMed] [Google Scholar]
  355. Galindo B. Antigen-mediated fusion of specifically sensitized rabbit alveolar macrophages. Infect Immun. 1972 Apr;5(4):583–594. doi: 10.1128/iai.5.4.583-594.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  356. Galindo B., Lazdins J., Castillo R. Fusion of normal rabbit alveolar macrophages induced by supernatant fluids from BCG-sensitized lymph node cells after elicitation by antigen. Infect Immun. 1974 Feb;9(2):212–216. doi: 10.1128/iai.9.2.212-216.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  357. Galindo B., Myrvik Q. N. Migratory response of granulomatous alveolar cells from BCG-sensitized rabbits. J Immunol. 1970 Jul;105(1):227–237. [PubMed] [Google Scholar]
  358. Gangadharam P. R., Hsu K. H. Mycobacterium abscessus infection in a puncture wound. Am Rev Respir Dis. 1972 Aug;106(2):275–277. doi: 10.1164/arrd.1972.106.2.275. [DOI] [PubMed] [Google Scholar]
  359. Gastambide-Odier M., Sarda P. Contribution à l'étude de la structure et de la biosynthèse de glycolipides spécifiques isolés de mycobactéries: les mycosides a et b. Pneumonologie. 1970;142(2):241–255. doi: 10.1007/BF02095222. [DOI] [PubMed] [Google Scholar]
  360. Gastambide-Odier M. Variantes de mycosides caractérisées par des résidus glycosidiques substitués par des chaînes acyles. Nature mycolique des mycosides G. Eur J Biochem. 1973 Feb 15;33(1):81–86. doi: 10.1111/j.1432-1033.1973.tb02657.x. [DOI] [PubMed] [Google Scholar]
  361. Gastambide-Odier M., Villé C. Desoxysucres isolés du mycoside A: identification des dérivés acétylés des méthyl 2,4-DI-O-méthyl-rhamnopyranoside, 2-O-méthyl-rhamnofuranoside, 3-O-méthyl-rhamnofuranoside, 2-O-méthyl-fucopyranoside et 3-O-méthyl-fucofuranoside. Bull Soc Chim Biol (Paris) 1970 Jul 18;52(6):679–693. [PubMed] [Google Scholar]
  362. Gelbart S. M., Juhasz S. E. Genetic transfer in Mycobacterium phlei. J Gen Microbiol. 1970 Dec;64(2):253–254. doi: 10.1099/00221287-64-2-253. [DOI] [PubMed] [Google Scholar]
  363. Gelbart S. M., Juhasz S. E. Transduction in mycobacterium phlei. Antonie Van Leeuwenhoek. 1973;39(1):1–10. doi: 10.1007/BF02578836. [DOI] [PubMed] [Google Scholar]
  364. Germain R. N., Williams R. M., Benacerraf B. Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents. J Natl Cancer Inst. 1975 Mar;54(3):709–720. [PubMed] [Google Scholar]
  365. Gershon R. K. T cell control of antibody production. Contemp Top Immunobiol. 1974;3:1–40. doi: 10.1007/978-1-4684-3045-5_1. [DOI] [PubMed] [Google Scholar]
  366. Ghuysen J. M. Use of bacteriolytic enzymes in determination of wall structure and their role in cell metabolism. Bacteriol Rev. 1968 Dec;32(4 Pt 2):425–464. [PMC free article] [PubMed] [Google Scholar]
  367. Girard D. E., Bagby G. C., Jr, Walsh J. R. Destructive polyarthritis secondary to Mycobacterium kansasii. Arthritis Rheum. 1973 Sep-Oct;16(5):665–669. doi: 10.1002/art.1780160511. [DOI] [PubMed] [Google Scholar]
  368. Glenchur H., Burge R. E., Froman S. Tuberculin activity of mycobacterial fractions obtained by chromatography. Appl Microbiol. 1973 Jan;25(1):5–10. doi: 10.1128/am.25.1.5-10.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  369. Glynn L. E. The chronicity of inflammation and its significance in rheumatoid arthritis. Ann Rheum Dis. 1968 Mar;27(2):105–121. doi: 10.1136/ard.27.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  370. Godwin M. C. Infection of knee joint by Mycobacterium kansasii. JAMA. 1965 Oct 4;194(1):88–89. [PubMed] [Google Scholar]
  371. Goldman D. S. Subcellular localization of individual mannose-containing phospholipids in Mycobacterium tuberculosis. Am Rev Respir Dis. 1970 Oct;102(4):543–555. doi: 10.1164/arrd.1970.102.4.543. [DOI] [PubMed] [Google Scholar]
  372. Goldstein A. L., Guha A., Howe M. L., White A. Ontogenesis of cell-mediated immunity in murine thymocytes and spleen cells and its acceleration by thymosin, a thymic hormone. J Immunol. 1971 Mar;106(3):773–780. [PubMed] [Google Scholar]
  373. Goldstein I. J., Misaki A. Interaction of concanavalin A with an arabinogalactan from the cell wall of Mycobacterium bovis. J Bacteriol. 1970 Aug;103(2):422–425. doi: 10.1128/jb.103.2.422-425.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  374. Gomes N. F., Ioneda T., Pudles J. Purification and chemical constitution of the phospholipids from Corynebacterium diphtheriae PW 8. Nature. 1966 Jul 2;211(5044):81–82. doi: 10.1038/211081a0. [DOI] [PubMed] [Google Scholar]
  375. Goodfellow M., Minnikin D. E., Patel P. V., Mordarska H. Free nocardomycolic acids in the classification of nocardias and strains of the 'rhodochrous' complex. J Gen Microbiol. 1973 Jan;74(1):185–188. doi: 10.1099/00221287-74-1-185. [DOI] [PubMed] [Google Scholar]
  376. Goodfellow M. Numerical taxonomy of some nocardioform bacteria. J Gen Microbiol. 1971 Nov;69(1):33–80. doi: 10.1099/00221287-69-1-33. [DOI] [PubMed] [Google Scholar]
  377. Goodwin T. W. Biosynthesis of carotenoids and plant triterpenes. Biochem J. 1971 Jul;123(3):293–329. doi: 10.1042/bj1230293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  378. Gordon J., White R. G. Surface peptido-glycolipid filaments on Mycobacterium leprae. Clin Exp Immunol. 1971 Oct;9(4):539–547. [PMC free article] [PubMed] [Google Scholar]
  379. Gordon R. E. Some strains in search of a genus--Corynebacterium, Mycobacterium, Nocardia or what? J Gen Microbiol. 1966 Jun;43(3):329–343. doi: 10.1099/00221287-43-3-329. [DOI] [PubMed] [Google Scholar]
  380. Goren M. B., Brokl O., Das B. C., Lederer E. Sulfolipid I of Mycobacterium tuberculosis, strain H37RV. Nature of the acyl substituents. Biochemistry. 1971 Jan 5;10(1):72–81. doi: 10.1021/bi00777a012. [DOI] [PubMed] [Google Scholar]
  381. Goren M. B., Brokl O., Schaefer W. B. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: correlation of virulence with elaboration of sulfatides and strongly acidic lipids. Infect Immun. 1974 Jan;9(1):142–149. doi: 10.1128/iai.9.1.142-149.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  382. Goren M. B., Brokl O., Schaefer W. B. Lipids of putative relevance to virulence in Mycobacterium tuberculosis: phthiocerol dimycocerosate and the attenuation indicator lipid. Infect Immun. 1974 Jan;9(1):150–158. doi: 10.1128/iai.9.1.150-158.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  383. Goren M. B. Cord factor revisited: a tribute to the late Dr. Hubert Bloch. Tubercle. 1975 Mar;56(1):65–71. doi: 10.1016/0041-3879(75)90008-2. [DOI] [PubMed] [Google Scholar]
  384. Goren M. B., McClatchy J. K., Martens B., Brokl O. Mycosides C: behavior as receptor site substance for mycobacteriophage D4. J Virol. 1972 Jun;9(6):999–1003. doi: 10.1128/jvi.9.6.999-1003.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  385. Goren M. B. Mycobacterial lipids: selected topics. Bacteriol Rev. 1972 Mar;36(1):33–64. doi: 10.1128/br.36.1.33-64.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  386. Goren M. B. Mycobacterial sulfolipids: spontaneous desulfation. Lipids. 1971 Jan;6(1):40–46. doi: 10.1007/BF02536373. [DOI] [PubMed] [Google Scholar]
  387. Goren M. B. Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. I. Purification and properties. Biochim Biophys Acta. 1970 Jun 9;210(1):116–126. doi: 10.1016/0005-2760(70)90067-6. [DOI] [PubMed] [Google Scholar]
  388. Goren M. B. Sulfolipid I of Mycobacterium tuberculosis, strain H37Rv. II. Structural studies. Biochim Biophys Acta. 1970 Jun 9;210(1):127–138. doi: 10.1016/0005-2760(70)90068-8. [DOI] [PubMed] [Google Scholar]
  389. Gould W. M., McMeekin D. R., Bright R. D. Mycobacterium marinum (balnei) infection. Report of a case with cutaneous and laryngeal lesions. Arch Dermatol. 1968 Feb;97(2):159–162. doi: 10.1001/archderm.97.2.159. [DOI] [PubMed] [Google Scholar]
  390. Grabar P. Hypothesis. Auto-antibodies and immunological theories: an analytical review. Clin Immunol Immunopathol. 1975 Nov;4(4):453–466. doi: 10.1016/0090-1229(75)90087-2. [DOI] [PubMed] [Google Scholar]
  391. Grange J. M., Nordstrom G. Bacteriophage typing of Mycobacterium ranae (Fortuitum). The correlation of lysis by mycobacteriophage BK4 and inositol utilisation. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Aug;81(4):408–412. doi: 10.1111/j.1699-0463.1973.tb02223.x. [DOI] [PubMed] [Google Scholar]
  392. Granger D. L., Yamamoto K. I., Ribi E. Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets. J Immunol. 1976 Feb;116(2):482–488. [PubMed] [Google Scholar]
  393. Grant J. Selective mycobacteriophage isolation with membrane filters. Appl Microbiol. 1971 Jun;21(6):1091–1091. doi: 10.1128/am.21.6.1091-1091.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  394. Gray G. R., Ballou C. E. The 6-O-methylglucose-containing lipopolysaccharides of Mycobacterium phlei. Locations of the acyl groups. J Biol Chem. 1972 Dec 25;247(24):8129–8135. [PubMed] [Google Scholar]
  395. Graybill J. R., Silva J., Jr, Fraser D. W., Lordon R., Rogers E. Disseminated mycobacteriosis due to Mycobacterium abcessus in two recipients of renal homografts. Am Rev Respir Dis. 1974 Jan;109(1):4–10. doi: 10.1164/arrd.1974.109.1.4. [DOI] [PubMed] [Google Scholar]
  396. Greenawalt J. W., Whiteside T. L. Mesosomes: membranous bacterial organelles. Bacteriol Rev. 1975 Dec;39(4):405–463. doi: 10.1128/br.39.4.405-463.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  397. Greenberg A. H., Greene M. Non-adaptive rejection of small tumour inocula as a model of immune surveillance. Nature. 1976 Nov 25;264(5584):356–359. doi: 10.1038/264356a0. [DOI] [PubMed] [Google Scholar]
  398. Gregonis D. E., Rilling H. C. The stereochemistry of trans-phytoene synthesis. Some observations on lycopersene as a carotene precursor and a mechanism for the synthesis of cis- and trans-phytoene. Biochemistry. 1974 Mar 26;13(7):1538–1542. doi: 10.1021/bi00704a033. [DOI] [PubMed] [Google Scholar]
  399. Grellert E., Ballou C. E. Biosynthesis of a mycobacterial lipopolysaccharide. Evidence for an acylpolysaccharide methyltransferase. J Biol Chem. 1972 May 25;247(10):3236–3241. [PubMed] [Google Scholar]
  400. Grillo-López A. J., Rivera E., Castillo-Staab M., Maldonado N. Disseminated M. kansasii infection in a patient with chronic granulocytic leukemia. Cancer. 1971 Aug;28(2):476–481. doi: 10.1002/1097-0142(197108)28:2<476::aid-cncr2820280229>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  401. Grosset J., Decroix G., Sors C. Les tuberculoses à Mycobacterium africanum chez les noirs africains de la région parisienne. Rev Tuberc Pneumol (Paris) 1971 Jun;35(4):430–436. [PubMed] [Google Scholar]
  402. Gruft H., Henning H. G. Pulmonary mycobacteriosis due to rapidly growing acid-fast bacillus, Mycobacterium chelonei. Am Rev Respir Dis. 1972 Apr;105(4):618–620. doi: 10.1164/arrd.1972.105.4.618. [DOI] [PubMed] [Google Scholar]
  403. Gruft H., Loder A. Enhancing effects of carbon dioxide on the primary isolation of acid-fast bacilli in a modified Lowenstein-Jensen medium. Appl Microbiol. 1971 Nov;22(5):944–945. doi: 10.1128/am.22.5.944-945.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  404. Gunnels J. J., Bates J. H. Characterization and mycobacteriophage typing of Mycobacterium xenopi. Am Rev Respir Dis. 1972 Mar;105(3):388–392. doi: 10.1164/arrd.1972.105.3.388. [DOI] [PubMed] [Google Scholar]
  405. Gunthorpe W. J., Stanford J. L. A study of Mycobacterium gordonae and Mycobacterium marianum (Scrofulaceum). Br J Exp Pathol. 1972 Dec;53(6):665–671. [PMC free article] [PubMed] [Google Scholar]
  406. HOLLAND J. J., PICKETT M. J. A cellular basis of immunity in experimental Brucella infection. J Exp Med. 1958 Sep 1;108(3):343–360. doi: 10.1084/jem.108.3.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  407. HORWITZ O., MEYER J. The safety record of BCG vaccination and untoward reactions observed after vaccination. Bibl Tuberc. 1957;13(12):245–271. [PubMed] [Google Scholar]
  408. HUGHES D. E., MOSS E. S., HOOD M., HENSON M. Virulence of Mycobacterium tuberculosis: evaluation of a test, using neutral red indicator. Am J Clin Pathol. 1954 May;24(5):621–625. doi: 10.1093/ajcp/24.5_ts.621. [DOI] [PubMed] [Google Scholar]
  409. Habib N. I., Warring F. C., Jr A fatal case of infection due to Mycobacterium bovis. Am Rev Respir Dis. 1966 May;93(5):804–810. doi: 10.1164/arrd.1966.93.5.804. [DOI] [PubMed] [Google Scholar]
  410. Hagihara Y., Shikada K. The base compositions of deoxyribonucleic acid isolated from mycobacteria. Kekkaku. 1969 Oct;44(10):321–324. [PubMed] [Google Scholar]
  411. Hagmar B., Kutti J., Lundin P., Norlin M., Weinfeld A., Wåhlén P. Disseminated infection caused by Mycobacterium kansasii. Report of a case and brief review of the literature. Acta Med Scand. 1969 Jul-Aug;186(1-2):93–99. [PubMed] [Google Scholar]
  412. Hahn H., Bierther M. Morphological changes induced by dextran sulfate 500 in mononuclear phagocytes of listeria-infected mice. Infect Immun. 1974 Nov;10(5):1110–1119. doi: 10.1128/iai.10.5.1110-1119.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  413. Hahn H. Effects of Dextran Sulfate 500 on Cell-Mediated Resistance to Infection with Listeria monocytogenes in Mice. Infect Immun. 1974 Nov;10(5):1105–1109. doi: 10.1128/iai.10.5.1105-1109.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  414. Hand W. L., Sanford J. P. Mycobacterium fortuitum--a human pathogen. Ann Intern Med. 1970 Dec;73(6):971–977. doi: 10.7326/0003-4819-73-6-971. [DOI] [PubMed] [Google Scholar]
  415. Harada K. Effect of prior oxidation on the acid-fastness of mycobacteria. Stain Technol. 1973 Nov;48(6):269–273. doi: 10.3109/10520297309116640. [DOI] [PubMed] [Google Scholar]
  416. Harrison S. C., Caspar D. L., Camerini-Otero R. D., Franklin R. M. Lipid and protein arrangement in bacteriophage PM2. Nat New Biol. 1971 Feb 17;229(7):197–201. doi: 10.1038/newbio229197a0. [DOI] [PubMed] [Google Scholar]
  417. Hart P. D., Armstrong J. A., Brown C. A., Draper P. Ultrastructural study of the behavior of macrophages toward parasitic mycobacteria. Infect Immun. 1972 May;5(5):803–807. doi: 10.1128/iai.5.5.803-807.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  418. Hart P. D., Armstrong J. A. Strain virulence and the lysosomal response in macrophages infected with Mycobacterium tuberculosis. Infect Immun. 1974 Oct;10(4):742–746. doi: 10.1128/iai.10.4.742-746.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  419. Hart P. D. Efficacy and applicability of mass B. C.G. vaccination in tuberculosis control. Br Med J. 1967 Mar 11;1(5540):587–592. doi: 10.1136/bmj.1.5540.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  420. Hart P. D., Gordon A. H. Suggested role of lysosomal lipid in the contrasting effects of 'triton WR-1339' and dextran on tuberculous infection. Nature. 1969 May 17;222(5194):672–673. doi: 10.1038/222672a0. [DOI] [PubMed] [Google Scholar]
  421. Heise E. R., Han S., Weiser R. S. In vitro studies on the mechanism of macrophage migration inhibition in tuberculin sensitivity. J Immunol. 1968 Nov;101(5):1004–1015. [PubMed] [Google Scholar]
  422. Hepper N. G., Karlson A. G., Leary F. J., Soule E. H. Genitourinary infection due to Mycobacterium kansasii. Mayo Clin Proc. 1971 Jun;46(6):387–390. [PubMed] [Google Scholar]
  423. Herberman R. B., Nunn M. E., Holden H. T., Lavrin D. H. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer. 1975 Aug 15;16(2):230–239. doi: 10.1002/ijc.2910160205. [DOI] [PubMed] [Google Scholar]
  424. Herndon J. H., Dantzker D. R., Lanoue A. M. Mycobacterium fortuitum infections involving the extremities. Report of three cases. J Bone Joint Surg Am. 1972 Sep;54(6):1279–1282. [PubMed] [Google Scholar]
  425. Hertzberg S., Jensen S. L. Bacterial carotenoids. XIX. The carotenoids of Mycobacterium phlei strain Vera. 1. The structures of the minor carotenoids. Acta Chem Scand. 1966;20(5):1187–1194. doi: 10.3891/acta.chem.scand.20-1187. [DOI] [PubMed] [Google Scholar]
  426. Hertzberg S., Liaaen Jensen S. Bacterial carotenoids XX. The carotenoids of Mycobacterium phlei strain Vera. 2. The structures of the phlei-xanthophylls--two novel tertiary glucosides. Acta Chem Scand. 1967;21(1):15–41. [PubMed] [Google Scholar]
  427. Hesselberg I. Drug resistance in the Swedish/Norwegian BCG strain. Bull World Health Organ. 1972;46(4):503–507. [PMC free article] [PubMed] [Google Scholar]
  428. Hetey L., Vandra E., Földes I. In vitro synthesis of antibody to phages of Mycobacterium phlei. Acta Microbiol Acad Sci Hung. 1968;15(2):125–127. [PubMed] [Google Scholar]
  429. Higashi Y., Strominger J. L., Sweeley C. C. Structure of a lipid intermediate in cell wall peptidoglycan synthesis: a derivative of a C55 isoprenoid alcohol. Proc Natl Acad Sci U S A. 1967 Jun;57(6):1878–1884. doi: 10.1073/pnas.57.6.1878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  430. Hill D. L., Ballou C. E. Biosynthesis of mannophospholipids by Mycobacterium phlei. J Biol Chem. 1966 Feb 25;241(4):895–902. [PubMed] [Google Scholar]
  431. Hill E. B., Wayne L. G., Gross W. M. Purification of mycobacterial deoxyribonucleic acid. J Bacteriol. 1972 Dec;112(3):1033–1039. doi: 10.1128/jb.112.3.1033-1039.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  432. Hobby G. L., Redmond W. B., Runyon E. H., Schaefer W. B., Wayne L. G., Wichelhausen R. H. A study on pulmonary disease associated with mycobacteria other than Mycobacterium tuberculosis: identification and characterization of the mycobacteria. 18. A report of the Veterans Administration-Armed Forces Cooperative Study. Am Rev Respir Dis. 1967 Jun;95(6):954–971. doi: 10.1164/arrd.1967.95.6.954. [DOI] [PubMed] [Google Scholar]
  433. Holmes R. K., Barksdale L. Comparative studies with tox plus and tox minus corynebacteriophages. J Virol. 1970 Jun;5(6):783–784. doi: 10.1128/jvi.5.6.783-794.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  434. Holmes R. K., Barksdale L. Genetic analysis of tox+ and tox- bacteriophages of Corynebacterium diphtheriae. J Virol. 1969 Jun;3(6):586–598. doi: 10.1128/jvi.3.6.586-598.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  435. Hopwood D. A., Chater K. F., Dowding J. E., Vivian A. Advances in Streptomyces coelicolor genetics. Bacteriol Rev. 1973 Sep;37(3):371–405. doi: 10.1128/br.37.3.371-405.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  436. Houbouyan L., Soria J., Soria C., Goguel A. Analysis of an autoimmune antibody (IgM class) in a case of chronic lymphocytic leukaemia. Haemostasis. 1974;3(3):171–182. doi: 10.1159/000214053. [DOI] [PubMed] [Google Scholar]
  437. Houchens D. P., Goldberg A. I., Gaston M. R., Kende M., Goldin A. Studies of the effects of Bacillus Calmette-Guérin on Moloney sarcoma virus-induced tumors in normal and immunosuppressed mice. Cancer Res. 1973 Apr;33(4):685–690. [PubMed] [Google Scholar]
  438. Howes C. D., Batra P. P. Accumulation of lycopene and inhibition of cyclic carotenoids in Mycobacterium in the presence of nicotine. Biochim Biophys Acta. 1970 Oct 27;222(1):174–179. doi: 10.1016/0304-4165(70)90362-4. [DOI] [PubMed] [Google Scholar]
  439. Howes C. D., Batra P. P., Blakeley C. F. Absolute requirement for oxygen during illumination for photoinduced carotenoid synthesis. Biochim Biophys Acta. 1969 Oct 21;189(2):298–299. doi: 10.1016/0005-2728(69)90056-5. [DOI] [PubMed] [Google Scholar]
  440. Howes C. D., Batra P. P. Mechanism of photoinduced carotenoid synthesis. Further studies on the action spectrum and other aspects of carotenogenesis. Arch Biochem Biophys. 1970 Mar;137(1):175–180. doi: 10.1016/0003-9861(70)90424-8. [DOI] [PubMed] [Google Scholar]
  441. Huempener H. R., Kingsolver W. R., Deuschle K. W. Tuberculous meningitis caused by both Mycobacterium tuberculosis and atypical mycobacteria. Am Rev Respir Dis. 1966 Oct;94(4):612–614. doi: 10.1164/arrd.1966.94.4.612. [DOI] [PubMed] [Google Scholar]
  442. Ilton M., Jevans A. W., McCarthy E. D., Vance D., White H. B., 3rd, Bloch K. Fatty acid synthetase activity in Mycobacterium phlei: regulation by polysaccharides. Proc Natl Acad Sci U S A. 1971 Jan;68(1):87–91. doi: 10.1073/pnas.68.1.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  443. Imaeda T. Electron microscopy. Approach to leprosy research. Int J Lepr. 1965 Jul-Sep;33(3 Suppl):669–688. [PubMed] [Google Scholar]
  444. Imaeda T., Rieber M. Mitomycin C-induced phage-like particles in a mutant of Mycobacterium tuberculosis BCG. J Bacteriol. 1968 Aug;96(2):557–559. doi: 10.1128/jb.96.2.557-559.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  445. Ingraham M. A., Steenbock H. The relation of micro-organisms to carotenoids and vitamin A: The production of carotenoids by Mycobacterium phlei. Biochem J. 1935 Nov;29(11):2553–2562. doi: 10.1042/bj0292553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  446. Inman P. M., Beck A., Brown A. E., Stanford J. L. Outbreak of injection abscesses due to Mycobacterium abscessus. Arch Dermatol. 1969 Aug;100(2):141–147. [PubMed] [Google Scholar]
  447. Ishibashi T., Fijiwara Y., Tanaka A., Sugiyama K. Antigenicity of wax D. IV. Its relationship to other hemagglutination reactions. Int Arch Allergy Appl Immunol. 1969;36(5):506–514. [PubMed] [Google Scholar]
  448. Ishibashi T., Hagimoto D., Shinozaki S., Tanaka A., Sugiyama K. Immunological adjuvants. V. A critical evaluation of minimal requirements for mycobacterial adjuvants to induce delayed hypersensitivity. Jpn J Exp Med. 1971 Apr;41(2):95–102. [PubMed] [Google Scholar]
  449. JACOB F., WOLLMAN E. L. Etude génétique d'un bactériophage tempéré d'Escherichia coli. III. Effet du rayonnement ultraviolet sur la recombinaison génétique. Ann Inst Pasteur (Paris) 1955 Jun;88(6):724–749. [PubMed] [Google Scholar]
  450. JAHN R. P. Silicosis and avian tuberculosis. Am Rev Respir Dis. 1959 Jul;80(1 Pt 1):78–84. doi: 10.1164/arrd.1959.80.1P1.78. [DOI] [PubMed] [Google Scholar]
  451. JENSEN S. L., COHEN-BAZIRE G., STANIER R. Y. Biosynthesis of carotenoids in purple bacteria: a reevaluation based on considerations of chemical structure. Nature. 1961 Dec 23;192:1168–1172. doi: 10.1038/1921168a0. [DOI] [PubMed] [Google Scholar]
  452. JOLLES P., BIGLER F., GENDRE T., LEDERER E. [On the chemical structure of "myoside C", a peptide-glycolipid from Mycobacterium avium]. Bull Soc Chim Biol (Paris) 1961;43:177–192. [PubMed] [Google Scholar]
  453. JOLLES P., SAMOUR MIGLIORE D., DEWIJS H., LEDERER E. CORRELATION OF ADJUVANT ACTIVITY AND CHEMICAL STRUCTURE OF MYCOBACTERIAL WAX D FRACTIONS: THE IMPORTANCE OF AMINO SUGARS. Biochim Biophys Acta. 1964 Nov 1;83:361–363. doi: 10.1016/0926-6526(64)90018-7. [DOI] [PubMed] [Google Scholar]
  454. JOLLES P., SAMOUR D., LEDERER E. ISOLEMENT DE FRACTIONS PEPTIDO-GLYCOLIPIDIQUES 'A PARTIR DES CIRES D DE MYCOBACT'ERIES BOVINES, ATYPIQUES, AVIAIRES ET SAPROPHYTES. Biochim Biophys Acta. 1963 Oct 29;78:342–350. doi: 10.1016/0006-3002(63)91644-5. [DOI] [PubMed] [Google Scholar]
  455. JOLLES P., SMOUR D., LEDERER E. Analytical studies on wax D, a macromolecular peptidoglycoplied fraction from humn strains of Mycobacterium tuberculosos. Arch Biochem Biophys. 1962 Sep;Suppl 1:283–289. [PubMed] [Google Scholar]
  456. JUHASZ S. E., BOENICKE R. POSSIBLE CLASSIFICATION OF RAPIDLY GROWING MYCOBACTERIA ON THE BASIS OF THEIR PHAGE SUSCEPTIBILITY. Can J Microbiol. 1965 Apr;11:235–241. doi: 10.1139/m65-030. [DOI] [PubMed] [Google Scholar]
  457. Janicki B. W., Aron S. A., Schechter G. P., McFarland W. Tuberculin antigens active in human lymphocyte blastogenesis. Proc Soc Exp Biol Med. 1972 Dec;141(3):809–813. doi: 10.3181/00379727-141-36877. [DOI] [PubMed] [Google Scholar]
  458. Janicki B. W., Chaparas S. D., Daniel T. M., Kubica G. P., Wright G. L., Yee G. S. A reference system for antigens of Mycobacterium tuberculosis. Am Rev Respir Dis. 1971 Oct;104(4):602–604. doi: 10.1164/arrd.1971.104.4.602. [DOI] [PubMed] [Google Scholar]
  459. Jenkins P. A., Marks J., Schaefer W. B. Lipid chromatography and seroagglutination in the classification of rapidly growing mycobacteria. Am Rev Respir Dis. 1971 Feb;103(2):179–187. doi: 10.1164/arrd.1971.103.2.179. [DOI] [PubMed] [Google Scholar]
  460. Johanson W. G., Jr, Nicholson D. P. Pulmonary disease due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis. Am Rev Respir Dis. 1969 Jan;99(1):73–85. doi: 10.1164/arrd.1969.99.1.73. [DOI] [PubMed] [Google Scholar]
  461. Johnson J. H., Reed B. C., Rilling H. C. Early photoinduced enzymes of photoinduced carotenogenesis in a Mycobacterium species. J Biol Chem. 1974 Jan 25;249(2):402–406. [PubMed] [Google Scholar]
  462. Jolly H. W., Jr, Seabury J. H. Infections with Myocbacterium marinum. Arch Dermatol. 1972 Jul;106(1):32–36. [PubMed] [Google Scholar]
  463. Jones T., Youmans G. P. Nonspecific inhibition of growth of intracellular Listeria monocytogenes by lymphocyte culture products. Infect Immun. 1974 Feb;9(2):472–474. doi: 10.1128/iai.9.2.472-474.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  464. Jones W. D., David H. L., Beam R. E. The occurrence of lipids in Mycobacteriophage D29 propagated in Mycobacterium smegmatis ATCC 607. Am Rev Respir Dis. 1970 Nov;102(5):814–817. doi: 10.1164/arrd.1970.102.5.814. [DOI] [PubMed] [Google Scholar]
  465. Jones W. D., David H. L. Preliminary observations on the occurrence of a streptomycin R-factor in Mycobacterium smegmatis ATCC 607. Tubercle. 1972 Mar;53(1):35–42. doi: 10.1016/0041-3879(72)90044-x. [DOI] [PubMed] [Google Scholar]
  466. Jones W. D., Jr, Abbott V. D., Vestal A. L., Kubica G. P. A hitherto undescribed group of nonchromogenic mycobacteria. Am Rev Respir Dis. 1966 Nov;94(5):790–795. doi: 10.1164/arrd.1966.94.5.790. [DOI] [PubMed] [Google Scholar]
  467. Juhlin I. Contribution to the classification of mycobacteria and nocardias. Acta Pathol Microbiol Scand. 1967;70(Suppl):1+–1+. [PubMed] [Google Scholar]
  468. Juhlin I., Winblad S. Sero-typing of mycobacteria by a new technique using antibody globulin adsorbed to staphylococcal protein A. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Feb;81(1):179–180. doi: 10.1111/j.1699-0463.1973.tb02203.x. [DOI] [PubMed] [Google Scholar]
  469. KELLENBERGER E. Vegetative bacteriophage and the maturation of the virus particles. Adv Virus Res. 1961;8:1–61. doi: 10.1016/s0065-3527(08)60682-x. [DOI] [PubMed] [Google Scholar]
  470. KELLER R. H., RUNYON E. H. MYCOBACTERIAL DISEASES. Am J Roentgenol Radium Ther Nucl Med. 1964 Sep;92:528–539. [PubMed] [Google Scholar]
  471. KINCADE G. F. Avian tuberculosis in the human. Can Med Assoc J. 1959 Jan 1;80(1):32–34. [PMC free article] [PubMed] [Google Scholar]
  472. KOTANI S., HASHIMOTO S., MATSUBARA T., KATO K., HARADA K., KOGAMI J. LYSIS OF ISOLATED BCG CELL WALLS WITH ENZYMES. 2. DEMONSTRATION OF 'BOUND WAX D' AS A COMPONENT OF BCG CELL WALLS. Biken J. 1963 Oct;6:181–196. [PubMed] [Google Scholar]
  473. KUBICA G. P., BEAM R. E., PALMER J. W. A METHOD FOR THE ISOLATION OF UNCLASSIFIED ACID-FAST BACILLI FROM SOIL AND WATER. Am Rev Respir Dis. 1963 Nov;88:718–720. doi: 10.1164/arrd.1963.88.5.718. [DOI] [PubMed] [Google Scholar]
  474. KUNKEL H. G., TAN E. M. AUTOANTIBODIES AND DISEASE. Adv Immunol. 1964;27:351–395. doi: 10.1016/s0065-2776(08)60711-7. [DOI] [PubMed] [Google Scholar]
  475. Kanai K. Affinity of lysosomal acid phosphatase to the surface of the tubercle bacillus. Jpn J Med Sci Biol. 1967 Oct;20(5):401–411. doi: 10.7883/yoken1952.20.401. [DOI] [PubMed] [Google Scholar]
  476. Kanai K. Detection of host-originated acid phosphatase on the surface of "in vivo grown tubercle bacilli". Jpn J Med Sci Biol. 1967 Feb;20(1):73–90. [PubMed] [Google Scholar]
  477. Kanai K., Kondo E. A suggested role of the lysosomal membrane as a part of the defence mechanism against tuberculous infection. Jpn J Med Sci Biol. 1970 Oct;23(5):295–302. doi: 10.7883/yoken1952.23.295. [DOI] [PubMed] [Google Scholar]
  478. Kanai K. Resistance to sodium hydroxide treatment of "in vivo grown tubercle bacilli". Jpn J Med Sci Biol. 1967 Feb;20(1):91–96. [PubMed] [Google Scholar]
  479. Kanai K., Wiegeshaus E., Smith D. W. Demonstration of mycolic acid and phthiocerol dimycocerosate in "in vivo grown tubercle bacilli". Jpn J Med Sci Biol. 1970 Oct;23(5):327–333. [PubMed] [Google Scholar]
  480. Kanemasa Y., Goldman D. S. Direct incorporation of octanoate into long-chain fatty acids by soluble enzymes of Mycobacterium tuberculosis. Biochim Biophys Acta. 1965 Jun 1;98(3):476–485. doi: 10.1016/0005-2760(65)90144-x. [DOI] [PubMed] [Google Scholar]
  481. Kanetsuna F., Blas G. S. Chemical analysis of a mycolic acid-arabinogalactan-mucopeptide complex of mycobacterial cell wall. Biochim Biophys Acta. 1970 Jun;208(3):434–443. doi: 10.1016/0304-4165(70)90216-3. [DOI] [PubMed] [Google Scholar]
  482. Kanetsuna F. Chemical analyses of mycobacterial cell walls. Biochim Biophys Acta. 1968 Apr 16;158(1):130–143. doi: 10.1016/0304-4165(68)90080-9. [DOI] [PubMed] [Google Scholar]
  483. Kantzler G. B., Lauteria S. F., Cusumano C. L., Lee J. D., Ganguly R., Waldman R. H. Immunosuppression during influenza virus infection. Infect Immun. 1974 Nov;10(5):996–1002. doi: 10.1128/iai.10.5.996-1002.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  484. Kaplan H., Clayton M. Carpal tunnel syndrome secondary to Mycobacterium kansasii infection. JAMA. 1969 May 19;208(7):1186–1188. [PubMed] [Google Scholar]
  485. Karassova V., Weissfeiler J., Krasznay E. Occurrence of atypical mycobacteria in Macacus rhesus. Acta Microbiol Acad Sci Hung. 1965;12(3):275–282. [PubMed] [Google Scholar]
  486. Karlson A. G., Carr D. T. Tuberculosis caused by Mycobacterium bovis. Report of sex cases: 1954-1968. Ann Intern Med. 1970 Dec;73(6):979–983. doi: 10.7326/0003-4819-73-6-979. [DOI] [PubMed] [Google Scholar]
  487. Kataoka T., Nojima S. The phospholipid compositions of some Actinomycetes. Biochim Biophys Acta. 1967 Dec 5;144(3):681–683. doi: 10.1016/0005-2760(67)90058-6. [DOI] [PubMed] [Google Scholar]
  488. Kataria Y. P. Observations on human infection with Mycobacterium bovis. Tubercle. 1969 Mar;50(1):14–21. doi: 10.1016/0041-3879(69)90004-x. [DOI] [PubMed] [Google Scholar]
  489. Kato K., Strominger J. L., Kotani S. Structure of the cell wall of Corynebacterium diphtheriae. I. Mechanism of hydrolysis by the L-3 enzyme and the structure of the peptide. Biochemistry. 1968 Aug;7(8):2762–2773. doi: 10.1021/bi00848a010. [DOI] [PubMed] [Google Scholar]
  490. Kato M. Antibody formation to trehalose-6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis. Infect Immun. 1972 Feb;5(2):203–212. doi: 10.1128/iai.5.2.203-212.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  491. Kato M., Asselineau J. Chemical structure and biochemical activity of cord factor analogs. 6,6'-Dimycoloyl sucrose and methyl 6-mycoloyl- -D-glucoside. Eur J Biochem. 1971 Oct 14;22(3):364–370. doi: 10.1111/j.1432-1033.1971.tb01553.x. [DOI] [PubMed] [Google Scholar]
  492. Kato M. Effect of anti-cord factor antibody on experimental tuberculosis in mice. Infect Immun. 1973 Jan;7(1):14–21. doi: 10.1128/iai.7.1.14-21.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  493. Kato M. Further study on neutralization of biochemical activity of cord factor by anti-cord factor antibody. Infect Immun. 1974 Jul;10(1):277–279. doi: 10.1128/iai.10.1.277-279.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  494. Kato M., Goren M. B. Synergistic action of cord factor and mycobacterial sulfatides on mitochondria. Infect Immun. 1974 Oct;10(4):733–741. doi: 10.1128/iai.10.4.733-741.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  495. Kato M. Immunochemical properties of anti-cord factor antibody. Infect Immun. 1973 Jan;7(1):9–13. doi: 10.1128/iai.7.1.9-13.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  496. Kato M., Maeda J. Isolation and biochemical activities of trehalose-6-monomycolate of Mycobacterium tuberculosis. Infect Immun. 1974 Jan;9(1):8–14. doi: 10.1128/iai.9.1.8-14.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  497. Kato M. Site II-specific inhibition of mitochondria oxidative phosphorylation by trehalose-6,6'-dimycolate (cord factor) of Mycobacterium tuberculosis. Arch Biochem Biophys. 1970 Oct;140(2):379–390. doi: 10.1016/0003-9861(70)90079-2. [DOI] [PubMed] [Google Scholar]
  498. Kato M., Tanaka A. Studies of a biochemical lesion in experimental tuberculosis in mice. V. Further study on a toxic lipid fraction in firmly bound lipids. Am Rev Respir Dis. 1967 Sep;96(3):460–468. doi: 10.1164/arrd.1967.96.3.460. [DOI] [PubMed] [Google Scholar]
  499. Kato M. The role of cord factor in pathogenesis of tuberculosis. Jpn J Med Sci Biol. 1971 Feb;24(1):47–51. [PubMed] [Google Scholar]
  500. Katz D. H., Benacerraf B. The regulatory influence of activated T cells on B cell responses to antigen. Adv Immunol. 1972;15:1–94. doi: 10.1016/s0065-2776(08)60683-5. [DOI] [PubMed] [Google Scholar]
  501. Keller J., Ballou C. E. The 6-O-methylglucose-containing lipopolysaccharide of Mycobacterium phlei. Identification of the lipid components. J Biol Chem. 1968 Jun 10;243(11):2905–2910. [PubMed] [Google Scholar]
  502. Khuller G. K., Brennan P. J. Further studies on the lipids of corynebacteria. The mannolipids of Corynebacterium aquaticum. Biochem J. 1972 Apr;127(2):369–373. doi: 10.1042/bj1270369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  503. Khuller G. K., Brennan P. J. The mannophosphoinositides of the unclassified Mycobacterium P 6 . Am Rev Respir Dis. 1972 Dec;106(6):892–896. doi: 10.1164/arrd.1972.106.6.892. [DOI] [PubMed] [Google Scholar]
  504. Khuller G. K., Brennan P. J. The polar lipids of some species of Nocardia. J Gen Microbiol. 1972 Nov;73(2):409–412. doi: 10.1099/00221287-73-2-409. [DOI] [PubMed] [Google Scholar]
  505. Khuller G. K., Subrahmanyam D. Antigenicity of phosphatidyl inositomannosides of Mycobacterium tuberculosis. Immunochemistry. 1971 Mar;8(3):251–256. doi: 10.1016/0019-2791(71)90479-4. [DOI] [PubMed] [Google Scholar]
  506. Kiessling R., Klein E., Pross H., Wigzell H. "Natural" killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell. Eur J Immunol. 1975 Feb;5(2):117–121. doi: 10.1002/eji.1830050209. [DOI] [PubMed] [Google Scholar]
  507. Kiessling R., Petranyi G., Kärre K., Jondal M., Tracey D., Wigzell H. Killer cells: a functional comparison between natural, immune T-cell and antibody-dependent in vitro systems. J Exp Med. 1976 Apr 1;143(4):772–780. doi: 10.1084/jem.143.4.772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  508. Kim K. S., Salton M. R., Barksdale L. Ultrastructure of superficial mycosidic integuments of Mycobacterium sp. J Bacteriol. 1976 Feb;125(2):739–743. doi: 10.1128/jb.125.2.739-743.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  509. Klebanoff S. J. Myeloperoxidase: contribution to the microbicidal activity of intact leukocytes. Science. 1970 Sep 11;169(3950):1095–1097. doi: 10.1126/science.169.3950.1095. [DOI] [PubMed] [Google Scholar]
  510. Kleinig H. Inhibition of carotenoid synthesis in Myxococcus fulvus (Myxobacterales). Arch Microbiol. 1974 May 16;97(3):217–226. doi: 10.1007/BF00403061. [DOI] [PubMed] [Google Scholar]
  511. Klun C. L., Youmans G. P. The effect of lymphocyte supernatant fluids on the intracellular growth of virulent tubercle bacilli. J Reticuloendothel Soc. 1973 Mar;13(3):263–274. [PubMed] [Google Scholar]
  512. Klun C. L., Youmans G. P. The induction by Listeria monocytogenes and plant mitogens of lymphocyte supernatant fluids which inhibit the growth of Mycobacterium tuberculosis within macrophages in vitro. J Reticuloendothel Soc. 1973 Mar;13(3):275–285. [PubMed] [Google Scholar]
  513. Knoche H. W., Koths K. E. Characterization of a fatty acid synthetase from Corynebacterium diphtheriae. J Biol Chem. 1973 May 25;248(10):3517–3519. [PubMed] [Google Scholar]
  514. Knoche H., Esders T. W., Koths K., Bloch K. Palmityl coenzyme A inhibition of fatty acid synthesis. Relief by bovine serum albumin and mycobacterial polysaccharides. J Biol Chem. 1973 Apr 10;248(7):2317–2322. [PubMed] [Google Scholar]
  515. Kochan I., Golden C. A. Immunological nature of antimycobacterial phenomenon in macrophages. Infect Immun. 1974 Feb;9(2):249–254. doi: 10.1128/iai.9.2.249-254.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  516. Kochan I. The role of iron in bacterial infections, with special consideration of host-tubercle bacillus interaction. Curr Top Microbiol Immunol. 1973;60:1–30. doi: 10.1007/978-3-642-65502-9_1. [DOI] [PubMed] [Google Scholar]
  517. Koenig M. G., Collins R. D., Heyssel R. M. Disseminated mycobacteriosis caused by Battey type mycobacteria. Ann Intern Med. 1966 Jan;64(1):145–154. doi: 10.7326/0003-4819-64-1-145. [DOI] [PubMed] [Google Scholar]
  518. Kolmanová A., Hochmannová J., Málek I. Carotenoids synthesized by UV-induced mutants of a non-acid-fast strain of Mycobacterium phlei. Folia Microbiol (Praha) 1970;15(6):426–430. doi: 10.1007/BF02880185. [DOI] [PubMed] [Google Scholar]
  519. Komuro K., Boyse E. A. In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes. Lancet. 1973 Apr 7;1(7806):740–743. doi: 10.1016/s0140-6736(73)92127-2. [DOI] [PubMed] [Google Scholar]
  520. Kondo E., Kanai K. A comparative observation on cholesterol ester contents of uninduced and induced mouse peritoneal cells. Jpn J Med Sci Biol. 1974 Apr;27(2):67–79. doi: 10.7883/yoken1952.27.67. [DOI] [PubMed] [Google Scholar]
  521. Kondo E., Kanai K. Further studies on the increase in cholesterol ester content of the lungs of tuberculous mice. Jpn J Med Sci Biol. 1974 Apr;27(2):59–65. doi: 10.7883/yoken1952.27.59. [DOI] [PubMed] [Google Scholar]
  522. Kondo E., Kanai K., Nishimura K., Tsumita T. Analysis of host-originated lipids associated with "in vivo grown tubercle bacilli". Jpn J Med Sci Biol. 1970 Oct;23(5):315–326. [PubMed] [Google Scholar]
  523. Kondo E., Kanai K. Separation of tuberculin-active proteins from the infected mouse lung tissue. Jpn J Med Sci Biol. 1972 Aug;25(4):249–257. doi: 10.7883/yoken1952.25.249. [DOI] [PubMed] [Google Scholar]
  524. Kondo E., Kanai K. Some immunological and toxic properties of mycobacteria grown in vivo. Jpn J Med Sci Biol. 1974 Feb;27(1):53–57. doi: 10.7883/yoken1952.27.53. [DOI] [PubMed] [Google Scholar]
  525. Konno K., Oizumi K., Ariji F., Yamaguchi J., Oka S. Mode of action of rifampin on mycobacteria. I. Electron microscopic study of the effect of rifampin on Mycobacterium tuberculosis. Am Rev Respir Dis. 1973 Jun;107(6):1002–1005. doi: 10.1164/arrd.1973.107.6.1002. [DOI] [PubMed] [Google Scholar]
  526. Konícková-Radochová M., Málek I. The induction of auxotrophic mutants of Mycobacterium phlei PA by ultraviolet radiation. Folia Microbiol (Praha) 1969;14(3):251–253. doi: 10.1007/BF02872786. [DOI] [PubMed] [Google Scholar]
  527. Konícková-Radochová M., Málek I. The mutagenic effect of nitrosoguanidine on Mycobacterium phlei PA. Folia Microbiol (Praha) 1969;14(3):201–207. doi: 10.1007/BF02872779. [DOI] [PubMed] [Google Scholar]
  528. Konícková-Radochová M., Málek I. The use of ethyl methanesulfonate for the induction of mutants in Mycobacterium phlei PA. Folia Microbiol (Praha) 1969;14(5):470–474. doi: 10.1007/BF02872793. [DOI] [PubMed] [Google Scholar]
  529. Koopman W. J., Gillis M. H., David J. R. Prevention of MIF activity by agents known to increase cellular cyclic AMP. J Immunol. 1973 Jun;110(6):1609–1614. [PubMed] [Google Scholar]
  530. Kornhauser A., Krinsky N. I., Huang P. K., Clagett D. C. A comparative study of photodynamic oxidation and radiofrequency-discharge-generated 1O2 oxidation of guanosine. Photochem Photobiol. 1973 Jul;18(1):63–69. doi: 10.1111/j.1751-1097.1973.tb06393.x. [DOI] [PubMed] [Google Scholar]
  531. Korsak T., Boisvert H. Mycobactéries à pigment rose. Ann Inst Pasteur (Paris) 1972 Jan;122(1):31–41. [PubMed] [Google Scholar]
  532. Korsak T. Occurrence of L-forms in a case of generalized mycobacteriosis due to Mycobacterium scrofulaceum. Acta Tuberc Pneumol Belg. 1975 Nov-Dec;66(6):445–469. [PubMed] [Google Scholar]
  533. Kostiala A. A. Delayed hypersensitivity in the guinea pig immunized with killed tubercle bacilli in adjuvant. 1. Development of peritoneal cell migration inhibition, skin reactions and antibodies to tuberculin purified protein derivative. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;79(2):275–280. [PubMed] [Google Scholar]
  534. Kostiala A. A. Delayed hypersensitivity in the guinea pig immunized with killed tubercle bacilli in adjuvant. 2. The effect of tuberculin purified protein derivative concentration on the inhibition of peritoneal cell migration. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;79(2):281–284. [PubMed] [Google Scholar]
  535. Kostiala A. A., Kosunen T. U. Delayed hypersensitivity in the guinea pig immunized with killed tubercle bacilli in adjuvant. 3. Peritoneal cell migration inhibition and macrophage cytophilic antibodies to tuberculin purified protein derivative. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(1):1–9. [PubMed] [Google Scholar]
  536. Kotani S., Kato T., Matsuda T., Kato K., Misaki A. Chemical structure of the antigenic determinants of cell wall polysaccharide of Mycobacterium tuberculosis strain H37Rv. Biken J. 1971 Dec;14(4):379–387. [PubMed] [Google Scholar]
  537. Kotani S., Narita T., Stewart-Tull D. E., Shimono T., Watanabe Y. Immunoadjuvant activities of cell walls and their water-soluble fractions prepared from various gram-positive bacteria. Biken J. 1975 Jun;18(2):77–92. [PubMed] [Google Scholar]
  538. Kotani S., Watanabe Y., Kinoshita F., Shimono T., Morisaki I. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids. Biken J. 1975 Jun;18(2):105–111. [PubMed] [Google Scholar]
  539. Kotani S., Watanabe Y., Shimono T., Kinoshita F., Narita T. Immunoadjuvant activities of peptidoglycan subunits from the cell walls of Staphyloccus aureus and Lactobacillus plantarum. Biken J. 1975 Jun;18(2):93–103. [PubMed] [Google Scholar]
  540. Kotani S., Yanagida I., Kato K., Matsuda T. Studies on peptides, glycopeptides and antigenic polysaccharide-glycopeptide complexes isolated from an L-11 enzyme lysate of the cell walls of Mycobacterium tuberculosis strain H37Rv. Biken J. 1970 Dec;13(4):249–275. [PubMed] [Google Scholar]
  541. Kozloff L. M., Sundar Raj C. V., Rao R. N., Chapman V. A., DeLong S. Structure of a transducing mycobacteriophage. J Virol. 1972 Feb;9(2):390–393. doi: 10.1128/jvi.9.2.390-393.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  542. Krahenbuhl J. L., Remington J. S. In vitro induction of nonspecific resistance in macrophages by specifically sensitized lymphocytes. Infect Immun. 1971 Oct;4(4):337–343. doi: 10.1128/iai.4.4.337-343.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  543. Kraiss J. P., Gelbart S. M., Juhasz S. E. A comparison of three mycobacteriophages. J Gen Virol. 1973 Jul;20(1):75–87. doi: 10.1099/0022-1317-20-1-75. [DOI] [PubMed] [Google Scholar]
  544. Krasil'nikov N. A., Koronelli T. V., Rozynov B. V., Kaliuzhnaia T. V. Mikolovyke kisloty okrashennykh parafinokisliaiushchikh mikobakterii. Mikrobiologiia. 1973 Mar-Apr;42(2):240–243. [PubMed] [Google Scholar]
  545. Kubica G. P., Baess I., Gordon R. E., Jenkins P. A., Kwapinski J. B., McDurmont C., Pattyn S. R., Saito H., Silcox V., Stanford J. L. A co-operative numerical analysis of rapidly growing mycobacteria. J Gen Microbiol. 1972 Nov;73(1):55–70. doi: 10.1099/00221287-73-1-55. [DOI] [PubMed] [Google Scholar]
  546. Kubica G. P. Differential identification of mycobacteria. VII. Key features for identification of clinically significant mycobacteria. Am Rev Respir Dis. 1973 Jan;107(1):9–21. doi: 10.1164/arrd.1973.107.1.9. [DOI] [PubMed] [Google Scholar]
  547. Kubica G. P., Dunbar F. P., Kim T. H. Response of hypersensitive mice to the footpad injection of living homologous or heterologous mycobacteria: preliminary report. Appl Microbiol. 1973 May;25(5):718–723. doi: 10.1128/am.25.5.718-723.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  548. Kubica G. P., Silcox V. A., Hall E. Numerical taxonomy of selected slowly growing mycobacteria. J Gen Microbiol. 1973 Jan;74(1):159–167. doi: 10.1099/00221287-74-1-159. [DOI] [PubMed] [Google Scholar]
  549. Kubica G. P., Silcox V. A. Numberical taxonomic analysis of some slowly growing mycobacteria using hypothetical median strain patterns. J Gen Microbiol. 1973 Jan;74(1):149–158. doi: 10.1099/00221287-74-1-149. [DOI] [PubMed] [Google Scholar]
  550. Kubin M., Kruml J., Horak Z., Lukavsky J., Vanek C. Pulmonary and nonpulmonary disease in humans due to avian mycobacteria. I. Clinical and epidemiologic analysis of nine cases observed in Czechoslovakia. Am Rev Respir Dis. 1966 Jul;94(1):20–30. doi: 10.1164/arrd.1966.94.1.20. [DOI] [PubMed] [Google Scholar]
  551. Kuwabara S. Amino acid sequence of tuberculin-active protein from Mycobacterium tuberculosis. J Biol Chem. 1975 Apr 10;250(7):2563–2568. [PubMed] [Google Scholar]
  552. Kuwabara S. Purification and properties of tuberculin-active protein from Mycobacterium tuberculosis. J Biol Chem. 1975 Apr 10;250(7):2556–2562. [PubMed] [Google Scholar]
  553. Kwapinski J. B., Alcasid A., Kwapinski E. H., Nairn V. The immunology of cytoplasmic antigens of mycobacteria. Can J Microbiol. 1972 Aug;18(8):1201–1211. doi: 10.1139/m72-188. [DOI] [PubMed] [Google Scholar]
  554. Kölbel H. K., Mohelska H. Versuch zur morphologischen Charakterisierung einiger Mykobakteriophagen (AG1, GS4E, D29, BK1. Zentralbl Bakteriol Orig A. 1971 Aug;217(4):507–528. [PubMed] [Google Scholar]
  555. Kühner A. L., David J. R. Partial characterization of murine migration inhibitory factor (MIF). J Immunol. 1976 Jan;116(1):140–145. [PubMed] [Google Scholar]
  556. L'Archevêque A., Dionne P., Klein J. M. Un cas d'adénite sous-maxillaire et préauriculaire gauche à mycobactérie de Battey (M. intracellulare. Union Med Can. 1970 Sep;99(9):1625–1629. [PubMed] [Google Scholar]
  557. LANE D. MYCOBACTERIUM ULCERANS INFECTION IN QUEENSLAND. Med J Aust. 1964 Jan 25;1:124–125. doi: 10.5694/j.1326-5377.1964.tb134099.x. [DOI] [PubMed] [Google Scholar]
  558. LANEELLE G., ASSELINEAU J. [Isolation of peptide lipids from Mycobacterium paratuberculosis]. Biochim Biophys Acta. 1962 Jun 4;59:731–732. doi: 10.1016/0006-3002(62)90661-3. [DOI] [PubMed] [Google Scholar]
  559. LANEELLE M. A., ASSELINEAU J., CASTELNUOVO G. ETUDES SUR LES MYCOBACT'ERIES ET LES NOCARDIAE. IV. COMPOSITION DES LIPIDES DE MYCOBACTERIUM RHODOCROUS, M. PELLEGRINO SP., ET DE QUELQUES SOUCHES DE NOCARDIAE. Ann Inst Pasteur (Paris) 1965 Jan;108:69–82. [PubMed] [Google Scholar]
  560. LEDERER E., PUDLES J. Sur l'isolement et la constitution chimique d'un hydroxyacide ramifié du bacille diphtérique. Bull Soc Chim Biol (Paris) 1951;33(8):1003–1011. [PubMed] [Google Scholar]
  561. LEE Y. C., BALLOU C. E. STRUCTURAL STUDIES ON THE MYO-INOSITOL MANNODIDES FROM THE GLYCOLIPIDS OF MYCOBACTERIUM TUBERCULOSIS AND MYCOBACTERIUM PHLEI. J Biol Chem. 1964 May;239:1316–1327. [PubMed] [Google Scholar]
  562. LENNARZ W. J., SCHEUERBRANDT G., BLOCH K. The biosynthesis of oleic and 10-methylstearic acids in Mycobacterium phlei. J Biol Chem. 1962 Mar;237:664–671. [PubMed] [Google Scholar]
  563. LINELL F., NORDEN A. Hudinfektioner i simhall genom ny art av Mycobacterium. Nord Med. 1952 Jun 27;47(26):888–891. [PubMed] [Google Scholar]
  564. LINELL F., NORDEN A. Mycobacterium balnei, a new acid-fast bacillus occurring in swimming pools and capable of producing skin lesions in humans. Acta Tuberc Scand Suppl. 1954;33:1–84. [PubMed] [Google Scholar]
  565. LWOFF A. Lysogeny. Bacteriol Rev. 1953 Dec;17(4):269–337. doi: 10.1128/br.17.4.269-337.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  566. LYNEN F. Biosynthesis of saturated fatty acids. Fed Proc. 1961 Dec;20:941–951. [PubMed] [Google Scholar]
  567. LaBelle Y. S., Walker R. W. The phospholipids of Mycobacterium smegmatis. Am Rev Respir Dis. 1972 Apr;105(4):625–628. doi: 10.1164/arrd.1972.105.4.625. [DOI] [PubMed] [Google Scholar]
  568. Lahav M., Chiu T. H., Lennarz W. J. Studies on the biosynthesis of mannan in Micrococcus lysodeikticus. II. The enzymatic synthesis of mannosyl-l-phosphoryl-undecaprenol. J Biol Chem. 1969 Nov 10;244(21):5890–5898. [PubMed] [Google Scholar]
  569. Lakshminarayan S., Sahn S. Disseminated infection caused by Mycobacterium avium. Report of a case with associated leukopenia. Am Rev Respir Dis. 1973 Jul;108(1):123–126. doi: 10.1164/arrd.1973.108.1.123. [DOI] [PubMed] [Google Scholar]
  570. Lamanna C. The Nature of the Acid-fast Stain. J Bacteriol. 1946 Jul;52(1):99–103. [PMC free article] [PubMed] [Google Scholar]
  571. Lampidis T., Barksdale L. Park-Williams number 8 strain of Corynebacterium diphtheriae. J Bacteriol. 1971 Jan;105(1):77–85. doi: 10.1128/jb.105.1.77-85.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  572. Laneelle G., Asselineau J., Chamoiseau G. Presence de mycosides C' (formes simplifiees de mycoside C) dans les bacteries isolees de bovins atteints du farcin. FEBS Lett. 1971 Dec 1;19(2):109–111. doi: 10.1016/0014-5793(71)80490-8. [DOI] [PubMed] [Google Scholar]
  573. Laneelle G., Asselineau J. Structure d'un glycoside de peptidolipide isolé d'une mycobactérie. Eur J Biochem. 1968 Sep 24;5(4):487–491. doi: 10.1111/j.1432-1033.1968.tb00396.x. [DOI] [PubMed] [Google Scholar]
  574. Lanéelle M. A., Lanéelle G. Structure d'acides mycoliques et d'un intermediaire dans la biosynthèse d'acides mycoliques dicarboxyliques. Eur J Biochem. 1970 Feb;12(2):296–300. doi: 10.1111/j.1432-1033.1970.tb00850.x. [DOI] [PubMed] [Google Scholar]
  575. Lavrin D. H., Rosenberg S. A., Connor R. J., Terry W. D. Immunoprophylaxis of methylcholanthrene-induced tumors in mice with Bacillus Calmette-Guérin and methanol-extracted residue. Cancer Res. 1973 Mar;33(3):472–477. [PubMed] [Google Scholar]
  576. Lebar R., Boutry J. M., Vincent C., Robineaux R., Voisin G. A. Studies on autoimmune encephalomyelitis in the guinea pig. II. An in vitro investigation on the nature, properties, and specificity of the serum-demyelinating factor. J Immunol. 1976 May;116(5):1439–1446. [PubMed] [Google Scholar]
  577. Lechevalier M. P., Horan A. C., Lechevalier H. Lipid composition in the classification of nocardiae and mycobacteria. J Bacteriol. 1971 Jan;105(1):313–318. doi: 10.1128/jb.105.1.313-318.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  578. Lechevalier M. P., Lechevalier H., Horan A. C. Chemical characteristics and classification of nocardiae. Can J Microbiol. 1973 Aug;19(8):965–972. doi: 10.1139/m73-154. [DOI] [PubMed] [Google Scholar]
  579. Lederer E., Adam A., Ciorbaru R., Petit J. F., Wietzerbin J. Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties. Mol Cell Biochem. 1975 May 30;7(2):87–104. doi: 10.1007/BF01792076. [DOI] [PubMed] [Google Scholar]
  580. Lederer E. The mycobacterial cell wall. Pure Appl Chem. 1971;25(1):135–165. doi: 10.1351/pac197125010135. [DOI] [PubMed] [Google Scholar]
  581. Lederer E. The origin and function of some methyl groups in branched-chain fatty acids, plant sterols and quinones. Biochem J. 1964 Dec;93(3):449–468. doi: 10.1042/bj0930449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  582. Lee Y. C., Ballou C. E. Complete structures of the glycophospholipids of mycobacteria. Biochemistry. 1965 Jul;4(7):1395–1404. doi: 10.1021/bi00883a026. [DOI] [PubMed] [Google Scholar]
  583. Lefford M. J. Editorial: Delayed hypersensitivity and immunity in tuberculosis. Am Rev Respir Dis. 1975 Mar;111(3):243–246. doi: 10.1164/arrd.1975.111.3.243. [DOI] [PubMed] [Google Scholar]
  584. Lesslie I. W., Magnus K., Stewart C. J. The prevalence of bovine type tuberculous infection in man in the English rural population. Tubercle. 1972 Sep;53(3):198–204. doi: 10.1016/0041-3879(72)90016-5. [DOI] [PubMed] [Google Scholar]
  585. Lester W. Unclassified mycobacterial diseases. Annu Rev Med. 1966;17:351–360. doi: 10.1146/annurev.me.17.020166.002031. [DOI] [PubMed] [Google Scholar]
  586. Levenson D. S., Harrison C. H. Mycobacterium fortuitum corneal ulcer. Arch Ophthalmol. 1966 Feb;75(2):189–191. doi: 10.1001/archopht.1966.00970050191007. [DOI] [PubMed] [Google Scholar]
  587. Lincoln E. M., Gilbert L. A. Disease in children due to mycobacteria other than Mycobacterium tuberculosis. Am Rev Respir Dis. 1972 May;105(5):683–714. doi: 10.1164/arrd.1972.105.5.683. [DOI] [PubMed] [Google Scholar]
  588. Lind A., Norlin M., Ouchterlony O. Studies on the precipitinogenic pattern of mycobacteria cultivated at various temperatures. Pneumonologie. 1970;142(2):283–289. doi: 10.1007/BF02095227. [DOI] [PubMed] [Google Scholar]
  589. Liu T. Y., Gotschlich E. C. Muramic acid phosphate as a component of the mucopeptide of Gram-positive bacteria. J Biol Chem. 1967 Feb 10;242(3):471–476. [PubMed] [Google Scholar]
  590. Lorian V. Direct cord reading agar in routine mycobacteriology. Appl Microbiol. 1969 Apr;17(4):559–562. doi: 10.1128/am.17.4.559-562.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  591. Lornitzo F. A. A protein-bound phosphorylated product as an intermediate in the biosynthesis of O-methyl glycerol by Mycobacterium tuberculosis. Biochim Biophys Acta. 1972 Jun 16;268(3):733–740. doi: 10.1016/0005-2744(72)90278-1. [DOI] [PubMed] [Google Scholar]
  592. Lornitzo F. A., Goldman D. S. Intracellular localization of a 6-O-methyl-D-glucose containing soluble polysaccharide from Mycobacterium tuberculosis. Biochim Biophys Acta. 1968 Jun 24;158(3):329–335. doi: 10.1016/0304-4165(68)90286-9. [DOI] [PubMed] [Google Scholar]
  593. Lotte A. Tuberculosis in children: a cooperative study in Europe. WHO Chron. 1972 Dec;26(12):550–554. [PubMed] [Google Scholar]
  594. Lunn H. F. Effects of climate on the localization and geographic distribution of mycobacterial skin ulcers. Dermatol Int. 1965 Apr-Jun;4(2):111–114. doi: 10.1111/j.1365-4362.1965.tb05134.x. [DOI] [PubMed] [Google Scholar]
  595. Lurie M. B., Dannenberg A. M. Macrophage Function in Infectious Disease with Inbred Rabbits. Bacteriol Rev. 1965 Dec;29(4):466–476. doi: 10.1128/br.29.4.466-476.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  596. Lynen F. The role of biotin-dependent carboxylations in biosynthetic reactions. Biochem J. 1967 Feb;102(2):381–400. doi: 10.1042/bj1020381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  597. MAGNUSSON M., ENGBAEK H. C., BENTZON M. W. Specificity of mycobacterial sensitins. II. Studies in guinea pigs with purified sensitin prepared from unclassified acid-fast bacilli. Am Rev Respir Dis. 1961 Jan;83:69–84. doi: 10.1164/arrd.1961.83.1.69. [DOI] [PubMed] [Google Scholar]
  598. MAGNUSSON M. Specificity of mycobacterial sensitins. I. Studies in guinea pigs with purified "tuberculin" prepared from mammalian and avian tubercle bacilli, Mycobacterium balnei, and other acid-fast bacilli. Am Rev Respir Dis. 1961 Jan;83:57–68. doi: 10.1164/arrd.1961.83.1.57. [DOI] [PubMed] [Google Scholar]
  599. MANTEN A. Antimicrobial susceptibility and some other properties of photochromogenic Mycobacteria associated with pulmonary disease. Antonie Van Leeuwenhoek. 1957;23(3-4):357–363. doi: 10.1007/BF02545888. [DOI] [PubMed] [Google Scholar]
  600. MARKS J., BIRN K. J. INFECTION DUE TO MYCOBACTERIUM AVIUM. Br Med J. 1963 Dec 14;2(5371):1503–1506. doi: 10.1136/bmj.2.5371.1503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  601. MARKS J. MYCOBACTERIAL DISEASE IN MAN AND ANIMALS. ASPECTS OF THE EPIDEMIOLOGY OF INFECTION BY 'ANONYMOUS' MYCOBACTERIA. Proc R Soc Med. 1964 Jun;57:479–480. [PMC free article] [PubMed] [Google Scholar]
  602. MARKS J., SCHWABACHER H. INFECTION DUE TO MYCOBACTERIUM XENOPEI. Br Med J. 1965 Jan 2;1(5426):32–33. doi: 10.1136/bmj.1.5426.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  603. MASCHER W. Tuberculin-negative tuberculosis. Am Rev Tuberc. 1951 May;63(5):501–525. doi: 10.1164/art.1951.63.5.501. [DOI] [PubMed] [Google Scholar]
  604. MASSON A. M., PRISSICK F. H. Cervical lymphadenitis in children caused by chromogenic Mycobacteria. Can Med Assoc J. 1956 Nov 15;75(10):798–803. [PMC free article] [PubMed] [Google Scholar]
  605. MATHEWS M. M. PROTECTIVE EFFECT OF BETA-CAROTENE LETHAL PHOTOSENSITIZATION BY HAEMATOPORPHYRIN. Nature. 1964 Sep 5;203:1092–1092. doi: 10.1038/2031092a0. [DOI] [PubMed] [Google Scholar]
  606. MATHEWS M. M., SISTROM W. R. Function of carotenoid pigments in non-photosynthetic bacteria. Nature. 1959 Dec 12;184(Suppl 24):1892–1893. doi: 10.1038/1841892a0. [DOI] [PubMed] [Google Scholar]
  607. MATHEWS M. M., SISTROM W. R. Intracellular location of carotenoid pigments and some respiratory enzymes in Sarcina lutea. J Bacteriol. 1959 Dec;78:778–787. doi: 10.1128/jb.78.6.778-787.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  608. MATHEWS M. M., SISTROM W. R. The function of the carotenoid pigments of Sarcina lutea. Arch Mikrobiol. 1960;35:139–146. doi: 10.1007/BF00425002. [DOI] [PubMed] [Google Scholar]
  609. MICHEL G. Composition des cires A de Mycobacterium marianum. C R Hebd Seances Acad Sci. 1957 May 6;244(19):2429–2432. [PubMed] [Google Scholar]
  610. MIKI K., MACKANESS G. B. THE PASSIVE TRANSFER OF ACQUIRED RESISTANCE TO LISTERIA MONOCYTOGENES. J Exp Med. 1964 Jul 1;120:93–103. doi: 10.1084/jem.120.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  611. MILLMAN I. Formation of protoplasts from mycobacteria by mycobacteriophage. Proc Soc Exp Biol Med. 1958 Oct;99(1):216–219. doi: 10.3181/00379727-99-24300. [DOI] [PubMed] [Google Scholar]
  612. MITCHISON D. A., SELKON J. B., LLOYD J. VIRULENCE IN THE GUINEA-PIG, SUSCEPTIBILITY TO HYDROGEN PEROXIDE, AND CATALASE ACTIVITY OF ISONIAZID-SENSITIVE TUBERCLE BACILLI FROM SOUTH INDIAN AND BRITISH PATIENTS. J Pathol Bacteriol. 1963 Oct;86:377–386. doi: 10.1002/path.1700860213. [DOI] [PubMed] [Google Scholar]
  613. MITCHISON D. A. THE VIRULENCE OF TUBERCLE BACILLI FROM PATIENTS WITH PULMONARY TUBERCULOSIS IN INDIA AND OTHER COUNTRIES. Bull Int Union Tuberc. 1964 Sep;35:287–306. [PubMed] [Google Scholar]
  614. MOLLOHAN C. S., ROMER M. S. Public health significance of swimming pool granuloma. Am J Public Health Nations Health. 1961 Jun;51:883–891. doi: 10.2105/ajph.51.6.883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  615. MOORE M., FRERICHS J. B. An unusual acid-fast infection of the knee with subcutaneous, abscess-like lesions of the gluteal region; report of a case with a study of the organism, Mycobacterium abscessus, n. sp. J Invest Dermatol. 1953 Feb;20(2):133–169. doi: 10.1038/jid.1953.18. [DOI] [PubMed] [Google Scholar]
  616. MORGAN J. K., BLOWERS R. SWIMMING-POOL GRANULOMA IN BRITAIN. Lancet. 1964 May 9;1(7341):1034–1036. doi: 10.1016/s0140-6736(64)91945-2. [DOI] [PubMed] [Google Scholar]
  617. MORISAWA S., TANAKA A., SHOJIMA K., YAMAMURA Y. Studies on tuberculin active peptide. I. The isolation, crystallization and properties of tuberculin active peptide from tubercle bacillus. Biochim Biophys Acta. 1960 Feb 26;38:252–258. doi: 10.1016/0006-3002(60)91239-7. [DOI] [PubMed] [Google Scholar]
  618. MUROHASHI T., TOKUNAGA T., MIZUGUCHI Y., MARUYAMA Y. PHAGE TYPING OF SLOW-GROWING MYCOBACTERIA. Am Rev Respir Dis. 1963 Nov;88:664–669. doi: 10.1164/arrd.1963.88.5.664. [DOI] [PubMed] [Google Scholar]
  619. Maberry J. D., Mullins J. F., Stone O. J. Cutaneous infection due to Mycobacterium kansasii. JAMA. 1965 Dec 6;194(10):1135–1137. [PubMed] [Google Scholar]
  620. MacLennan I. C. Antibody in the induction and inhibition of lymphocyte cytotoxicity. Transplant Rev. 1972;13:67–90. doi: 10.1111/j.1600-065x.1972.tb00060.x. [DOI] [PubMed] [Google Scholar]
  621. Macham L. P., Ratledge C. A new group of water-soluble iron-binding compounds from Mycobacteria: the exochelins. J Gen Microbiol. 1975 Aug;89(2):379–382. doi: 10.1099/00221287-89-2-379. [DOI] [PubMed] [Google Scholar]
  622. Macham L. P., Ratledge C., Nocton J. C. Extracellular iron acquisition by mycobacteria: role of the exochelins and evidence against the participation of mycobactin. Infect Immun. 1975 Dec;12(6):1242–1251. doi: 10.1128/iai.12.6.1242-1251.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  623. Machida Y., Bergeron R., Flick P., Bloch K. Effects of cyclodextrins on fatty acid synthesis. J Biol Chem. 1973 Sep 10;248(17):6246–6247. [PubMed] [Google Scholar]
  624. Machida Y., Bloch K. Complex formation between mycobacterial polysaccharides and fatty acyl-CoA derivatives. Proc Natl Acad Sci U S A. 1973 Apr;70(4):1146–1148. doi: 10.1073/pnas.70.4.1146. [DOI] [PMC free article] [PubMed] [Google Scholar]
  625. Mackaness G. B. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969 May 1;129(5):973–992. doi: 10.1084/jem.129.5.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  626. Magnus K. Epidemiological basis of tuberculosis eradication. 3. Risk of pulmonary tuberculosis after human and bovine infection. Bull World Health Organ. 1966;35(4):483–508. [PMC free article] [PubMed] [Google Scholar]
  627. Magnusson M. A comparative study of Mycobacterium gastri and Mycobacterium kansasii by delayed type skin reactions in guinea pigs. Am Rev Respir Dis. 1971 Sep;104(3):377–384. doi: 10.1164/arrd.1971.104.3.377. [DOI] [PubMed] [Google Scholar]
  628. Magnusson M. Identification of species of Mycobacterium on the basis of the specificity of the delayed type reaction in guinea-pigs. Z Tuberk Erkr Thoraxorg. 1967;127(1):55–56. [PubMed] [Google Scholar]
  629. Magnusson M., Mariat F. Delineation of Nocardia farcinica by delayed type skin reactions on guinea pigs. J Gen Microbiol. 1968 Apr;51(1):151–158. doi: 10.1099/00221287-51-1-151. [DOI] [PubMed] [Google Scholar]
  630. Maguire A. Lupus murinus. The discovery, diagnosis and treatment of seventeen cases of lupus murinus. Br J Dermatol. 1968 Jul;80(7):419–423. doi: 10.1111/j.1365-2133.1968.tb11976.x. [DOI] [PubMed] [Google Scholar]
  631. Maillard J., Bloom B. R. Immunological adjuvants and the mechanism of cell cooperation. J Exp Med. 1972 Jul 1;136(1):185–190. doi: 10.1084/jem.136.1.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  632. Majerus P. W., Vagelos P. R. Fatty acid biosynthesis and the role of the acyl carrier protein. Adv Lipid Res. 1967;5:1–33. [PubMed] [Google Scholar]
  633. Mankiewicz E. Bacteriophage types of mycobacteria. Can J Public Health. 1972 Jul-Aug;63(4):342–354. [PubMed] [Google Scholar]
  634. Marks J., Jenkins P. A., Kilpatrick G. S., Engbaek H. C., Vergmann B. Pulmonary tuberculosis due to B.C.G. Br Med J. 1971 Jul 24;3(5768):229–230. doi: 10.1136/bmj.3.5768.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  635. Marks J., Jenkins P. A., Schaefer W. B. Identification and incidence of a third type of Mycobacterium avium. Tubercle. 1969 Dec;50(4):394–395. [PubMed] [Google Scholar]
  636. Marks J., Jenkins P. A. The opportunist mycobacteria--a 20-year retrospect. Postgrad Med J. 1971 Nov;47(553):705–709. doi: 10.1136/pgmj.47.553.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  637. Marks J., Jenkins P. A., Tsukamura M. Mycobacterium szulgai--a new pathogen. Tubercle. 1972 Sep;53(3):210–214. doi: 10.1016/0041-3879(72)90018-9. [DOI] [PubMed] [Google Scholar]
  638. Marx J. J., Jr, Burrell R. Delayed hypersensitivity to beryllium compounds. J Immunol. 1973 Aug;111(2):590–598. [PubMed] [Google Scholar]
  639. Mastrangelo M. J., Kim Y. H., Bornstein R. S., Chee D. O., Sulit H. L., Yarbro J. W., Prehn R. T. Clinical and histologic correlation of melanoma regression after intralesional BCG therapy: a case report. J Natl Cancer Inst. 1974 Jan;52(1):19–24. doi: 10.1093/jnci/52.1.19. [DOI] [PubMed] [Google Scholar]
  640. Mathews-Roth M. M., Krinsky N. I. Carotenoid pigments and the stability of the cell membrane of Sarcina lutea. Biochim Biophys Acta. 1970 Apr 21;203(2):357–359. doi: 10.1016/0005-2736(70)90155-0. [DOI] [PubMed] [Google Scholar]
  641. Mathews-Roth M. M., Krinsky N. I. Studies on the protective function of the carotenoid pigments of Sarcina lutea. Photochem Photobiol. 1970 Jun;11(6):419–428. doi: 10.1111/j.1751-1097.1970.tb06014.x. [DOI] [PubMed] [Google Scholar]
  642. Mathews-Roth M. M., Pathak U. A., Fitzpatrick T. B., Harber L. C., Kass E. H. Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria. JAMA. 1974 May 20;228(8):1004–1008. [PubMed] [Google Scholar]
  643. Mathews-Roth M. M., Wilson T., Fujimori E., Krinsky N. I. Carotenoid chromophore length and protection against photosensitization. Photochem Photobiol. 1974 Mar;19(3):217–222. doi: 10.1111/j.1751-1097.1974.tb06501.x. [DOI] [PubMed] [Google Scholar]
  644. Mathews M. M., Krinsky N. I. The relationship between carotenoid pigments and resistance to radiation in non-photosynthetic bacteria. Photochem Photobiol. 1965 Sep;4(4):813–817. doi: 10.1111/j.1751-1097.1965.tb07923.x. [DOI] [PubMed] [Google Scholar]
  645. Mathews M. M. Ultrastructure of nonphotosynthetic carotenoid-containing bacteria. J Bacteriol. 1966 Mar;91(3):1369–1371. doi: 10.1128/jb.91.3.1369-1371.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  646. Matsuhashi M., Dietrich C. P., Strominger J. L. Incorporation of glycine into the cell wall glycopeptide in Staphylococcus aureus: role of sRNA and lipid intermediates. Proc Natl Acad Sci U S A. 1965 Aug;54(2):587–594. doi: 10.1073/pnas.54.2.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  647. Matsumura S., Brindley D. N., Bloch K. Acyl carrier protein from Mycobacterium phlei. Biochem Biophys Res Commun. 1970 Feb 6;38(3):369–377. doi: 10.1016/0006-291x(70)90723-0. [DOI] [PubMed] [Google Scholar]
  648. Matsumura S. Conformation of acyl carrier protein from Mycobacterium phlei. Biochem Biophys Res Commun. 1970 Jan 23;38(2):238–243. doi: 10.1016/0006-291x(70)90702-3. [DOI] [PubMed] [Google Scholar]
  649. Maugh T. H., 2nd Bioregulators: alteration of gene expression in citrus fruit. Science. 1974 May 10;184(4137):655–655. doi: 10.1126/science.184.4137.655. [DOI] [PubMed] [Google Scholar]
  650. Maurice M. T., Vacheron M. J., Michel G. Isolément d'acides nocardiques de plusieurs espéces de Nocardia. Chem Phys Lipids. 1971 Oct;7(1):9–18. doi: 10.1016/0009-3084(71)90017-x. [DOI] [PubMed] [Google Scholar]
  651. McCarthy C. Effect of palmitic acid utilization on cell division in Mycobacterium avium. Infect Immun. 1974 Feb;9(2):363–372. doi: 10.1128/iai.9.2.363-372.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  652. McCarthy C. Utilization of palmitic acid by Mycobacterium avium. Infect Immun. 1971 Sep;4(3):199–204. doi: 10.1128/iai.4.3.199-204.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  653. McCracken G. H., Jr, Reynolds R. C. Primary lymphopenic immunologic deficiency. Disseminated Mycobacterium kansasii infection. Am J Dis Child. 1970 Aug;120(2):143–147. doi: 10.1001/archpedi.1970.02100070087011. [DOI] [PubMed] [Google Scholar]
  654. McCullough W. G., Merkal R. S. Iron-chelating compound from Mycobacterium avium. J Bacteriol. 1976 Oct;128(1):15–20. doi: 10.1128/jb.128.1.15-20.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  655. McDermott J. C., Ben-Aziz A., Singh R. K., Britton G., Goodwin T. W. Recent studies of carotenoid biosynthesis in bacteria. Pure Appl Chem. 1973;35(1):29–45. doi: 10.1351/pac197335010029. [DOI] [PubMed] [Google Scholar]
  656. McDonald P. J., Tomasovic A. A., Evans C. Mycobacterium xenopei pulmonary infection in man. Med J Aust. 1971 Apr 17;1(16):873–873. doi: 10.5694/j.1326-5377.1971.tb87905.x. [DOI] [PubMed] [Google Scholar]
  657. McNulty M. S., Winder F. G. Partial purification and properties of a DNA polymerase from Mycobacterium smegmatis. Biochim Biophys Acta. 1971 Dec 16;254(2):213–225. doi: 10.1016/0005-2787(71)90830-6. [DOI] [PubMed] [Google Scholar]
  658. Meltzer M. S., Leonard E. J. Enhanced tumor growth in animals pretreated with complete Freund's adjuvant. J Natl Cancer Inst. 1973 Jan;50(1):209–218. doi: 10.1093/jnci/50.1.209. [DOI] [PubMed] [Google Scholar]
  659. Menezes J., Pavilanis V. Properties of mycobacteriophage C2. Experientia. 1969 Oct 15;25(10):1112–1113. doi: 10.1007/BF01901466. [DOI] [PubMed] [Google Scholar]
  660. Menezes J. The fluorescent staining of a mycobacteriophage (C2) nucleic acid. Can J Microbiol. 1971 Feb;17(2):171–174. doi: 10.1139/m71-029. [DOI] [PubMed] [Google Scholar]
  661. Merser C., Sinay P., Adam A. Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives. Biochem Biophys Res Commun. 1975 Oct 27;66(4):1316–1322. doi: 10.1016/0006-291x(75)90503-3. [DOI] [PubMed] [Google Scholar]
  662. Meyer T. J., Ribi E. E., Azuma I., Zbar B. Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. J Natl Cancer Inst. 1974 Jan;52(1):103–111. doi: 10.1093/jnci/52.1.103. [DOI] [PubMed] [Google Scholar]
  663. Middlebrook G., Coleman C. M., Schaefer W. B. SULFOLIPID FROM VIRULENT TUBERCLE BACILLI. Proc Natl Acad Sci U S A. 1959 Dec;45(12):1801–1804. doi: 10.1073/pnas.45.12.1801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  664. Minden P., Sharpton T. R., McClatchy J. K. Shared antigens between human malignant melanoma cells and Mycobacterium bovis (BCG). J Immunol. 1976 May;116(5):1407–1414. [PubMed] [Google Scholar]
  665. Minnikin D. E., Abdolrahimzadeh H., Baddiley J. The occurrence of phosphatidylethanolamine and glycosyl diglycerides in thermophilic bacilli. J Gen Microbiol. 1974 Aug;83(2):415–418. doi: 10.1099/00221287-83-2-415. [DOI] [PubMed] [Google Scholar]
  666. Misaki A., Ikawa N., Kotani S., Kato T. Cell wall arabinogalactan of Mycobacterium phlei. Biochim Biophys Acta. 1970 Aug 14;215(2):405–408. doi: 10.1016/0304-4165(70)90040-1. [DOI] [PubMed] [Google Scholar]
  667. Misaki A., Seto N., Azuma I. Structure and immunological properties of D-arabino-D-galactans isolated from cell walls of Mycobacterium species. J Biochem. 1974 Jul;76(1):15–27. doi: 10.1093/oxfordjournals.jbchem.a130540. [DOI] [PubMed] [Google Scholar]
  668. Misaki A., Yukawa S. Studies on cell walls of Mycobacteria. II. Constitution of polysaccharides from BCG cell walls. J Biochem. 1966 May;59(5):511–520. doi: 10.1093/oxfordjournals.jbchem.a128335. [DOI] [PubMed] [Google Scholar]
  669. Misaki A., Yukawa S., Tsuchiya K., Yamasaki T. Studies on cell walls of Mycobacteria. I. Chemical and biological properties of the cell walls and the mucopeptide of BCG. J Biochem. 1966 Apr;59(4):388–396. doi: 10.1093/oxfordjournals.jbchem.a128314. [DOI] [PubMed] [Google Scholar]
  670. Mishell R. I., Dutton R. W. Immunization of dissociated spleen cell cultures from normal mice. J Exp Med. 1967 Sep 1;126(3):423–442. doi: 10.1084/jem.126.3.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  671. Mitchison D. A. Regional variation in the guinea-pig virulence and other characteristics of tubercle bacilli. Pneumonologie. 1970;142(2):131–137. doi: 10.1007/BF02095209. [DOI] [PubMed] [Google Scholar]
  672. Mittag T., Kornfeld P., Tormay A., Woo C. Detection of anti-acetylcholine receptor factors in serum and thymus from patients with myasthenia gravis. N Engl J Med. 1976 Mar 25;294(13):691–694. doi: 10.1056/NEJM197603252941303. [DOI] [PubMed] [Google Scholar]
  673. Mizuguchi Y. Effect of ultraviolet-sensitive mutants on gene inheritance in mycobacterial matings. J Bacteriol. 1974 Feb;117(2):914–916. doi: 10.1128/jb.117.2.914-916.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  674. Mizuguchi Y. Segregation of unselected markers in mycobacterial recombinants. Jpn J Microbiol. 1972 Mar;16(2):77–81. doi: 10.1111/j.1348-0421.1972.tb00632.x. [DOI] [PubMed] [Google Scholar]
  675. Mizuguchi Y., Tokunaga T. Method for isolation of deoxyribonucleic acid from mycobacteria. J Bacteriol. 1970 Nov;104(2):1020–1021. doi: 10.1128/jb.104.2.1020-1021.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  676. Mizuguchi Y., Tokunaga T. Recombination between Mycobacterium smegmatis strains Jucho and Lacticola. Jpn J Microbiol. 1971 Jul;15(4):359–366. doi: 10.1111/j.1348-0421.1971.tb00592.x. [DOI] [PubMed] [Google Scholar]
  677. Mizuguchi Y. [Synchronization of Mycobacterium smegmatis culture by phenethyl alcohol and nitrosoguanidine mutagenesis]. Igaku To Seibutsugaku. 1970 Nov 11;81(5):215–220. [PubMed] [Google Scholar]
  678. Modolell M., Luckenbach G. A., Parant M., Munder P. G. The adjuvant activity of a mycobacterial water soluble adjuvant (WSA) in vitro. I. The requirement of macrophages. J Immunol. 1974 Jul;113(1):395–403. [PubMed] [Google Scholar]
  679. Molony J., Connolly K. Knee arthropathy secondary to Mycobacterium scrofulaceum. Ann Rheum Dis. 1973 Jan;32(1):69–71. doi: 10.1136/ard.32.1.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  680. Moore V. L., Myrvik Q. N., Kato M. Role of cord factor (trehalose-6,6'-dimycolate) in allergic granuloma formation in rabbits. Infect Immun. 1972 Jul;6(1):5–8. doi: 10.1128/iai.6.1.5-8.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  681. Morozov V. L., Kitaev M. I., Akulov V. D., Toropova L. A. Ob immunokhimicheskoi prirode i biologicheskoi aktivnosti autoantitel, obrazuiushchikhsia v kul'ture limfotsitov krovi bol'nykh tuberkulezom legkikh. Probl Tuberk. 1976 Feb;(21):72–77. [PubMed] [Google Scholar]
  682. Morris C. A., Grant G. H. Cervical adenitis caused by Mycobacterium chelonei (M. abscessus). J Clin Pathol. 1972 Nov;25(11):1006–1006. doi: 10.1136/jcp.25.11.1006-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  683. Morris C. A., Grant G. H., Everall P. H., Myres A. T. Tuberculoid lymphadenitis due to Mycobacterium chelonei. J Clin Pathol. 1973 Jun;26(6):422–426. doi: 10.1136/jcp.26.6.422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  684. Morris S. A., Subden R. E. Effects of ultraviolet radiation on carotenoid-containing and albino strains of Neurospora crassa. Mutat Res. 1974 Feb;22(2):105–109. doi: 10.1016/0027-5107(74)90089-x. [DOI] [PubMed] [Google Scholar]
  685. Motomiya M., Fujimoto M., Sato H., Oka S. Biological activities of phospholipids from an unclassified mycobacteria, P-6, scotochromogen. Sci Rep Res Inst Tohoku Univ Med. 1968 Oct;15(1):10–13. [PubMed] [Google Scholar]
  686. Motomiya M., Fukushi K., Fujimoto M., Sato H., Oka S. Subcellar distribution of phospholipids in an unclassified mycobacteria, P-6, scotochromogen. Sci Rep Res Inst Tohoku Univ Med. 1968 Oct;15(1):14–19. [PubMed] [Google Scholar]
  687. Motomiya M., Mayama A., Fujimoto M., Sato H., Oka S. A study of phospholipids from an unclassified mycobacteria, P 6. Sci Rep Res Inst Tohoku Univ Med. 1968 Oct;15(1):1–9. [PubMed] [Google Scholar]
  688. Moulton R. G., Dietz T. M., Marcus S. Isolation of specific and nonspecific components from purified protein derivative. Am Rev Respir Dis. 1972 Aug;106(2):213–218. doi: 10.1164/arrd.1972.106.2.213. [DOI] [PubMed] [Google Scholar]
  689. Munder P. G., Modolell M. Adjuvant induced formation of lysophosphatides and their role in the immune response. Int Arch Allergy Appl Immunol. 1973;45(1):133–135. doi: 10.1159/000231016. [DOI] [PubMed] [Google Scholar]
  690. Munro A. J., Taussig M. J. Two genes in the major histocompatibility complex control immune response. Nature. 1975 Jul 10;256(5513):103–106. doi: 10.1038/256103a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  691. Murohashi T., Kondo E., Yoshida K. The role of lipids in acid-fastness of mycobacteria. Am Rev Respir Dis. 1969 May;99(5):794–798. doi: 10.1164/arrd.1969.99.5.794. [DOI] [PubMed] [Google Scholar]
  692. Möller G. Effect of B-cell mitogens on lymphocyte subpopulations possesing C'3 and Fc receptors. J Exp Med. 1974 Apr 1;139(4):969–982. doi: 10.1084/jem.139.4.969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  693. Möller G. Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes. Clin Exp Immunol. 1969 Jan;4(1):65–82. [PMC free article] [PubMed] [Google Scholar]
  694. NOLL H., BLOCH H., ASSELINEAU J., LEDERER E. The chemical structure of the cord factor of Mycobacterium tuberculosis. Biochim Biophys Acta. 1956 May;20(2):299–309. doi: 10.1016/0006-3002(56)90289-x. [DOI] [PubMed] [Google Scholar]
  695. NOLL H. The chemistry of cord factor, a toxic glycolipid of M. tuberculosis. Bibl Tuberc. 1956;(10):149–183. [PubMed] [Google Scholar]
  696. NORDEN A., LINELL F. A new type of pathogenic Mycobacterium. Nature. 1951 Nov 10;168(4280):826–826. doi: 10.1038/168826a0. [DOI] [PubMed] [Google Scholar]
  697. Nakamura R. M., Chisari F. V., Edgington T. S. Laboratory tests for diagnosis of autoimmune diseases. Prog Clin Pathol. 1975;6:177–203. [PubMed] [Google Scholar]
  698. Narumi K., Keller J. M., Ballou C. E. Biosynthesis of a mycobacterial lipopolysaccharide. Incorporation of (14C)acyl groups by whole cells in vivo. Biochem J. 1973 Feb;132(2):329–340. doi: 10.1042/bj1320329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  699. Nathan C. F., Karnovsky M. L., David J. R. Alterations of macrophage functions by mediators from lymphocytes. J Exp Med. 1971 Jun 1;133(6):1356–1376. doi: 10.1084/jem.133.6.1356. [DOI] [PMC free article] [PubMed] [Google Scholar]
  700. Nathan C. F., Remold H. G., David J. R. Characterization of a lymphocyte factor which alters macrophage functions. J Exp Med. 1973 Feb 1;137(2):275–290. doi: 10.1084/jem.137.2.275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  701. Nayebi M. The effect of mechanical agitation and CO2 on the growth of the BCG, H37Ra and RlRv strains of Mycobacterium tuberculosis. J Med Lab Technol. 1970 Apr;27(2):218–221. [PubMed] [Google Scholar]
  702. Neiburger R. G., Youmans G. P., Youmans A. S. Relationship between tuberculin hypersensitivity and cellular immunity to infection in mice vaccinated with viable attenuated Mycobacterial cells or with Mycobacterial ribonucleic acid preparations. Infect Immun. 1973 Jul;8(1):42–47. doi: 10.1128/iai.8.1.42-47.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  703. Neta R., Salvin S. B. Specific depression of delayed hypersensitivity to purified proteins, with relation to production of circulating antibody. Cell Immunol. 1973 Nov;9(2):242–250. doi: 10.1016/0008-8749(73)90075-0. [DOI] [PubMed] [Google Scholar]
  704. Neta R., Salvin S. B. Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol. 1974 Dec;113(6):1716–1725. [PubMed] [Google Scholar]
  705. Nicholson D. P., Sevier W. R. Mycobacterium fortuitum as a pathogen. A case report. Am Rev Respir Dis. 1971 Nov;104(5):747–750. doi: 10.1164/arrd.1971.104.5.747. [DOI] [PubMed] [Google Scholar]
  706. Nordström G., Grange J. M. Bacteriophage typing of Mycobacterium ranae (Fortuitum). The use of unadapted and adapted phages in the development of a typing system. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Feb;82(1):87–93. doi: 10.1111/j.1699-0463.1974.tb02297.x. [DOI] [PubMed] [Google Scholar]
  707. Norlin M., Ernevad H. Purification and separation of antigens in preparations of mycobacteria. Bull Int Union Tuberc. 1966 Jun;38(1):29–34. [PubMed] [Google Scholar]
  708. Nyka W. Influence of oxidation and reduction on the acid-fastness of mycobacteria. Infect Immun. 1971 Oct;4(4):513–515. doi: 10.1128/iai.4.4.513-515.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  709. Nyka W. Method for staining both acid-fast and chromophobic tubercle bacilli with carbolfuschsin. J Bacteriol. 1967 Apr;93(4):1458–1460. doi: 10.1128/jb.93.4.1458-1460.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  710. Nyka W., O'Neill E. F. A new approach to the study of non-acid-fast mycobacteria. Ann N Y Acad Sci. 1970 Oct 30;174(2):862–871. doi: 10.1111/j.1749-6632.1970.tb45605.x. [DOI] [PubMed] [Google Scholar]
  711. OWEN M., SMITH A., COULTRAS J. Granulomatous lesions occurring at site of injections of vaccines and antibiotics. South Med J. 1963 Sep;56:949–952. doi: 10.1097/00007611-196309000-00004. [DOI] [PubMed] [Google Scholar]
  712. Offer R. C., Karlson A. G., Spittell J. A., Jr Infection caused by Mycobacterium fortuitum. Mayo Clin Proc. 1971 Nov;46(11):747–750. [PubMed] [Google Scholar]
  713. Ogawa T., Hiraki M. Studies on atypical mycobacteria. VII. The transformation of the color of atypical mycobacteria. Kitasato Arch Exp Med. 1969 Jun;42(1):15–26. [PubMed] [Google Scholar]
  714. Oka S., Fukushi K., Fujimoto M., Sato H., Motomiya M. La distribution subcellulaire des phospholipides de la Mycobactérie. C R Seances Soc Biol Fil. 1968;162(8):1648–1650. [PubMed] [Google Scholar]
  715. Okumura K., Tada T. Regulation of homocytotropic antibody formation in the rat. VI. Inhibitory effect of thymocytes on the homocytotropic antibody response. J Immunol. 1971 Dec;107(6):1682–1689. [PubMed] [Google Scholar]
  716. Okuyama H., Kankura T., Nojima S. Positional distribution of fatty acids in phospholipids from Mycobacteria. J Biochem. 1967 Jun;61(6):732–737. doi: 10.1093/oxfordjournals.jbchem.a128607. [DOI] [PubMed] [Google Scholar]
  717. Olakowski T., Mardoń K. The restorative influence of repeated tuberculin testing on tuberculin sensitivity in BCG-vaccinated schoolchildren. Bull World Health Organ. 1971;45(5):649–655. [PMC free article] [PubMed] [Google Scholar]
  718. Olitzki A. L., Davis C. L., Schaefer W. B., Cohn M. L. Colony variants of avian-Battey group Mycobacteria intracerebrally injected into mice. Pathol Microbiol (Basel) 1969;34(5):316–323. doi: 10.1159/000162176. [DOI] [PubMed] [Google Scholar]
  719. Outteridge P. M., Lepper A. W. Immunosuppressive factors released by transforming lymphocytes in the delayed hypersensitivity skin response to tuberculin. Immunology. 1973 Dec;25(6):981–994. [PMC free article] [PubMed] [Google Scholar]
  720. Owens D. W., McBride M. E. Sporotrichoid cutaneous infection with Mycobacterium kansasii. Arch Dermatol. 1969 Jul;100(1):54–58. [PubMed] [Google Scholar]
  721. PALMER C. E. Tuberculin sensitivity and contact with tuberculosis; further evidence of nonspecific sensitivity. Am Rev Tuberc. 1953 Nov;68(5):678–694. doi: 10.1164/art.1953.68.5.678. [DOI] [PubMed] [Google Scholar]
  722. PARLETT R. C., YOUMANS G. P. Antigenic relationships between ninety-eight strains of mycobacteria using gel-diffusion precipitation techniques. Am Rev Tuberc. 1958 Mar;77(3):450–461. doi: 10.1164/artpd.1958.77.3.450. [DOI] [PubMed] [Google Scholar]
  723. PATERSON A. B. The incidence and causes of tuberculin reactions in non-tuberculous cattle. Bibl Tuberc. 1956;(10):101–129. [PubMed] [Google Scholar]
  724. PEARSON C. M., WAKSMAN B. H., SHARP J. T. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. V. Changes affecting the skin and mucous membranes. Comparison of the experimental process with human disease. J Exp Med. 1961 Mar 1;113:485–510. doi: 10.1084/jem.113.3.485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  725. PENSO G., CASTELNUOVO G., GAUDIANO A., PRINCIVALLE M., ZAMPIERI A., VELLA L. Studi e ricerche sui micobatteri. VIII. Un nuovo bacillo tubercolare, il Mycobacterium minetti n. sp; studio microbiologico e patogenetico. Rend Ist Sup Sanit. 1952;15(7):491–554. [PubMed] [Google Scholar]
  726. PFUETZE K. H., LEVAN V. O., REIMANN A. F., BERG G. S., LESTER W. PHOTOCHROMOGENIC MYCOBACTERIAL PULMONARY DISEASE. Am Rev Respir Dis. 1965 Sep;92:470–475. doi: 10.1164/arrd.1965.92.3.470. [DOI] [PubMed] [Google Scholar]
  727. PHILPOTT J. A., Jr, WOODBURNE A. R., PHILPOTT O. S., SCHAEFER W. B., MOLLOHAN C. S. SWIMMING POOL GRANULOMA. A STUDY OF 290 CASES. Arch Dermatol. 1963 Aug;88:158–162. doi: 10.1001/archderm.1963.01590200046008. [DOI] [PubMed] [Google Scholar]
  728. PIERARD A., GOLDMAN D. S. Enzyme systems in the mycobacteria. 14. Fatty acid synthesis in cell-free extracts of Mycobacterium tuberculosis. Arch Biochem Biophys. 1963 Jan;100:56–65. doi: 10.1016/0003-9861(63)90034-1. [DOI] [PubMed] [Google Scholar]
  729. PIERCE-CHASE C. H., FAUVE R. M., DUBOS R. CORYNEBACTERIAL PSEUDOTUBERCULOSIS IN MICE. I. COMPARATIVE SUSCEPTIBILITY OF MOUSE STRAINS TO EXPERIMENTAL INFECTION WITH CORYNEBACTERIUM KUTSCHERI. J Exp Med. 1964 Aug 1;120:267–281. doi: 10.1084/jem.120.2.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  731. PORTER J. W., ANDERSON D. G. The biosynthesis of carotenes. Arch Biochem Biophys. 1962 Jun;97:520–528. doi: 10.1016/0003-9861(62)90116-9. [DOI] [PubMed] [Google Scholar]
  732. PORTER J. W., LINCOLN R. E. Lycopersicon selections containing a high content of carotenes and colorless polyenes; the mechanism of carotene biosynthesis. Arch Biochem. 1950 Jul;27(2):390–403. [PubMed] [Google Scholar]
  733. PRISSICK F. H., MASSON A. M. Yellow-pigmented pathogenic mycobacteria from cervical lymphadenitis. Can J Microbiol. 1957 Feb;3(1):91–100. doi: 10.1139/m57-011. [DOI] [PubMed] [Google Scholar]
  734. PUDLES J., LEDERER E. Sur l'isolement et la constitution chimique de l'acide coryno-mycolénique et de deux cétones des lipides du bacille diphterique. Bull Soc Chim Biol (Paris) 1954;36(6-7):759–777. [PubMed] [Google Scholar]
  735. PUDLES J., LEDERER E. Sur la constitution chimique d'un acide mycolique insaturé isolé du bacille diphtérique (Corynebacterium diphtheriae). Biochim Biophys Acta. 1953 May;11(1):163–164. doi: 10.1016/0006-3002(53)90023-7. [DOI] [PubMed] [Google Scholar]
  736. Palmer C. E., Long M. W. Effects of infection with atypical mycobacteria on BCG vaccination and tuberculosis. Am Rev Respir Dis. 1966 Oct;94(4):553–568. doi: 10.1164/arrd.1966.94.4.553. [DOI] [PubMed] [Google Scholar]
  737. Pangborn M. C. Biology of the mycobacterioses. Structure of mycobacterial phosphatides. Ann N Y Acad Sci. 1968 Sep 5;154(1):133–139. doi: 10.1111/j.1749-6632.1968.tb16703.x. [DOI] [PubMed] [Google Scholar]
  738. Pangborn M. C., McKinney J. A. Purification of serologically active phosphoinositides of Mycobacterium tuberculosis. J Lipid Res. 1966 Sep;7(5):627–633. [PubMed] [Google Scholar]
  739. Patterson R. J., Youmans G. P. Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis. Infect Immun. 1970 Jun;1(6):600–603. doi: 10.1128/iai.1.6.600-603.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  740. Pattyn S. R., Hermans-Boveroulle M. T., van Ermengem J. Untersuchungen an langsam wachsenden, scotochromatogenen Mykobakterien (Runyon Gruppe II) Zentralbl Bakteriol Orig. 1968;207(4):509–516. [PubMed] [Google Scholar]
  741. Pattyn S. R., Magnusson M., Stanford J. L., Grange J. M. A study of Mycobacterium fortuitum (ranae). J Med Microbiol. 1974 Feb;7(1):67–76. doi: 10.1099/00222615-7-1-67. [DOI] [PubMed] [Google Scholar]
  742. Pattyn S. R., Vandepitte J., Portaels F., De Muynck A. Cases of Mycobacterium borstelense and M. abscessus infection observed in Belgium. J Med Microbiol. 1971 Feb;4(1):145–149. doi: 10.1099/00222615-4-1-145. [DOI] [PubMed] [Google Scholar]
  743. Pawlowski Z., Schultz M. G. Taeniasis and cysticercosis (Taenia saginata). Adv Parasitol. 1972;10:269–343. doi: 10.1016/s0065-308x(08)60176-1. [DOI] [PubMed] [Google Scholar]
  744. Perlmann P., Perlmann H., Wasserman J., Packalén T. Lysis of chicken erythrocytes sensitized with PPD by lymphoid cells from guinea pigs immunized with tubercle bacilli. Int Arch Allergy Appl Immunol. 1970;38(2):204–216. doi: 10.1159/000230273. [DOI] [PubMed] [Google Scholar]
  745. Perlmann P., Perlmann H., Wigzell H. Lymphocyte mediated cytotoxicity in vitro. Induction and inhibition by humoral antibody and nature of effector cells. Transplant Rev. 1972;13:91–114. doi: 10.1111/j.1600-065x.1972.tb00061.x. [DOI] [PubMed] [Google Scholar]
  746. Petit J. -F., Adam A., Wietzerbin-Falszpan J. Isolation of UDP-N-glycolylmuramyl-(Ala, Glu, DAP) from mycobacterium phlei. FEBS Lett. 1970 Jan 15;6(1):55–57. doi: 10.1016/0014-5793(70)80042-4. [DOI] [PubMed] [Google Scholar]
  747. Petit J. F., Adam A., Wietzerbin-Falszpan J., Lederer E., Ghuysen J. M. Chemical structure of the cell wall of Mycobacterium smegmatis. I. Isolation and partial characterization of the peptidoglycan. Biochem Biophys Res Commun. 1969 May 22;35(4):478–485. doi: 10.1016/0006-291x(69)90371-4. [DOI] [PubMed] [Google Scholar]
  748. Pettit J. H. Infection à "Mycobacterium ulcerans". Symptômes, diagnostic différentiel et traitement. Bull Soc Fr Dermatol Syphiligr. 1970;77(5):696–699. [PubMed] [Google Scholar]
  749. Pfuetze K. H., Hubble R. Nontuberculous mycobacterial diseases. Dis Mon. 1968 Sep;:1–39. doi: 10.1016/s0011-5029(68)80005-7. [DOI] [PubMed] [Google Scholar]
  750. Pieroni R. E., Stevens D. L., Stojanović A., Levine L. Investigation of the responsiveness of BCG-vaccinated children with whooping-cough to tuberculin. Int Arch Allergy Appl Immunol. 1972;42(4):583–589. doi: 10.1159/000230638. [DOI] [PubMed] [Google Scholar]
  751. Pigretti M., Vilkas E., Lederer E., Bloch H. Propriétés chimiques et biologiques de fractions phosphatidiques isolées de "l'antigène méthylique" de Mycobacterium tuberculosis. Bull Soc Chim Biol (Paris) 1965;47(11):2039–2046. [PubMed] [Google Scholar]
  752. Pokorný J., Wisingerová E., Sassmanová E., Sulová J. Isolation and purification of the mycobacterial phages. Am Rev Respir Dis. 1968 Aug;98(2):292–294. doi: 10.1164/arrd.1968.98.2.292. [DOI] [PubMed] [Google Scholar]
  753. Portelance V., Asselineau J. Nonphosphorus contaminants of mycobacterial phospholipid preparations. Am Rev Respir Dis. 1971 Jun;103(6):853–854. doi: 10.1164/arrd.1971.103.6.853. [DOI] [PubMed] [Google Scholar]
  754. Prebble J., Huda A. S. Sensitivity of the electron transport chain of pigmented and non-pigmented Sarcina membranes to photodynamic action. Photochem Photobiol. 1973 Apr;17(4):255–264. doi: 10.1111/j.1751-1097.1973.tb06354.x. [DOI] [PubMed] [Google Scholar]
  755. Procházka P., Nohýnek M., Rokos J. Esterases in mycobacteria. IV. The effect of macromolecular compounds isolated from a submerged culture of Mycobacterium phlei on the temporary activation of esterases. Folia Microbiol (Praha) 1972;17(3):205–212. doi: 10.1007/BF02875815. [DOI] [PubMed] [Google Scholar]
  756. Ptashne M. ISOLATION OF THE lambda PHAGE REPRESSOR. Proc Natl Acad Sci U S A. 1967 Feb;57(2):306–313. doi: 10.1073/pnas.57.2.306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  757. Pust R. E., Onubogu H. O., Egornu L. I., Smithwick R. Pulmonary disease due to Mycobacterium fortuitum in a Nigerian. Am Rev Respir Dis. 1973 Dec;108(6):1416–1420. doi: 10.1164/arrd.1973.108.6.1416. [DOI] [PubMed] [Google Scholar]
  758. Quagliata F., Phillips-Quagliata J. M. Competence of thoracic duct cells in the transfer of adjuvant disease and delayed hypersensitivity. Evidence that mycobacterial components are required for the successful transfer of the disease. Cell Immunol. 1972 Jan;3(1):78–87. doi: 10.1016/0008-8749(72)90228-6. [DOI] [PubMed] [Google Scholar]
  759. RICHMOND L., CUMMINGS M. M. An evaluation of methods of testing the virulence of acid-fast bacilli. Am Rev Tuberc. 1950 Dec;62(6):632–637. doi: 10.1164/art.1950.62.6.632. [DOI] [PubMed] [Google Scholar]
  760. RILLING H. C. A STUDY OF INHIBITION OF CAROTENOID SYNTHESIS. Arch Biochem Biophys. 1965 Apr;110:39–46. doi: 10.1016/0003-9861(65)90152-9. [DOI] [PubMed] [Google Scholar]
  761. RILLING H. C. ON THE MECHANISM OF PHOTOINDUCTION OF CAROTENOID SYNTHESIS. Biochim Biophys Acta. 1964 May 25;79:464–475. doi: 10.1016/0926-6577(64)90212-8. [DOI] [PubMed] [Google Scholar]
  762. RILLING H. C. Photoinduction of carotenoid synthesis of a Mycobacterium sp. Biochim Biophys Acta. 1962 Jul 16;60:548–556. doi: 10.1016/0006-3002(62)90873-9. [DOI] [PubMed] [Google Scholar]
  763. RODDA G. M. PHAGE PATTERNS OF THE FAST-GROWING ACID-FAST BACTERIA. Aust J Exp Biol Med Sci. 1964 Aug;42:457–464. doi: 10.1038/icb.1964.43. [DOI] [PubMed] [Google Scholar]
  764. ROSS A. J. Mycobacterium salmoniphilium sp. nov. from salmonoid fishes. Am Rev Respir Dis. 1960 Feb;81:241–250. doi: 10.1164/arrd.1960.81.2.241. [DOI] [PubMed] [Google Scholar]
  765. ROWLEY D., TURNER K. J., JENKIN C. R. THE BASIS FOR IMMUNITY TO MOUSE TYPHOID. 3. CELL-BOUND ANTIBODY. Aust J Exp Biol Med Sci. 1964 Apr;42:237–248. doi: 10.1038/icb.1964.25. [DOI] [PubMed] [Google Scholar]
  766. RUNYON E. H. Anonymous mycobacteria in pulmonary disease. Med Clin North Am. 1959 Jan;43(1):273–290. doi: 10.1016/s0025-7125(16)34193-1. [DOI] [PubMed] [Google Scholar]
  767. RUSSELL R. L., JANN G. J., FROMAN S. LYSOGENY IN THE MYCOBACTERIA. II. SOME PHAGE-HOST RELATIONSHIPS OF LYSOGENIC MYCOBACTERIA. Am Rev Respir Dis. 1963 Oct;88:528–538. doi: 10.1164/arrd.1963.88.4.528. [DOI] [PubMed] [Google Scholar]
  768. RUSSELL R. L., JANN G. J., FROMAN S. Lysogeny in the mycobacteria. 1. The establishment of lysogeny. Am Rev Respir Dis. 1960 Sep;82:384–393. doi: 10.1164/arrd.1960.82.3.384. [DOI] [PubMed] [Google Scholar]
  769. Radochová M., Konícek J., Málek I. The mutagenic effect of ultraviolet radiation and nitrous acid on Mycobacterium phlei. Folia Microbiol (Praha) 1966;11(3):163–168. doi: 10.1007/BF02901427. [DOI] [PubMed] [Google Scholar]
  770. Raj C. V., Ramakrishnan T. Transduction in Mycobacterium smegmatis. Nature. 1970 Oct 17;228(5268):280–281. doi: 10.1038/228280b0. [DOI] [PubMed] [Google Scholar]
  771. Raleigh J. W., Wichelhausen R. Exogenous reinfection with Mycobacterium tuberculosis confirmed by phage typing. Am Rev Respir Dis. 1973 Sep;108(3):639–642. doi: 10.1164/arrd.1973.108.3.639. [DOI] [PubMed] [Google Scholar]
  772. Ramakrishnan T., Murthy P. S., Gopinathan K. P. Intermediary metabolism of mycobacteria. Bacteriol Rev. 1972 Mar;36(1):65–108. doi: 10.1128/br.36.1.65-108.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  773. Ratledge C., Marshall B. J. Iron transport in Mycobacterium smegmatis: the role of mycobactin. Biochim Biophys Acta. 1972 Aug 18;279(1):58–74. doi: 10.1016/0304-4165(72)90241-3. [DOI] [PubMed] [Google Scholar]
  774. Razin S., Shafer Z. Incorporation of cholesterol by membranes of bacterial L-phase variants with an appendix on the determination of the L-phase parentage by the electrophoretic patterns of cell proteins. J Gen Microbiol. 1969 Nov;58(3):327–339. doi: 10.1099/00221287-58-3-327. [DOI] [PubMed] [Google Scholar]
  775. Reggiardo Z., Middlebrook G. Failure of passive serum transfer of immunity against aerogenic tuberculosis in rabbits. Proc Soc Exp Biol Med. 1974 Jan;145(1):173–175. doi: 10.3181/00379727-145-37771. [DOI] [PubMed] [Google Scholar]
  776. Reid I. S. Mycobacterium ulcerans infection: a report of 13 cases at the Port Moresby General Hospital, Papua. Med J Aust. 1967 Mar 4;1(9):427–431. doi: 10.5694/j.1326-5377.1967.tb21363.x. [DOI] [PubMed] [Google Scholar]
  777. Reid J. D. The pathogenesis of the immunologic granuloma. N Z Med J. 1970 Jun;71(457):375–378. [PubMed] [Google Scholar]
  778. Reznikov M., Dawson D. J. Serological examination of some strains that are in the Mycobacterium avium-intracellulare-scrofulaceum complex but do not belong to Schaefer's serotypes. Appl Microbiol. 1973 Oct;26(4):470–473. doi: 10.1128/am.26.4.470-473.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  779. Reznikov M., Leggo J. H., Dawson D. J. Investigation by seroagglutination of strains of the Mycobacterium intracellulare-M. scrofulaceum group from house dusts and sputum in Southeastern Queensland. Am Rev Respir Dis. 1971 Dec;104(6):951–953. doi: 10.1164/arrd.1971.104.6.951. [DOI] [PubMed] [Google Scholar]
  780. Reznikov M., Leggo J. H. Modification of Schaefer's procedure for serotyping of organisms of the Mycobacterium avium-M. intracellulare-M. scrofulaceum complex. Appl Microbiol. 1972 Apr;23(4):819–823. doi: 10.1128/am.23.4.819-823.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  781. Ribi E., Anacker R. L., Barclay W. R., Brehmer W., Harris S. C., Leif W. R., Simmons J. Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the Rheusus monkey. J Infect Dis. 1971 May;123(5):527–538. doi: 10.1093/infdis/123.5.527. [DOI] [PubMed] [Google Scholar]
  782. Richards O. W. THE STAINING OF ACID-FAST TUBERCLE BACTERIA. Science. 1941 Feb 21;93(2408):190–190. doi: 10.1126/science.93.2408.190. [DOI] [PubMed] [Google Scholar]
  783. Richerson H. B. Cutaneous basophil (Jones-Mote) hypersensitivity after "tolerogenic" doses of intravenous ovalbumin in the guinea pig. J Exp Med. 1971 Sep 1;134(3 Pt 1):630–641. doi: 10.1084/jem.134.3.630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  784. Richerson H. B., Dvorak H. F., Leskowitz S. Cutaneous basophilic hypersensitivity: a new interpretation of the Jones-Mote reaction. J Immunol. 1969 Dec;103(6):1431–1434. [PubMed] [Google Scholar]
  785. Richter P. E., Tomasovic A. A., Paxon T. G. Pulmonary disease related to Mycobacterium xenopei. Med J Aust. 1969 Jun 14;1(24):1246–1247. doi: 10.5694/j.1326-5377.1969.tb62301.x. [DOI] [PubMed] [Google Scholar]
  786. Ridell M., Norlin M. Serological study of nocardia by using mycobacterial precipitation reference systems. J Bacteriol. 1973 Jan;113(1):1–7. doi: 10.1128/jb.113.1.1-7.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  787. Roberts D. B., Wright G. L., Jr, Affronti L. F., Reich M. Characterization and comparison of mycobacterial antigens by two-dimensional immunoelectrophoresis. Infect Immun. 1972 Oct;6(4):564–573. doi: 10.1128/iai.6.4.564-573.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  788. Rocklin R. E., Kitzmiller J. L., Carpenter C. B., Garovoy M. R., David J. R. Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med. 1976 Nov 25;295(22):1209–1213. doi: 10.1056/NEJM197611252952201. [DOI] [PubMed] [Google Scholar]
  789. Rocklin R. E., MacDermott R. P., Chess L., Schlossman S. F., David J. R. Studies on mediator production by highly purified human T and B lymphocytes. J Exp Med. 1974 Nov 1;140(5):1303–1316. doi: 10.1084/jem.140.5.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  790. Rocklin R. E. Production of migration inhibitory factor by non-dividing lymphocytes. J Immunol. 1973 Mar;110(3):674–678. [PubMed] [Google Scholar]
  791. Roos P., Gaudier B., Ballester L. Sphéroplastes de B.C.G. induits par un bactériophage spécifique. Ann Inst Pasteur Lille. 1969;20:75–83. [PubMed] [Google Scholar]
  792. Ross G. W., Singleton L., Chanter K. V. Isolation of a peptidoglycolipid from M. johnei and its possible use in intradermal tests. J Comp Pathol. 1967 Jul;77(3):255–262. doi: 10.1016/0021-9975(67)90034-5. [DOI] [PubMed] [Google Scholar]
  793. Runyon E. H. Identification of mycobacterial pathogens utilizing colony characteristics. Am J Clin Pathol. 1970 Oct;54(4):578–586. doi: 10.1093/ajcp/54.4.578. [DOI] [PubMed] [Google Scholar]
  794. Runyon E. H. Micobacterium intracellulare. Am Rev Respir Dis. 1967 May;95(5):861–865. doi: 10.1164/arrd.1967.95.5.861. [DOI] [PubMed] [Google Scholar]
  795. Runyon E. H. Mycobacteria and mycobacterioses. Kekkaku. 1972 Oct;47(10):331–337. [PubMed] [Google Scholar]
  796. Runyon E. H. Pathogenic mycobacteria. Bibl Tuberc. 1965;21:235–287. [PubMed] [Google Scholar]
  797. Runyon E. H. Ten mycobacterial pathogens. Tubercle. 1974 Sep;55(3):235–240. doi: 10.1016/0041-3879(74)90051-8. [DOI] [PubMed] [Google Scholar]
  798. SAITO K., NAKANO M., AKIYAMA T., USHIBA D. Passive transfer of immunity to typhoid by macrophages. J Bacteriol. 1962 Sep;84:500–507. doi: 10.1128/jb.84.3.500-507.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  799. SCHAEFER W. B., MARSHAK A., BURKHART B. The growth of Mycobacterium tuberculosis as a function of its nutrients. J Bacteriol. 1949 Nov;58(5):549–563. doi: 10.1128/jb.58.5.549-563.1949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  800. SCHWABACHER H. A strain of Mycobacterium isolated from skin lesions of a cold-blooded animal, Xenopus laevis, and its relation to atypical acid-fast bacilli occurring in man. J Hyg (Lond) 1959 Mar;57(1):57–67. doi: 10.1017/s0022172400019896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  801. SEGAL W., BLOCH H. Pathogenic and immunogenic differentiation of Mycobacterium tuberculosis grown in vitro and in vivo. Am Rev Tuberc. 1957 Mar;75(3):495–500. doi: 10.1164/artpd.1957.75.3.495. [DOI] [PubMed] [Google Scholar]
  802. SEGAL W. COMPARATIVE STUDY OF IN VIVO AND IN VITRO GROWN MYCOBACTERIUM TUBERCULOSIS. IV. IMMUNOGENIC DIFFERENTIATION. Proc Soc Exp Biol Med. 1965 Jan;118:214–218. doi: 10.3181/00379727-118-29801. [DOI] [PubMed] [Google Scholar]
  803. SEGAL W. COMPARATIVE STUDY OF MYCOBACTERIUM GROWN IN VIVO AND IN VITRO. V. DIFFERENCES IN STAINING PROPERTIES. Am Rev Respir Dis. 1965 Feb;91:285–287. doi: 10.1164/arrd.1965.91.2.285. [DOI] [PubMed] [Google Scholar]
  804. SEGAL W., MILLER W. T. COMPARATIVE STUDY OF IN VIVO AND IN VITRO GROWN MYCOBACTERIUM TUBERCULOSIS. 3. LIPID COMPOSITION. Proc Soc Exp Biol Med. 1965 Mar;118:613–616. doi: 10.3181/00379727-118-29919. [DOI] [PubMed] [Google Scholar]
  805. SELLERS M. I., TOKUYASU K., PRICE Z., FROMAN S. Electron microscopic studies of mycobacteriophages. Am Rev Tuberc. 1957 Dec;76(6):964–969. doi: 10.1164/artpd.1957.76.6.964. [DOI] [PubMed] [Google Scholar]
  806. SEVER J. L. Passive transfer of resistance to tuberculosis through use of monocytes. Proc Soc Exp Biol Med. 1960 Feb;103:326–329. doi: 10.3181/00379727-103-25506. [DOI] [PubMed] [Google Scholar]
  807. SHOCKET E., DROSD R. E., TATE C. F., Jr GRANULOMA OF THE SKIN DUE TO MYCOBACTERIUM FORTUITUM. South Med J. 1964 Nov;57:1352–1356. doi: 10.1097/00007611-196411000-00019. [DOI] [PubMed] [Google Scholar]
  808. SISTROM W. R., GRIFFITHS M., STANIER R. Y. The biology of photosynthetic bacterium which lacks colored carotenoids. J Cell Physiol. 1956 Dec;48(3):473–515. doi: 10.1002/jcp.1030480309. [DOI] [PubMed] [Google Scholar]
  809. SMITH D. W., RANDALL H. M., GASTAMBIDE-ODIER M. M., KOEVOET A. L. The characterization of mycobacterial strains by the composition of their lipide extracts. Ann N Y Acad Sci. 1957 Sep 7;69(1):145–157. doi: 10.1111/j.1749-6632.1957.tb49655.x. [DOI] [PubMed] [Google Scholar]
  810. SMITH D. W., RANDALL H. M., MACLENNAN A. P., LEDERER E. Mycosides: a new class of type-specific glycolipids of Mycobacteria. Nature. 1960 Jun 11;186:887–888. doi: 10.1038/186887a0. [DOI] [PubMed] [Google Scholar]
  811. SMITH D. W., RANDALL H. M., MACLENNAN A. P., PUTNEY R. K., RAO S. V. Detection of specific lipids in mycobacteria by infrared spectroscopy. J Bacteriol. 1960 Feb;79:217–229. doi: 10.1128/jb.79.2.217-229.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  812. SOHLER A., ROMANO A. H., NICKERSON W. J. Biochemistry of the Actinomycetales. III. Cell wall composition and the action of lysozyme upon cells and cell walls of the Actinomycetales. J Bacteriol. 1958 Mar;75(3):283–290. doi: 10.1128/jb.75.3.283-290.1958. [DOI] [PMC free article] [PubMed] [Google Scholar]
  813. SOMMER A. F., WILLIAMS R. M., MANDEL A. D. Mycobacterium balnei infection. Report of two cases. Arch Dermatol. 1962 Sep;86:316–323. doi: 10.1001/archderm.1962.01590090058014. [DOI] [PubMed] [Google Scholar]
  814. STEWART-TULL D. E., WHITE R. G. THE OCCURRENCE OF MURAMIC ACID IN WAX D PREPARATIONS OF MYCOBACTERIA. J Gen Microbiol. 1964 Jan;34:43–49. doi: 10.1099/00221287-34-1-43. [DOI] [PubMed] [Google Scholar]
  815. SULA L. The use of an antituberculous vaccine from the Mycobacterium tuberculosis, typus murinus-Wells, adapted for deep culture in a synthetic liquid medium; first communication: preparation of the murinus-vaccine. Acta Tuberc Scand. 1955;31(2):190–196. [PubMed] [Google Scholar]
  816. SUTTON W. B. Mechanism of action and crystallization of lactic oxidative decarboxylase from Mycobacterium phlei. J Biol Chem. 1957 May;226(1):395–405. [PubMed] [Google Scholar]
  817. SWIFT S., COHEN H. Granulomas of the skin due to Mycobacterium balnei after abrasions from a fish tank. N Engl J Med. 1962 Dec 13;267:1244–1246. doi: 10.1056/NEJM196212132672408. [DOI] [PubMed] [Google Scholar]
  818. Sage R. E., Derrington A. W. Opportunistic cutaneous Mycobacterium marinum infection mimicking Mycobacterium ulcerans in lymphosarcoma. Med J Aust. 1973 Sep 1;2(9):434–437. doi: 10.5694/j.1326-5377.1973.tb115208.x. [DOI] [PubMed] [Google Scholar]
  819. Saier M. H., Jr, Ballou C. E. The 6-O-methylglucose-containig lipopolysaccharide of Mycobacterium phlei. Complet structure of the polysaccharide. J Biol Chem. 1968 Aug 25;243(16):4332–4341. [PubMed] [Google Scholar]
  820. Saier M. H., Jr, Ballou C. E. The 6-O-methylglucose-containing lipopolysaccharide of Mycobacterium phlei. Identification of D-glyceric acid and 3-O-methyl-D-glucose in the polysaccharide. J Biol Chem. 1968 Mar 10;243(5):992–1005. [PubMed] [Google Scholar]
  821. Saier M. H., Jr, Ballou C. E. The 6-O-methylglucose-containing lipopolysaccharide of Mycobacterium phlei. Structure of the reducing end of the polysaccharide. J Biol Chem. 1968 Aug 25;243(16):4319–4331. [PubMed] [Google Scholar]
  822. Saito H., Tasaka H., Osasa S., Yamura T., Fukuhara T. Disseminated Mycobacterium intracellulare infection. Am Rev Respir Dis. 1974 May;109(5):572–576. doi: 10.1164/arrd.1974.109.5.572. [DOI] [PubMed] [Google Scholar]
  823. Saito R., Tanaka A., Sugiyama K., Azuma I., Yamamura Y. Adjuvant effect of cord factor, a mycobacterial lipid. Infect Immun. 1976 Mar;13(3):776–781. doi: 10.1128/iai.13.3.776-781.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  824. Saito R., Tanaka A., Sugiyama K. Cord factor not toxic in rats. Am Rev Respir Dis. 1975 Oct;112(4):578–580. doi: 10.1164/arrd.1975.112.4.578. [DOI] [PubMed] [Google Scholar]
  825. Salton M. R., Freer J. H. Composition of the membranes isolated from several Gram-positive bacteria. Biochim Biophys Acta. 1965 Oct 18;107(3):531–538. doi: 10.1016/0304-4165(65)90197-2. [DOI] [PubMed] [Google Scholar]
  826. Salvin S. B., Neta R. A possible relationship between delayed hypersensitivity and cell-mediated immunity. Am Rev Respir Dis. 1975 Apr;111(4):373–377. doi: 10.1164/arrd.1975.111.4.373. [DOI] [PubMed] [Google Scholar]
  827. Salvin S. B., Nishio J., Shonnard J. T. Two new inhibitory activities in blood of mice with delayed hypersensitivity, after challenge with specific antigen. Infect Immun. 1974 Apr;9(4):631–635. doi: 10.1128/iai.9.4.631-635.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  828. Salvin S. B., Youngner J. S., Lederer W. H. Migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. Infect Immun. 1973 Jan;7(1):68–75. doi: 10.1128/iai.7.1.68-75.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  829. Sato S., Imi M. The surface structure of M. leprae. Int J Lepr Other Mycobact Dis. 1968 Jul-Sep;36(3):303–308. [PubMed] [Google Scholar]
  830. Schaefer W. B., Beer J. V., Wood N. A., Boughton E., Jenkins P. A., Marks J. A bacteriological study of endemic tuberculosis in birds. J Hyg (Lond) 1973 Sep;71(3):549–557. doi: 10.1017/s0022172400046532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  831. Schaefer W. B., Birn K. J., Jenkins P. A., Marks J. Infection with the avian-Battey group of mycobacteria in England and Wales. Br Med J. 1969 May 17;2(5654):412–415. doi: 10.1136/bmj.2.5654.412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  832. Schaefer W. B., Davis C. L., Cohn M. L. Pathogenicity of transparent, opaque, and rough variants of Mycobacterium avium in chickens and mice. Am Rev Respir Dis. 1970 Oct;102(4):499–506. doi: 10.1164/arrd.1970.102.4.499. [DOI] [PubMed] [Google Scholar]
  833. Schaefer W. B. Incidence of the serotypes of Mycobacerium avium and atypical mycobacteria in human and animal diseases. Am Rev Respir Dis. 1968 Jan;97(1):18–23. doi: 10.1164/arrd.1968.97.1.18. [DOI] [PubMed] [Google Scholar]
  834. Schaefer W. B., Lewis C. W., Jr Effect of oleic acid on growth and cell structure of mycobacteria. J Bacteriol. 1965 Nov;90(5):1438–1447. doi: 10.1128/jb.90.5.1438-1447.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  835. Schaefer W. B. Serologic identification and classification of the atypical mycobacteria by their agglutination. Am Rev Respir Dis. 1965 Dec;92(6):85–93. doi: 10.1164/arrd.1965.92.6P2.85. [DOI] [PubMed] [Google Scholar]
  836. Schaefer W. B. Serologic identification of the atypical mycobacteria and its value in epidemiologic studies. Am Rev Respir Dis. 1967 Jul;96(1):115–118. doi: 10.1164/arrd.1967.96.1.115. [DOI] [PubMed] [Google Scholar]
  837. Schaefer W. B. Type-specificity of atypical mycobacteria in agglutination and antibody absorption tests. Am Rev Respir Dis. 1967 Dec;96(6):1165–1168. doi: 10.1164/arrd.1967.96.6.1165. [DOI] [PubMed] [Google Scholar]
  838. Schaefer W. B., Wolinsky E., Jenkins P. A., Marks J. Mycobacterium szulgai-a new pathogen. Serologic identification and report of five new cases. Am Rev Respir Dis. 1973 Dec;108(6):1320–1326. doi: 10.1164/arrd.1973.108.6.1320. [DOI] [PubMed] [Google Scholar]
  839. Schinitsky M. R., Hyman L. R., Blazkovec A. A., Burkholder P. M. Bacillus Calmette-Guérin vaccination and skin tumor promotion with croton oil in mice. Cancer Res. 1973 Apr;33(4):659–663. [PubMed] [Google Scholar]
  840. Schleifer K. H., Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev. 1972 Dec;36(4):407–477. doi: 10.1128/br.36.4.407-477.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  841. Schmelev N. A. Polymorphism of mycobacteria and shifts of host immunity. Bull Int Union Tuberc. 1970 Jun;43:179–181. [PubMed] [Google Scholar]
  842. Schonell M. E., Crofton J. W., Stuart A. E., Wallace A. Disseminated infection with Mycobacterium avium: I. Clinical features, treatment and pathology. Tubercle. 1968 Mar;49(1):12–30. doi: 10.1016/s0041-3879(68)80003-0. [DOI] [PubMed] [Google Scholar]
  843. Schröder K. H., Magnusson M. Mycobacterium kanasii und seine Varianten. Zentralbl Bakteriol Orig. 1968;207(4):498–509. [PubMed] [Google Scholar]
  844. Schultz J. C., Elbein A. D. Biosynthesis of glycosyldiglycerides in Mycobacterium smegmatis. J Bacteriol. 1974 Jan;117(1):107–115. doi: 10.1128/jb.117.1.107-115.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  845. Schultz J., Elbein A. D. Biosynthesis of mannosyl--and glucosyl-phosphoryl polyprenols in Mycobacterium smegmatis. Evidence for oligosaccharide-phosphoryl-polyprenols. Arch Biochem Biophys. 1974 Jan;160(1):311–322. doi: 10.1016/s0003-9861(74)80039-1. [DOI] [PubMed] [Google Scholar]
  846. Schwab J. H. Suppression of the immune response by microorganisms. Bacteriol Rev. 1975 Jun;39(2):121–143. doi: 10.1128/br.39.2.121-143.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  847. Shaw N. Bacterial glycolipids. Bacteriol Rev. 1970 Dec;34(4):365–377. doi: 10.1128/br.34.4.365-377.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  848. Shevach E., Herberman R., Lieberman R., Frank M. M., Green I. Receptors for immunoglobulin and complement on mouse leukemias and lymphomas. J Immunol. 1972 Feb;108(2):325–328. [PubMed] [Google Scholar]
  849. Shima K., Dannenberg A. M., Jr, Ando M., Chandrasekhar S., Seluzicki J. A., Fabrikant J. I. Macrophage accumulation, division, maturation, and digestive and microbicidal capacities in tuberculous lesions. I. Studies involving their incorporation of tritiated thymidine and their content of lysosomal enzymes and bacilli. Am J Pathol. 1972 Apr;67(1):159–180. [PMC free article] [PubMed] [Google Scholar]
  850. Shulman S. Thyroid antigens and autoimmunity. Adv Immunol. 1971;14:85–185. doi: 10.1016/s0065-2776(08)60284-9. [DOI] [PubMed] [Google Scholar]
  851. Silver J., Benacerraf B. Dissociation of T cell helper function and delayed hypersensitivity. J Immunol. 1974 Dec;113(6):1872–1875. [PubMed] [Google Scholar]
  852. Simmons R. L., Rios A., Kersey J. H. Regression of spontaneous mammary carcinomas using direct injections of neuraminidase and BCG. J Surg Res. 1972 Feb;12(2):57–61. doi: 10.1016/0022-4804(72)90121-7. [DOI] [PubMed] [Google Scholar]
  853. Simon C. Infections par mycobactéries atypiques. Pediatrie. 1966 Jan-Feb;21(1):33–45. [PubMed] [Google Scholar]
  854. Singleton L., Ross G. W., Chanter K. V. A comparative intradermal test with peptidoglycolipids (PMKO) from Mycobacterium avium and Mycobacterium johnei. J Comp Pathol. 1970 Jan;80(1):31–35. doi: 10.1016/0021-9975(70)90028-9. [DOI] [PubMed] [Google Scholar]
  855. Sjöberg O., Hedfors E. Antibody-induced lymphocyte-mediated cytotoxicity in sarcoidosis patients and healthy controls. Cell Immunol. 1974 Mar 30;11(1-3):401–408. doi: 10.1016/0008-8749(74)90038-0. [DOI] [PubMed] [Google Scholar]
  856. Slosárek M. DNA base composition and Adansonian analysis of mycobacteria. Folia Microbiol (Praha) 1970;15(6):431–436. doi: 10.1007/BF02880186. [DOI] [PubMed] [Google Scholar]
  857. Slotnick I. J., Sacks H. J. Osteomyelitis caused by Mycobacterium fortuitum: report of a case. Am J Clin Pathol. 1973 Apr;59(4):574–575. doi: 10.1093/ajcp/59.4.574. [DOI] [PubMed] [Google Scholar]
  858. Smith D. T. Diagnostic and prognostic significance of the quantitative tuberculin tests. The influence of subclinical infections with atypical mycobacteria. Ann Intern Med. 1967 Nov;67(5):919–946. doi: 10.7326/0003-4819-67-5-919. [DOI] [PubMed] [Google Scholar]
  859. Smith J. H. Epidemiologic observations on cases of Buruli ulcer seen in a hospital in the Lower Congo. Am J Trop Med Hyg. 1970 Jul;19(4):657–663. doi: 10.4269/ajtmh.1970.19.657. [DOI] [PubMed] [Google Scholar]
  860. Smith W. L., Ballou C. E. The 6-O-methylglucose-containing lipopolysaccharides of Mycobacterium phlei. Locations of the neutral and acidic acyl groups. J Biol Chem. 1973 Oct 25;248(20):7118–7125. [PubMed] [Google Scholar]
  861. Snow G. A., White A. J. Chemical and biological properties of mycobactins isolated from various mycobacteria. Biochem J. 1969 Dec;115(5):1031–1050. doi: 10.1042/bj1151031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  862. Snyder M. L., Bullock W., Parker R. B. Studies on the oral filamentous bacteria. I. Cell wall composition of Actinomyces, Nocardia, Bacterionema and Leptotrichia. J Infect Dis. 1967 Oct;117(4):332–340. doi: 10.1093/infdis/117.4.332. [DOI] [PubMed] [Google Scholar]
  863. Sowell J. M., Russell R. M., Ionata V. J. Tuberculin tine test conversion among United States Army enlisted personnel in Vietnam. Mil Med. 1973 Feb;138(2):96–98. [PubMed] [Google Scholar]
  864. Spector W. G. The granulomatous inflammatory exudate. Int Rev Exp Pathol. 1969;8:1–55. [PubMed] [Google Scholar]
  865. Spitznagel J. K., Allison A. C. Mode of action of adjuvants: effects on antibody responses to macrophage-associated bovine serum albumin. J Immunol. 1970 Jan;104(1):128–139. [PubMed] [Google Scholar]
  866. Stadecker M. J., Leskowitz S. The cutaneous basophil response to mitogens. J Immunol. 1974 Aug;113(2):496–500. [PubMed] [Google Scholar]
  867. Stanford J. L. An immunodiffusion analysis of Mycobacterium lepraemurium Marchoux and Sorel. J Med Microbiol. 1973 Nov;6(4):435–439. doi: 10.1099/00222615-6-4-435. [DOI] [PubMed] [Google Scholar]
  868. Stanford J. L. An immunodiffusion analysis of strains of Mycobacterium ulcerans isolated in Australia, Malaya, Mexico, Uganda and Zaire. J Med Microbiol. 1973 Aug;6(3):405–408. doi: 10.1099/00222615-6-3-405. [DOI] [PubMed] [Google Scholar]
  869. Stanford J. L., Beck A. An antigenic analysis of the mycobacteria, Mycobacterium fortuitum, Myco. kansasii, Myco. phlei, Myco. smegmatis and Myco. tuberculosis. J Pathol Bacteriol. 1968 Jan;95(1):131–139. doi: 10.1002/path.1700950116. [DOI] [PubMed] [Google Scholar]
  870. Stanford J. L., Beck A. Bacteriological and serological studies of fast growing mycobacteria identified as Mycobacterium friedmannii. J Gen Microbiol. 1969 Sep;58(1):99–106. doi: 10.1099/00221287-58-1-99. [DOI] [PubMed] [Google Scholar]
  871. Stanford J. L., Gunthorpe W. J. A study of some fast-growing scotochromogenic mycobacteria including species descriptions of Mycobacterium gilvum (new species) and Mycobacterium duv alii (new species). Br J Exp Pathol. 1971 Dec;52(6):627–637. [PMC free article] [PubMed] [Google Scholar]
  872. Stanford J. L., Gunthorpe W. J. Serological and bacteriological investigation of Mycobacterium ranae (fortuitum). J Bacteriol. 1969 May;98(2):375–383. doi: 10.1128/jb.98.2.375-383.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  873. Stanford J. L., Pattyn S. R., Portaels F., Gunthorpe W. J. Studies on Mycobacterium chelonei. J Med Microbiol. 1972 May;5(2):177–182. doi: 10.1099/00222615-5-2-177. [DOI] [PubMed] [Google Scholar]
  874. Stanford J. L., Revill W. D., Gunthorpe W. J., Grange J. M. The production and preliminary investigation of Burulin, a new skin test reagent for Mycobacterium ulcerans infection. J Hyg (Lond) 1975 Feb;74(1):7–16. doi: 10.1017/s0022172400046659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  875. Steward A. M. Tuberculin reaction in cancer patients, "Mantoux release," and lymphosuppressive-stimulatory factors. J Natl Cancer Inst. 1973 Mar;50(3):625–632. doi: 10.1093/jnci/50.3.625. [DOI] [PubMed] [Google Scholar]
  876. Stewart-Tull D. E., Arbuthnott J. P., Freer J. H. Some properties of IgG1 and IgG2 globulins from normal and adjuvant stimulated guinea-pigs. Immunochemistry. 1975 Dec;12(12):941–947. doi: 10.1016/0019-2791(75)90257-8. [DOI] [PubMed] [Google Scholar]
  877. Stewart-Tull D. E., Shimono T., Kotani S., Kato M., Ogawa Y., Yamamura Y., Koga T., Pearson C. M. The adjuvant activity of a non-toxic, water-soluble glycopeptide present in large quantities in the culture filtrate of Mycobacterium tuberculosis strain DT. Immunology. 1975 Jul;29(1):1–15. [PMC free article] [PubMed] [Google Scholar]
  878. Stewart-Tull D. E., White R. G. The influence of age of culture on the production of adjuvant-active peptidoglycolipids by saprophytic mycobacteria. Immunology. 1967 Mar;12(3):349–359. [PMC free article] [PubMed] [Google Scholar]
  879. Stewart-Tull D. E., Wilkinson P. C. The affinity of mycobacterial glycopetides for guinea-pig gamma immunoglobulin and its fragments. Immunology. 1973 Aug;25(2):205–216. [PMC free article] [PubMed] [Google Scholar]
  880. Stewart-Tull D. E., Wilkinson P. C., White R. G. The affinity of a mycobacterial glycopeptide for guinea-pig gamma-globulin. Immunology. 1965 Aug;9(2):151–160. [PMC free article] [PubMed] [Google Scholar]
  881. Subrahmanyam D., Singhvi D. R. Phosphatide antigens of mycobacteria. Proc Soc Exp Biol Med. 1965 Oct;120(1):102–105. doi: 10.3181/00379727-120-30456. [DOI] [PubMed] [Google Scholar]
  882. Sugita K., Tsuda T., Sakakibara T., Ushiku R., Takahashi T. Studies on the bacteriophage susceptibility against Mycobacterium tuberculosis. 1. The difference in lysis range of mycobacteriophage propagated on various host strains. Yokohama Med Bull. 1965 Dec;16(6):229–235. [PubMed] [Google Scholar]
  883. Sula L., Galliová J., Mára M. A sudden decrease in the lipid content of Mycobacterium bovis BCG and Mycobacterium microti MP. A preliminary communication. Zentralbl Bakteriol Orig A. 1972 Feb;219(2):264–265. [PubMed] [Google Scholar]
  884. Sula L., Redmond W. B., Coster J. F., Baess I., Bates J. H., Caroli G., Mankiewicz E., Murohashi T., Vandra E. WHO cooperative studies on the phage-typing of mycobacteria. 1. Phage lysis of Czechoslovak and Italian strains of Mycobacterium tuberculosis. Bull World Health Organ. 1973;48(1):57–63. [PMC free article] [PubMed] [Google Scholar]
  885. Sullivan P. A. Crystallization and properties of L-lactate oxidase from Mycobacterium smegmatis. Biochem J. 1968 Nov;110(2):363–371. doi: 10.1042/bj1100363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  886. Sushida K., Hirano N. [Isolation of bacteriophage of tubercle bacilli (H37Rv) by addition of protamilase and buillon]. Igaku To Seibutsugaku. 1970 Nov 11;81(5):221–225. [PubMed] [Google Scholar]
  887. Sutherland I. Fifty years of BCG. Tubercle. 1972 Jun;53(2):150–151. doi: 10.1016/0041-3879(72)90036-0. [DOI] [PubMed] [Google Scholar]
  888. Sutherland I. Future policy for BCG vaccination in Britain. Postgrad Med J. 1971 Nov;47(553):756–758. doi: 10.1136/pgmj.47.553.756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  889. TAKEYA K., AMAKO K. THE STRUCTURE OF MYCOBACTERIOPHAGES. Virology. 1964 Nov;24:461–466. doi: 10.1016/0042-6822(64)90185-0. [DOI] [PubMed] [Google Scholar]
  890. TAKEYA K., HISATSUNE K., INOUE Y. Mycobacterial cell walls. II. Chemical composition of the "basal layer". J Bacteriol. 1963 Jan;85:24–30. doi: 10.1128/jb.85.1.24-30.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  891. TAKEYA K., HISATSUNE K. Mycobacterial cell walls. I. Methods of preparation and treatment with various chemicals. J Bacteriol. 1963 Jan;85:16–23. doi: 10.1128/jb.85.1.16-23.1963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  892. TAKEYA K., KOIKE M., MORI R., YUDA Y., TODA T. Light and electron microscope studies of Mycobacterium-mycobacteriophage interactions. II. Electron microscope studies. J Bacteriol. 1959 Sep;78:313–319. doi: 10.1128/jb.78.3.313-319.1959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  893. TAKEYA K., MORI R., KOIKE M., TODA T. Paired fibrous structure in mycobacteria. Biochim Biophys Acta. 1958 Oct;30(1):197–198. doi: 10.1016/0006-3002(58)90265-8. [DOI] [PubMed] [Google Scholar]
  894. TAKEYA K., MORI R., TOKUNAGA T., KOIKE M., HISATSUNE K. Further studies on the paired fibrous structure of mycobacterial cell wall. J Biophys Biochem Cytol. 1961 Feb;9:496–501. doi: 10.1083/jcb.9.2.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  895. TAKEYA K., YOSHIMURA T., YAMAURA K., TODA T. Studies on the biologic properties of mycobacteriophage. Am Rev Respir Dis. 1959 Oct;80:543–553. doi: 10.1164/arrd.1959.80.4P1.543. [DOI] [PubMed] [Google Scholar]
  896. TANAKA A. FRACTIONATION OF WAX D, A PEPTIDOGLYCOLIPID OF MYCOBACTERIUM TUBERCULOSIS. Biochim Biophys Acta. 1963 Aug 27;70:483–485. doi: 10.1016/0006-3002(63)90784-4. [DOI] [PubMed] [Google Scholar]
  897. TSUJI S., ITO K., OSHIMA S. The role of humoral factors in native and acquired resistance to tuberculosis. Am Rev Tuberc. 1957 Jul;76(1):90–102. doi: 10.1164/artpd.1957.76.1.90. [DOI] [PubMed] [Google Scholar]
  898. TSUKAMURA M. [A GROUP OF MYCOBACTERIA FROM SOIL SOURCES RESEMBLING NONPHOTOCHROMOGENS (GROUP 3). A DESCRIPTION OF MYCOBACTERIUM NONCHROMOGENICUM]. Igaku To Seibutsugaku. 1965 Aug 10;71:110–113. [PubMed] [Google Scholar]
  899. TSUKAMURA M. [A THERMORESISTANT, MYCOBACTERIAL STRAIN THOUGHT TO BE A NEW SPECIES]. Igaku To Seibutsugaku. 1965 Jul 10;71:52–54. [PubMed] [Google Scholar]
  900. TSUKAMURA S. BIOLOGICAL SIGNIFICANCE OF PIGMENTS OF MYCOBACTERIA. (III). RESISTANCE TO ULTRAVIOLET IRRADIATION OF VARIOUS UNCLASSIFIED MYCOBACTERIA. Jpn J Tuberc Chest Dis. 1964 Jul;12:7–9. [PubMed] [Google Scholar]
  901. TSUKAMURA S. BIOLOGICAL SIGNIFICANCE OF PIGMENTS OF MYCOBACTERIA. I. ARTIFICIAL INDUCTION OF PIGMENTLESS MUTANTS FROM PHOTOCHROMOGENS AND SCOTOCHROMOGENS BY ULTRAVIOLET IRRADIATION. II. CORRELATION OF PIGMENT FORMATION WITH THE VIRULENCE. Jpn J Tuberc Chest Dis. 1964 Jul;12:1–6. [PubMed] [Google Scholar]
  902. TURIAN G., HAXO F. Further use of diphenylamine for the study of carotenoid biosynthesis in mycobacterium phlei. J Bacteriol. 1952 May;63(5):690–691. doi: 10.1128/jb.63.5.690-691.1952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  903. TURNER L., STINSON I. MYCOBACTERIUM FORTUITUM; AS A CAUSE OF CORNEAL ULCER. Am J Ophthalmol. 1965 Aug;60:329–331. [PubMed] [Google Scholar]
  904. Takayama K., Goldman D. S. Enzymatic synthesis of mannosyl-1-phosphoryl-decaprenol by a cell-free system of Mycobacterium tuberculosis. J Biol Chem. 1970 Dec 10;245(23):6251–6257. [PubMed] [Google Scholar]
  905. Takayama K., Goldman D. S. Pathway for the synthesis of mannophospholipids in Mycobacterium tuberculosis. Biochim Biophys Acta. 1969 Jan 21;176(1):196–198. doi: 10.1016/0005-2760(69)90089-7. [DOI] [PubMed] [Google Scholar]
  906. Takayama K., Keith A. D., Snipes W. Effect of isoniazid on the protoplasmic viscosity in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1975 Jan;7(1):22–24. doi: 10.1128/aac.7.1.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  907. Takayama K., Schnoes H. K., Semmler E. J. Characterization of the alkali-stable mannophospholipids of Mycobacterium smegmatis. Biochim Biophys Acta. 1973 Aug 23;316(2):212–221. doi: 10.1016/0005-2760(73)90011-8. [DOI] [PubMed] [Google Scholar]
  908. Takayama K. Selective action of isoniazid on the synthesis of cell wall mycolates in mycobacteria. Ann N Y Acad Sci. 1974 May 10;235(0):426–438. doi: 10.1111/j.1749-6632.1974.tb43281.x. [DOI] [PubMed] [Google Scholar]
  909. Takayama K., Wang L., David H. L. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1972 Jul;2(1):29–35. doi: 10.1128/aac.2.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  910. Takayama K., Wang L., Merkal R. S. Scanning electron microscopy of the H37Ra strain of Mycobacterium tuberculosis exposed to isoniazid. Antimicrob Agents Chemother. 1973 Jul;4(1):62–65. doi: 10.1128/aac.4.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  911. Takayama Kuni, Armstrong Emma Lee. Mannolipid synthesis in a cell-free system of Mycobacterium smegmatis. FEBS Lett. 1971 Oct 15;18(1):67–69. doi: 10.1016/0014-5793(71)80408-8. [DOI] [PubMed] [Google Scholar]
  912. Takemori S., Nakai Y., Nakazawa K., Katagiri M., Nakamura T. A lactate oxygenase from Mycobacterium phlei. II. Spectral characteristics in aerobic and anaerobic reactions. Arch Biochem Biophys. 1973 Jan;154(1):137–146. doi: 10.1016/0003-9861(73)90042-8. [DOI] [PubMed] [Google Scholar]
  913. Takemori S., Nakazawa K., Nakai Y., Suzuki K., Katagiri M. A lactate oxygenase from Mycobacterium phlei. Improved purification and some properties of the enzyme. J Biol Chem. 1968 Jan 25;243(2):313–319. [PubMed] [Google Scholar]
  914. Takemori S., Tajima H., Kawahara F., Nakai Y., Katagiri M. A lactate oxygenase from Mycobacterium phlei. 3. Evidence for the subunit structure. Arch Biochem Biophys. 1974 Jan;160(1):289–303. doi: 10.1016/s0003-9861(74)80037-8. [DOI] [PubMed] [Google Scholar]
  915. Takemori S., Tajima H., Kawahara F., Nakai Y., Katagiri M. A lactate oxygenase from Mycobacterium phlei. 3. Evidence for the subunit structure. Arch Biochem Biophys. 1974 Jan;160(1):289–303. doi: 10.1016/s0003-9861(74)80037-8. [DOI] [PubMed] [Google Scholar]
  916. Takeya K., Tokiwa H. Bacteriocin-typing of Mycobacterium tuberculosis. Am Rev Respir Dis. 1974 Feb;109(2):304–305. doi: 10.1164/arrd.1974.109.2.304. [DOI] [PubMed] [Google Scholar]
  917. Taub R. N., Gershon R. K. The effect of localized injection of adjuvant material on the draining lymph node. 3. Thymus dependence. J Immunol. 1972 Feb;108(2):377–386. [PubMed] [Google Scholar]
  918. Taub R. N., Krantz A. R., Dresser D. W. The effect of localized injection of adjuvant material on the draining lymph node. I. Histology. Immunology. 1970 Feb;18(2):171–186. [PMC free article] [PubMed] [Google Scholar]
  919. Taussig M. J. Antigenic competition. Curr Top Microbiol Immunol. 1973;60:125–174. doi: 10.1007/978-3-642-65502-9_4. [DOI] [PubMed] [Google Scholar]
  920. Taussig M. J. The effect of Freund's complete adjuvant on the specificity of an immune response, and its relationship to antigenic competition. Cell Immunol. 1974 Mar 30;11(1-3):484–487. doi: 10.1016/0008-8749(74)90046-x. [DOI] [PubMed] [Google Scholar]
  921. Thacore H., Willett H. P. The formation of spheroplasts of Mycobacterium tuberculosis in tissue culture cells. Am Rev Respir Dis. 1966 May;93(5):786–796. doi: 10.1164/arrd.1966.93.5.786. [DOI] [PubMed] [Google Scholar]
  922. Thestrup-Pedersen K. Suppression of tuberculin skin reactivity by prior tuberculin skin testing. Immunology. 1975 Feb;28(2):343–348. [PMC free article] [PubMed] [Google Scholar]
  923. Thestrup-Pedersen K. Temporary suppression of lymphocyte transformation after tuberculin skin testing. Immunology. 1974 Dec;27(6):965–971. [PMC free article] [PubMed] [Google Scholar]
  924. Thoen C. O., Karlson A. G., Ellefson R. D. Mechanisms of changes in serum lipid-lipoprotein profiles in infectious disease: Mycobacterium bovis infection in rabbits. Mayo Clin Proc. 1972 Apr;47(4):270–272. [PubMed] [Google Scholar]
  925. Thoen C. O., Karlson A. G., Ellefson R. D. Serum lipid-lipoprotein profiles in rabbits infected with Mycobacterium bovis, Listeria monocytogenes, Pasteurella pseudotuberculosis and with M. avium. Mayo Clin Proc. 1972 Apr;47(4):258–269. [PubMed] [Google Scholar]
  926. Thompson J. S., Severson C. D., Stearns N. A., Kasik J. E. Immunological distinction of mycobacterial beta-lactamases. Infect Immun. 1972 Apr;5(4):542–546. doi: 10.1128/iai.5.4.542-546.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  927. Toida I. Effects of cord factor on microsomal enzymes. Am Rev Respir Dis. 1974 Nov;110(5):641–646. doi: 10.1164/arrd.1974.110.5.641. [DOI] [PubMed] [Google Scholar]
  928. Toida I. Effects of cord factor on pyrazinamide deamidase. Am Rev Respir Dis. 1973 Sep;108(3):694–697. doi: 10.1164/arrd.1973.108.3.694. [DOI] [PubMed] [Google Scholar]
  929. Tokunaga T., Maruyama Y., Murohashi T. Classification of subtypes of human tubercle bacilli by phage susceptibility. Am Rev Respir Dis. 1968 Mar;97(3):469–471. doi: 10.1164/arrd.1968.97.3.469. [DOI] [PubMed] [Google Scholar]
  930. Tokunaga T., Maruyama Y., Murohashi T. [Further studies on the phage typing of rapidly growing Mycobacteria]. Nihon Saikingaku Zasshi. 1965 Sep;20(9):554–559. doi: 10.3412/jsb.20.554. [DOI] [PubMed] [Google Scholar]
  931. Toussaint A. J., Fife E. H., Parlett R. C., Affronti L. F., Wright G. L., Reich M., Morse W. C. A soluble antigen fluorescent antibody test for the serodiagnosis of Mycobacterium tuberculosis infection. Am J Clin Pathol. 1969 Dec;52(6):708–713. doi: 10.1093/ajcp/52.6.708. [DOI] [PubMed] [Google Scholar]
  932. Tsang A. Y., Farber E. R. The primary isolation of mycobacterium ulcerans. Am J Clin Pathol. 1973 May;59(5):688–692. doi: 10.1093/ajcp/59.5.688. [DOI] [PubMed] [Google Scholar]
  933. Tsukamura M. Adansonian classification of mycobacteria. J Gen Microbiol. 1966 Nov;45(2):253–273. doi: 10.1099/00221287-45-2-253. [DOI] [PubMed] [Google Scholar]
  934. Tsukamura M. Identification of mycobacteria. Tubercle. 1967 Dec;48(4):311–338. doi: 10.1016/s0041-3879(67)80040-0. [DOI] [PubMed] [Google Scholar]
  935. Tsukamura M., Mizuno S., Gane N. F., Mills A., King L. Mycobacterium rhodesiae sp. nov. A new species of rapid-growing scotochromogenic mycobacteria. Jpn J Microbiol. 1971 Sep;15(5):407–416. doi: 10.1111/j.1348-0421.1971.tb00598.x. [DOI] [PubMed] [Google Scholar]
  936. Tsukamura M., Mizuno S. Mycobacterium obuense, a rapidly growing scotochromogenic mycobacterium capable of forming a black product from p-aminosalicylate and salicylate. J Gen Microbiol. 1971 Oct;68(2):129–134. doi: 10.1099/00221287-68-2-129. [DOI] [PubMed] [Google Scholar]
  937. Tsukamura M., Mizuno S., Tsukamura S. Classification of rapidly growing mycobacteria. Jpn J Microbiol. 1968 Jun;12(2):151–166. doi: 10.1111/j.1348-0421.1968.tb00379.x. [DOI] [PubMed] [Google Scholar]
  938. Tsukamura M. Mycobacterium chitae: a new species. Jpn J Microbiol. 1967 Mar;11(1):43–47. doi: 10.1111/j.1348-0421.1967.tb00319.x. [DOI] [PubMed] [Google Scholar]
  939. Tsukamura M., Nakamura E., Kurita I., Nakamura T. Isolation of Mycobacterium chelonei subspecies chelonei (Mycobacterium borstelense) from pulmonary lesions of 9 patients. Am Rev Respir Dis. 1973 Sep;108(3):683–685. doi: 10.1164/arrd.1973.108.3.683. [DOI] [PubMed] [Google Scholar]
  940. Tsukamura M., Tsukamura S. A practical system for identification of Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium kansasii, and Mycobacterium fortuitum. Scand J Respir Dis. 1967;48(1):58–70. [PubMed] [Google Scholar]
  941. Tsukamura M., Tsukamura S. [Mycobacterium aurum; a new species]. Igaku To Seibutsugaku. 1966 May 10;72(5):270–273. [PubMed] [Google Scholar]
  942. Tsukamura M. Variability of the pigmentation of mycobacteria by the composition of medium. Pneumonologie. 1970;142(2):93–101. doi: 10.1007/BF02095202. [DOI] [PubMed] [Google Scholar]
  943. Tung K. K., Ballou C. E. Biosynthesis of a mycobacterial lipopolysaccharide. Properties of the polysaccharide: acyl coenzyme A acyltransferase reaction. J Biol Chem. 1973 Oct 25;248(20):7126–7133. [PubMed] [Google Scholar]
  944. Turcotte R., Boulanger R. P. Comparison between the attigenic components extracted from virulent and avirulent strains of mycobacteria. Can J Microbiol. 1971 Jan;17(1):95–100. doi: 10.1139/m71-016. [DOI] [PubMed] [Google Scholar]
  945. Turcotte R. The variations in the antigenic composition of Mycobacterium tuberculosis during the growth cycle as measured by the passive hemagglutination and precipitation reactions. Can J Microbiol. 1969 Jul;15(7):681–688. doi: 10.1139/m69-121. [DOI] [PubMed] [Google Scholar]
  946. Turk J. L., Bryceson A. D. Immunological phenomena in leprosy and related diseases. Adv Immunol. 1971;13:209–266. doi: 10.1016/s0065-2776(08)60185-6. [DOI] [PubMed] [Google Scholar]
  947. Turk J. L., Polak L., Parker D. Control mechanisms in delayed-type hypersensitivity. Br Med Bull. 1976 May;32(2):165–170. doi: 10.1093/oxfordjournals.bmb.a071350. [DOI] [PubMed] [Google Scholar]
  948. Turner L. Atypical mycobacterial infections in ophthalmology. Trans Am Ophthalmol Soc. 1970;68:667–729. [PMC free article] [PubMed] [Google Scholar]
  949. Tárnok I., Tárnok Z. Carotene and xanthophylls in mycobacteria. I. Technical procedures; thin-layer chromatographic patterns of mycobacterial pigments. Tubercle. 1970 Sep;51(3):305–312. doi: 10.1016/0041-3879(70)90024-3. [DOI] [PubMed] [Google Scholar]
  950. Tárnok I., Tárnok Z. Carotenes and xanthophylls in mycobacteria. II. Lycopene, alpha- and beta-carotene and xanthophyll in mycobacterial pigments. Tubercle. 1971 Jun;52(2):127–135. doi: 10.1016/0041-3879(71)90019-5. [DOI] [PubMed] [Google Scholar]
  951. Uhr J. W. Delayed hypersensitivity. Physiol Rev. 1966 Jul;46(3):359–419. doi: 10.1152/physrev.1966.46.3.359. [DOI] [PubMed] [Google Scholar]
  952. Unanue E. R., Cerottini J. C. The immunogenicity of antigen bound to the plasma membrane of macrophages. J Exp Med. 1970 Apr 1;131(4):711–725. doi: 10.1084/jem.131.4.711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  953. Unanue E. R. Thymus dependency of the immune response to hemocyanin: an evaluation of the role of macrophages in thymectomized mice. J Immunol. 1970 Dec;105(6):1339–1343. [PubMed] [Google Scholar]
  954. VOLINI F., COLTON R., LESTER W. DISSEMINATED INFECTION CAUSED BY BATTEY TYPE MYCOBACTERIA. Am J Clin Pathol. 1965 Jan;43:39–46. doi: 10.1093/ajcp/43.1.39. [DOI] [PubMed] [Google Scholar]
  955. Vacheron M. J., Guinand M., Michel G., Ghuysen J. M. Structural investigations on cell walls of Nocardia sp. The wall lipid and peptidoglycan moieties of Nocardia kirovani. Eur J Biochem. 1972 Aug 18;29(1):156–166. doi: 10.1111/j.1432-1033.1972.tb01970.x. [DOI] [PubMed] [Google Scholar]
  956. Valdivia J. A. Mycobacterium habana: clinical and epidemiological significance. Ann Soc Belg Med Trop. 1973;53(4):263–266. [PubMed] [Google Scholar]
  957. Vance D. E., Esders T. W., Bloch K. On the role of a palmityl thioesterase in fatty acid elongation. J Biol Chem. 1973 Apr 10;248(7):2310–2316. [PubMed] [Google Scholar]
  958. Vance D. E., Mitsuhashi O., Bloch K. Purification and properties of the fatty acid synthetase from Mycobacterium phlei. J Biol Chem. 1973 Apr 10;248(7):2303–2309. [PubMed] [Google Scholar]
  959. Vandepitte J., Desmyter J., Gatti F. Mycobacteria, skins, and needles. Lancet. 1969 Sep 27;2(7622):691–691. doi: 10.1016/s0140-6736(69)90396-1. [DOI] [PubMed] [Google Scholar]
  960. Vandra E., Fodor T. Phage typing of Mycobacterium tuberculosis strains isolated in Hungary. Acta Microbiol Acad Sci Hung. 1971;18(3):155–158. [PubMed] [Google Scholar]
  961. Vandra E. Untersuchungen über die Phagenadsorption bei lysogenen Mycobakterienstämmen. Pneumonologie. 1970;142(2):158–164. doi: 10.1007/BF02095211. [DOI] [PubMed] [Google Scholar]
  962. Vilkas E., Amar C., Markovits J., Vliegenthart J. F., Kamerling J. P. Occurrence of a galactofuranose disaccharide in immunoadjuvant fractions of Mycobacterium tuberculosis (Cell walls and wax D). Biochim Biophys Acta. 1973 Feb 28;297(2):423–435. doi: 10.1016/0304-4165(73)90089-5. [DOI] [PubMed] [Google Scholar]
  963. Vilkas E., Lederer E. N-methylation de peptides par a methode de Hakomori. Structure du mycoside Cbl. Tetrahedron Lett. 1968 May;(26):3089–3092. doi: 10.1016/s0040-4039(00)89603-3. [DOI] [PubMed] [Google Scholar]
  964. Virgilio L. A., Johnston W. W. Fatal pulmonary infection with Mycobacterium fortuitum, Report of a Case. N C Med J. 1973 Oct;34(10):796–798. [PubMed] [Google Scholar]
  965. Voiland A., Bruneteau M., Michel G. Etude du mycoside C 2 de Mycobacterium avium. Détermination de la structure. Eur J Biochem. 1971 Jul 29;21(2):285–291. doi: 10.1111/j.1432-1033.1971.tb01468.x. [DOI] [PubMed] [Google Scholar]
  966. Volpe J. J., Vagelos P. R. Saturated fatty acid biosynthesis and its regulation. Annu Rev Biochem. 1973;42:21–60. doi: 10.1146/annurev.bi.42.070173.000321. [DOI] [PubMed] [Google Scholar]
  967. WAKSMAN B. H., PEARSON C. M., SHARP J. T. Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. II. Evidence that the disease is a disseminated immunologic response to exogenous antigen. J Immunol. 1960 Oct;85:403–417. [PubMed] [Google Scholar]
  968. WALKER H. H., SHINN M. F., HIGAKI M., OGATA J. Some characteristics of "swimming pool" disease in Hawaii. Hawaii Med J. 1962 May-Jun;21:403–409. [PubMed] [Google Scholar]
  969. WEISSFEILER J., KARASSOVA V., HOLLAND J. ATYPICAL MYCOBACTERIA IN MONKEYS. Acta Microbiol Acad Sci Hung. 1964;11:403–407. [PubMed] [Google Scholar]
  970. WELLS A. Q., AGIUS E., SMITH N. Mycobacterium fortuitum. Am Rev Tuberc. 1955 Jul;72(1):53–63. doi: 10.1164/artpd.1955.72.1.53. [DOI] [PubMed] [Google Scholar]
  971. WELLS A. Q. The vole bacillus vaccine. Bibl Tuberc. 1957;13(12):61–78. [PubMed] [Google Scholar]
  972. WELLS A. Q., WYLIE J. A. Vaccination against tuberculosis with the vole bacillus. Br Med Bull. 1954;10(2):96–100. doi: 10.1093/oxfordjournals.bmb.a069413. [DOI] [PubMed] [Google Scholar]
  973. WHITE R. G., COONS A. H., CONNOLLY J. M. Studies on antibody production. IV. The role of a wax fraction of Mycobacterium tuberculosis in adjuvant emulsions on the production of antibody to egg albumin. J Exp Med. 1955 Jul 1;102(1):83–104. doi: 10.1084/jem.102.1.83. [DOI] [PMC free article] [PubMed] [Google Scholar]
  974. WHITE R. G., MARSHALL A. H. The role of various chemical fractions of M. tuberculosis and other Mycobacteria in the production of allergic encephalomyelitis. Immunology. 1958 Apr;1(2):111–122. [PMC free article] [PubMed] [Google Scholar]
  975. WILLETT H. P. The production of lysine from diaminopimelic acid by cell-free extracts of Mycobacterium tuberculosis. Am Rev Respir Dis. 1960 May;81:653–659. doi: 10.1164/arrd.1960.81.5.653. [DOI] [PubMed] [Google Scholar]
  976. WINTER F. E., RUNYON E. H. PREPATELLAR BURSITIS CAUSED BY MYCOBACTERIUM MARINUM (BALNEI); CASE REPORT, CLASSIFICATION, AND REVIEW OF THE LITERATURE. J Bone Joint Surg Am. 1965 Mar;47:375–379. [PubMed] [Google Scholar]
  977. WITTS L. J. Arthur Quinton Wells, 22nd June 1896-9th October 1956. J Pathol Bacteriol. 1958 Apr;75(2):495–501. doi: 10.1002/path.1700750237. [DOI] [PubMed] [Google Scholar]
  978. WOLINSKY E. The role of scotochromogenic mycobacteria in human disease. Ann N Y Acad Sci. 1963 Feb 28;106:67–71. doi: 10.1111/j.1749-6632.1963.tb16623.x. [DOI] [PubMed] [Google Scholar]
  979. WOOD L. E., BUHLER V. B., POLLAK A. Human infection with the yellow acid-fast bacillus; a report of fifteen additional cases. Am Rev Tuberc. 1956 Jun;73(6):917–929. doi: 10.1164/artpd.1956.73.6.917. [DOI] [PubMed] [Google Scholar]
  980. Wager O. Immunopathogenic mechanisms in rheumatoid diseases with special reference to IgM rheumatoid factor. Scand J Rheumatol Suppl. 1975;12:67–76. [PubMed] [Google Scholar]
  981. Wagstaff M., Broughton A., Jones F. R. The reaction kinetics of gastric intrinsic factor and IgG intrinsic factor blocking antibody: a soluble system. Immunochemistry. 1976 May;13(5):437–441. doi: 10.1016/0019-2791(76)90380-3. [DOI] [PubMed] [Google Scholar]
  982. Wahl S. M., Iverson G. M., Oppenheim J. J. Induction of guinea pig B-cell lymphokine synthesis by mitogenic and nonmitogenic signals to Fc, Ig, and C3 receptors. J Exp Med. 1974 Dec 1;140(6):1631–1645. doi: 10.1084/jem.140.6.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  983. Waksman B. H., Namba Y. On soluble mediators of immunologic regulation. Cell Immunol. 1976 Jan;21(1):161–176. doi: 10.1016/0008-8749(76)90337-3. [DOI] [PubMed] [Google Scholar]
  984. Walker R. W., Barakat H., Hung J. G. The positional distribution of fatty acids in the phospholipids and triglycerides of Mycobacterium smegmatis and M. bovis BCG. Lipids. 1970 Aug;5(8):684–691. doi: 10.1007/BF02531435. [DOI] [PubMed] [Google Scholar]
  985. Walker R. W., Prome J. C., Lacave C. S. Biosynthesis of mycolic acids. Formation of a C32 beta-keto ester from palmitic acid in a cell-free system of Corynebacterium diphtheriae. Biochim Biophys Acta. 1973 Oct 17;326(1):52–62. doi: 10.1016/0005-2760(73)90027-1. [DOI] [PubMed] [Google Scholar]
  986. Wallen W. C., Dean J. H., Lucas D. O. Interferon and the cellular immune response: separation of interferon-producing cells from DNA-synthetic cells. Cell Immunol. 1973 Jan;6(1):110–122. doi: 10.1016/0008-8749(73)90011-7. [DOI] [PubMed] [Google Scholar]
  987. Wang L., Kusaka T., Goldman D. S. Elongation of fatty acids in Mycobacterium tuberculosis. J Bacteriol. 1970 Mar;101(3):781–785. doi: 10.1128/jb.101.3.781-785.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  988. Wang L., Takayama K. Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1972 Dec;2(6):438–441. doi: 10.1128/aac.2.6.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  989. Ward D. E. Buruli ulcer. Br Med J. 1970 Aug 8;3(5718):346–346. doi: 10.1136/bmj.3.5718.346-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  990. Warner N. L. Membrane immunoglobulins and antigen receptors on B and T lymphocytes. Adv Immunol. 1974;19(0):67–216. doi: 10.1016/s0065-2776(08)60252-7. [DOI] [PubMed] [Google Scholar]
  991. Wassermann H. E. Avian tuberculosis endophthalmitis. Arch Ophthalmol. 1973 Apr;89(4):321–323. doi: 10.1001/archopht.1973.01000040323013. [DOI] [PubMed] [Google Scholar]
  992. Watanakunakorn C., Trott A. Vertebral osteomyelitis due to Mycobacterium kansasii. Am Rev Respir Dis. 1973 May;107(5):846–850. doi: 10.1164/arrd.1973.107.5.846. [DOI] [PubMed] [Google Scholar]
  993. Watkinson R. J., Hussey H., Baddiley J. Shared lipid phosphate carrier in the biosynthesis of teichoic acid and peptidoglycan. Nat New Biol. 1971 Jan 13;229(2):57–59. doi: 10.1038/newbio229057a0. [DOI] [PubMed] [Google Scholar]
  994. Wayne L. G. Classification and identification of mycobacteria. 3. Species within group 3. Am Rev Respir Dis. 1966 Jun;93(6):919–928. doi: 10.1164/arrd.1966.93.6.919. [DOI] [PubMed] [Google Scholar]
  995. Wayne L. G., Diaz G. A. Autolysis and secondary growth of Mycobacterium tuberculosis in submerged culture. J Bacteriol. 1967 Apr;93(4):1374–1381. doi: 10.1128/jb.93.4.1374-1381.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  996. Wayne L. G., Dietz T. M., Gernez-Rieux C., Jenkins P. A., Käppler W., Kubica G. P., Kwapinski J. B., Meissner G., Pattyn S. R., Runyon E. H. A co-operative numerical anaysis of scotochromogenic slowly growing mycobacteria. J Gen Microbiol. 1971 Jun;66(3):255–271. doi: 10.1099/00221287-66-3-255. [DOI] [PubMed] [Google Scholar]
  997. Wayne L. G., Doubek J. R., Diaz G. A. Classification and indentification of mycobacteria. IV. Some important scotochromogens. Am Rev Respir Dis. 1967 Jul;96(1):88–95. doi: 10.1164/arrd.1967.96.1.88. [DOI] [PubMed] [Google Scholar]
  998. Wayne L. G., Gross W. M. Base composition of deoxyribonucleic acid isolated from mycobacteria. J Bacteriol. 1968 Dec;96(6):1915–1919. doi: 10.1128/jb.96.6.1915-1919.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  999. Wayne L. G., Runyon E. H., Kubica G. P. Mycobacteria: a guide to nomenclatural usage. Am Rev Respir Dis. 1969 Nov;100(5):732–734. doi: 10.1164/arrd.1969.100.5.732. [DOI] [PubMed] [Google Scholar]
  1000. Wehrli W., Staehelin M. Actions of the rifamycins. Bacteriol Rev. 1971 Sep;35(3):290–309. doi: 10.1128/br.35.3.290-309.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  1001. Weiner I. M., Higuchi T., Rothfield L., Saltmarsh-Andrew M., Osborn M. J., Horecker B. L. Biosynthesis of bacterial lipopolysaccharide. V. Lipid-linked intermediates in the biosynthesis of the O-antigen groups of Salmonella typhimurium. Proc Natl Acad Sci U S A. 1965 Jul;54(1):228–235. doi: 10.1073/pnas.54.1.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  1002. Weir M. P., Langridge W. H., 3rd, Walker R. W. Relationships between oleic acid uptake and lipid metabolism in Mycobacterium smegmatis. Am Rev Respir Dis. 1972 Sep;106(3):450–457. doi: 10.1164/arrd.1972.106.3.450. [DOI] [PubMed] [Google Scholar]
  1003. Weiszfeiler G., Karasseva V., Karczag E. A new mycobacterium species: Mycobacterium asiaticum n. sp. Acta Microbiol Acad Sci Hung. 1971;18(4):247–252. [PubMed] [Google Scholar]
  1004. Weiszfeiler J., Jókay I., Karczag E., Almássy K., Somos P. Taxonomic studies on mycobacteria on the basis of their antigenic structure. Acta Microbiol Acad Sci Hung. 1968;15(1):69–76. [PubMed] [Google Scholar]
  1005. White H. B., 3rd, Mitsuhashi O., Bloch K. Pyridine nucleotide requirements of fatty acid synthetases. J Biol Chem. 1971 Aug 10;246(15):4751–4754. [PubMed] [Google Scholar]
  1006. Wiant J. R. Mycobacterial diseases. Ariz Med. 1971 Feb;28(2):96–100. [PubMed] [Google Scholar]
  1007. Wieland T. Poisonous principles of mushrooms of the genus Amanita. Four-carbon amines acting on the central nervous system and cell-destroying cyclic peptides are produced. Science. 1968 Mar 1;159(3818):946–952. doi: 10.1126/science.159.3818.946. [DOI] [PubMed] [Google Scholar]
  1008. Wietzerbin-Falszpan J., Das B. C., Azuma I., Adam A., Petit J. F., Lederer E. Isolation and mass spectrometric identification of the peptide subunits of mycobacterial cell walls. Biochem Biophys Res Commun. 1970 Jul 13;40(1):57–63. doi: 10.1016/0006-291x(70)91045-4. [DOI] [PubMed] [Google Scholar]
  1009. Wietzerbin-Falszpan J., Das B. C., Gros C., Petit J. F., Lederer E. The amino acids of the cell wall of Mycobacterium tuberculosis var. bovis, strain BCG. Presence of a poly(L-glutamic acid). Eur J Biochem. 1973 Feb 1;32(3):525–532. doi: 10.1111/j.1432-1033.1973.tb02637.x. [DOI] [PubMed] [Google Scholar]
  1010. Wietzerbin J., Das B. C., Petit J. F., Lederer E., Leyh-Bouille M., Ghuysen J. M. Occurrence of D-alanyl-(D)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria. Biochemistry. 1974 Aug 13;13(17):3471–3476. doi: 10.1021/bi00714a008. [DOI] [PubMed] [Google Scholar]
  1011. Wigle W. D., Ashley M. J., Killough E. M., Cosens M. Bovine tuberculosis in humans in Ontario. The epidemiologic features of 31 active cases occurring between 1964 and 1970. Am Rev Respir Dis. 1972 Oct;106(4):528–534. doi: 10.1164/arrd.1972.106.4.528. [DOI] [PubMed] [Google Scholar]
  1012. Wilkinson P. C. Adjuvant granuloma and its effect on the immune response in the gunea pig. Pathol Eur. 1966;1(1):204–216. [PubMed] [Google Scholar]
  1013. Willett H. P., Thacore H. Formation of spheroplasts of Mycobacterium tuberculosis by lysozyme in combination with certain enzymes of rabbit peritoneal monocytes. Can J Microbiol. 1967 May;13(5):481–488. doi: 10.1139/m67-063. [DOI] [PubMed] [Google Scholar]
  1014. Willett H. P., Thacore H. The induction by lysozyme of an L-type growth in Mycobacterium tuberculosis. Can J Microbiol. 1966 Feb;12(1):11–16. doi: 10.1139/m66-003. [DOI] [PubMed] [Google Scholar]
  1015. Williams C. S., Riordan D. C. Mycobacterium marinum (atypical acid-fast bacillus) infections of the hand. J Bone Joint Surg Am. 1973 Jul;55(5):1042–1050. [PubMed] [Google Scholar]
  1016. Williams R. M., Germain R. N., Benacerraf B. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells. J Natl Cancer Inst. 1975 Mar;54(3):697–708. [PubMed] [Google Scholar]
  1017. Winblad B., Duchek M. Comparison between microscopical methods and cultivation for demonstration of tubercle bacilli in experimental tuberculous infection. Acta Pathol Microbiol Scand A. 1973 Nov;81(6):824–830. doi: 10.1111/j.1699-0463.1973.tb03576.x. [DOI] [PubMed] [Google Scholar]
  1018. Winblad S., Ericson C. Sensitized sheep red cells as a reactant for Staphylococcus aureus protein A. Methodology and epidemiology with special reference to weakly reacting methicillin-resistant strains. Acta Pathol Microbiol Scand B Microbiol Immunol. 1973 Feb;81(1):150–156. [PubMed] [Google Scholar]
  1019. Winder F. G., Collins P. B. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. J Gen Microbiol. 1970 Sep;63(1):41–48. doi: 10.1099/00221287-63-1-41. [DOI] [PubMed] [Google Scholar]
  1020. Winder F. G., Tighe J. J., Brennan P. J. Turnover of acylglucose, acyltrehalose and free trehalose during growth of Mycobacterium smegmatis on glucose. J Gen Microbiol. 1972 Dec;73(3):539–546. doi: 10.1099/00221287-73-3-539. [DOI] [PubMed] [Google Scholar]
  1021. Winslow C. E., Broadhurst J., Buchanan R. E., Krumwiede C., Rogers L. A., Smith G. H. The Families and Genera of the Bacteria: Final Report of the Committee of the Society of American Bacteriologists on Characterization and Classification of Bacterial Types. J Bacteriol. 1920 May;5(3):191–229. doi: 10.1128/jb.5.3.191-229.1920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  1022. Wolfe S. A., Tracey D. E., Henney C. S. Introduction of "natural" killer' cells by BCG. Nature. 1976 Aug 12;262(5569):584–586. doi: 10.1038/262584a0. [DOI] [PubMed] [Google Scholar]
  1023. Wolinsky E., Gomez F., Zimpfer F. Sporotrichoid Mycobacterium marinum infection treated with rifampin-ethambutol. Am Rev Respir Dis. 1972 Jun;105(6):964–967. doi: 10.1164/arrd.1972.105.6.964. [DOI] [PubMed] [Google Scholar]
  1024. Wolinsky E., Kapur V. N., Rynearson T. K. Avian tubercle bacillus infection in a patient with silicosis. Am Rev Respir Dis. 1967 Dec;96(6):1229–1232. doi: 10.1164/arrd.1967.96.6.1229. [DOI] [PubMed] [Google Scholar]
  1025. Wolinsky E. Nontuberculous mycobacterial infections of man. Med Clin North Am. 1974 May;58(3):639–648. doi: 10.1016/s0025-7125(16)32149-6. [DOI] [PubMed] [Google Scholar]
  1026. Worcel A., Goldman D. S., Sachs I. B. Properties and fine structure of the ribosomes from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A. 1968 Sep;61(1):122–129. doi: 10.1073/pnas.61.1.122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  1027. Wright A., Dankert M., Fennessey P., Robbins P. W. Characterization of a polyisoprenoid compound functional in O-antigen biosynthesis. Proc Natl Acad Sci U S A. 1967 Jun;57(6):1798–1803. doi: 10.1073/pnas.57.6.1798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  1028. Wright A. Mechanism of conversion of the salmonella O antigen by bacteriophageepsilon 34. J Bacteriol. 1971 Mar;105(3):927–936. doi: 10.1128/jb.105.3.927-936.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  1029. Wright G. L., Jr, Affronti L. F., Reich M. Characterization and comparison of mycobacterial antigens by two-dimensional polyacrylamide gel electrophoresis. Infect Immun. 1972 Apr;5(4):482–490. doi: 10.1128/iai.5.4.482-490.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  1030. Wright G. L., Jr, Roberts D. B. Two-dimensional immunoelectrophoresis of mycobacterial antigens. Comparison with a reference system. Am Rev Respir Dis. 1974 Feb;109(2):306–310. doi: 10.1164/arrd.1974.109.2.306. [DOI] [PubMed] [Google Scholar]
  1031. Wunsh S. E., Byle G. L., Leopold I. H., Littman M. L. Mycobacterium fortuitum infection of corneal graft. Arch Ophthalmol. 1969 Nov;82(5):602–607. doi: 10.1001/archopht.1969.00990020600006. [DOI] [PubMed] [Google Scholar]
  1032. YAMAGUCHI T. COMPARISON OF THE CELL-WALL COMPOSITION OF MORPHOLOGICALLY DISTINCT ACTINOMYCETES. J Bacteriol. 1965 Feb;89:444–453. doi: 10.1128/jb.89.2.444-453.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  1033. YOUMANS A. S., YOUMANS G. P. IMMUNOGENIC ACTIVITY OF A RIBOSOMAL FRACTION OBTAINED FROM MYCOBACTERIUM TUBERCULOSIS. J Bacteriol. 1965 May;89:1291–1298. doi: 10.1128/jb.89.5.1291-1298.1965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  1034. YOUMANS G. P. THE PATHOGENIC "ATYPICAL" MYCOBACTERIA. Annu Rev Microbiol. 1963;17:473–494. doi: 10.1146/annurev.mi.17.100163.002353. [DOI] [PubMed] [Google Scholar]
  1035. Yamamura Y., Ogawa Y., Maeda H., Yamamura Y. Prevention of tuberculous cavity formation by desensitization with tuberculin-active peptide. Am Rev Respir Dis. 1974 Jun;109(6):594–601. doi: 10.1164/arrd.1974.109.6.594. [DOI] [PubMed] [Google Scholar]
  1036. Yarkoni E., Bekierkunst A., Asselineau J., Toubiana R., Toubiana M. J., Lederer E. Supression of growth of Ehrlich ascites tumor cells in mice pretreated with synthetic analogs of trehalose-6,6-dimycolate (cord factor). J Natl Cancer Inst. 1973 Aug;51(2):717–720. [PubMed] [Google Scholar]
  1037. Yeager H., Jr, Raleigh J. W. Pulmonary disease due to Mycobacterium intracellulare. Am Rev Respir Dis. 1973 Sep;108(3):547–552. doi: 10.1164/arrd.1973.108.3.547. [DOI] [PubMed] [Google Scholar]
  1038. Yegian D., Vanderlinde R. J. The Nature of Acid-Fastness. J Bacteriol. 1947 Dec;54(6):777–783. doi: 10.1128/jb.54.6.777-783.1947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  1039. Yoder W. D., Schaefer W. B. Comparison of the seroagglutination test with the pathogenicity test in the chicken for the identification of Mycobacterium avium and Mycobacterium intracellulare. Am Rev Respir Dis. 1971 Feb;103(2):173–178. doi: 10.1164/arrd.1971.103.2.173. [DOI] [PubMed] [Google Scholar]
  1040. Yoneda M., Fukui Y. Isolation, purification, and characterization of extracellular antigens of Mycobacterium tuberculosis. Am Rev Respir Dis. 1965 Dec;92(6):9–18. doi: 10.1164/arrd.1965.92.6P2.9. [DOI] [PubMed] [Google Scholar]
  1041. Youatt J. A review of the action of isoniazid. Am Rev Respir Dis. 1969 May;99(5):729–749. doi: 10.1164/arrd.1969.99.5.729. [DOI] [PubMed] [Google Scholar]
  1042. Youmans A. S., Youmans G. P. Effect of trypsin and ribonuclease on the immunogenic activity of ribosomes and ribonucleic acid isolated from Mycobacterium tuberculosis. J Bacteriol. 1966 Jun;91(6):2146–2154. doi: 10.1128/jb.91.6.2146-2154.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  1043. Youmans A. S., Youmans G. P. The relationship between sedimentation value and immunogenic acitivity of mycobacterial ribonucleic acid. J Immunol. 1973 Feb;110(2):581–586. [PubMed] [Google Scholar]
  1044. Youmans G. P. Relation between delayed hypersensitivity and immunity in tuberculosis. Am Rev Respir Dis. 1975 Feb;111(2):109–118. doi: 10.1164/arrd.1975.111.2.109. [DOI] [PubMed] [Google Scholar]
  1045. Youngner J. S., Salvin S. B. Production and properties of migration inhibitory factor and interferon in the circulation of mice with delayed hypersensitivity. J Immunol. 1973 Dec;111(6):1914–1922. [PubMed] [Google Scholar]
  1046. ZALOKAR M. Biosynthesis of carotenoids in Neurospora; action spectrum of photoactivation. Arch Biochem Biophys. 1955 Jun;56(2):318–325. doi: 10.1016/0003-9861(55)90252-6. [DOI] [PubMed] [Google Scholar]
  1047. ZALOKAR M. Variations in the production of carotenoids in Neurospora. Arch Biochem Biophys. 1957 Aug;70(2):561–567. doi: 10.1016/0003-9861(57)90143-1. [DOI] [PubMed] [Google Scholar]
  1048. Zbar B., Rapp H. J., Ribi E. E. Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets. J Natl Cancer Inst. 1972 Mar;48(3):831–835. [PubMed] [Google Scholar]
  1049. Zbar B., Tanaka T. Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis. Science. 1971 Apr 16;172(3980):271–273. doi: 10.1126/science.172.3980.271. [DOI] [PubMed] [Google Scholar]
  1050. Zeitz S. J., Ostrow J. H., Van Arsdel P. P., Jr Humoral and cellular immunity in the anergic tuberculosis patient. A prospective study. J Allergy Clin Immunol. 1974 Jan;53(1):20–26. doi: 10.1016/0091-6749(74)90095-5. [DOI] [PubMed] [Google Scholar]
  1051. Zeligman I. Mycobacterium marinum granuloma. A disease acquired in the tributaries of Chesapeake Bay. Arch Dermatol. 1972 Jul;106(1):26–31. doi: 10.1001/archderm.106.1.26. [DOI] [PubMed] [Google Scholar]
  1052. Zimmerman L. E., Turner L., McTigue J. W. Mycobacterium fortuitum infection of the cornea. A report of to cases. Arch Ophthalmol. 1969 Nov;82(5):596–601. doi: 10.1001/archopht.1969.00990020594005. [DOI] [PubMed] [Google Scholar]
  1053. van Furth R., Cohn Z. A. The origin and kinetics of mononuclear phagocytes. J Exp Med. 1968 Sep 1;128(3):415–435. doi: 10.1084/jem.128.3.415. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Bacteriological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES